false 2024 Q3 --12-31 0001744494 0001744494 2024-01-01 2024-09-30 0001744494 adn:CommonStockParValue0.0001PerShareMember 2024-01-01 2024-09-30 0001744494 adn:WarrantsMember 2024-01-01 2024-09-30 0001744494 2024-12-24 0001744494 2024-09-30 0001744494 2023-12-31 0001744494 2024-07-01 2024-09-30 0001744494 2023-07-01 2023-09-30 0001744494 2023-01-01 2023-09-30 0001744494 adn:PreferredStockSeriesAMember 2024-06-30 0001744494 adn:PreferredStockSeriesSeedMember 2024-06-30 0001744494 us-gaap:CommonStockMember 2024-06-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001744494 us-gaap:RetainedEarningsMember 2024-06-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001744494 2024-06-30 0001744494 adn:PreferredStockSeriesAMember 2023-06-30 0001744494 adn:PreferredStockSeriesSeedMember 2023-06-30 0001744494 us-gaap:CommonStockMember 2023-06-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001744494 us-gaap:RetainedEarningsMember 2023-06-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001744494 2023-06-30 0001744494 adn:PreferredStockSeriesAMember 2023-12-31 0001744494 adn:PreferredStockSeriesSeedMember 2023-12-31 0001744494 us-gaap:CommonStockMember 2023-12-31 0001744494 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001744494 us-gaap:RetainedEarningsMember 2023-12-31 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001744494 adn:PreferredStockSeriesAMember 2022-12-31 0001744494 adn:PreferredStockSeriesSeedMember 2022-12-31 0001744494 us-gaap:CommonStockMember 2022-12-31 0001744494 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001744494 us-gaap:RetainedEarningsMember 2022-12-31 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001744494 2022-12-31 0001744494 adn:PreferredStockSeriesAMember 2024-07-01 2024-09-30 0001744494 adn:PreferredStockSeriesSeedMember 2024-07-01 2024-09-30 0001744494 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001744494 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001744494 adn:PreferredStockSeriesAMember 2023-07-01 2023-09-30 0001744494 adn:PreferredStockSeriesSeedMember 2023-07-01 2023-09-30 0001744494 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001744494 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001744494 adn:PreferredStockSeriesAMember 2024-01-01 2024-09-30 0001744494 adn:PreferredStockSeriesSeedMember 2024-01-01 2024-09-30 0001744494 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001744494 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001744494 adn:PreferredStockSeriesAMember 2023-01-01 2023-09-30 0001744494 adn:PreferredStockSeriesSeedMember 2023-01-01 2023-09-30 0001744494 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001744494 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001744494 adn:PreferredStockSeriesAMember 2024-09-30 0001744494 adn:PreferredStockSeriesSeedMember 2024-09-30 0001744494 us-gaap:CommonStockMember 2024-09-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001744494 us-gaap:RetainedEarningsMember 2024-09-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001744494 adn:PreferredStockSeriesAMember 2023-09-30 0001744494 adn:PreferredStockSeriesSeedMember 2023-09-30 0001744494 us-gaap:CommonStockMember 2023-09-30 0001744494 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001744494 us-gaap:RetainedEarningsMember 2023-09-30 0001744494 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001744494 2023-09-30 0001744494 adn:AMCIAcquisitionCorpMember 2021-02-04 0001744494 us-gaap:CashEquivalentsMember 2024-09-30 0001744494 us-gaap:CashEquivalentsMember 2024-09-25 0001744494 adn:AdventTechnologiesIncMember 2024-01-01 2024-09-30 0001744494 adn:AdventTechnologiesIncMember adn:DirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesIncMember adn:IndirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesIncMember 2023-01-01 2023-09-30 0001744494 adn:AdventTechnologiesSAMember 2024-01-01 2024-09-30 0001744494 adn:AdventTechnologiesSAMember adn:DirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesSAMember adn:IndirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesSAMember 2023-01-01 2023-09-30 0001744494 adn:AdventTechnologiesLLCMember 2024-01-01 2024-09-30 0001744494 adn:AdventTechnologiesLLCMember adn:DirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesLLCMember adn:IndirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesLLCMember 2023-01-01 2023-09-30 0001744494 adn:AdventTechnologiesGmbHMember 2024-01-01 2024-09-30 0001744494 adn:AdventTechnologiesGmbHMember adn:DirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesGmbHMember adn:IndirectOwnershipMember 2024-09-30 0001744494 adn:AdventTechnologiesGmbHMember 2023-01-01 2023-09-30 0001744494 adn:ConvertibleBondLoanMember 2022-05-25 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-01-01 2024-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:CommonStockMember 2024-09-30 0001744494 adn:WorkingCapitalWarrantsMember 2024-01-01 2024-09-30 0001744494 adn:WorkingCapitalWarrantsMember us-gaap:CommonStockMember 2024-09-30 0001744494 us-gaap:InvestorMember 2024-01-01 2024-09-30 0001744494 adn:PrivatePlacementWarrantMember 2024-01-01 2024-09-30 0001744494 adn:PrivatePlacementWarrantMember us-gaap:CommonStockMember 2024-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001744494 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001744494 us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001744494 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001744494 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001744494 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001744494 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001744494 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001744494 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-06-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-06-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-12-31 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-12-31 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-07-01 2024-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-07-01 2023-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-01-01 2023-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-09-30 0001744494 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-09-30 0001744494 adn:VassiliosGregoriouMember 2024-09-30 0001744494 adn:VassiliosGregoriouMember 2023-12-31 0001744494 adn:MariaGregoriouMember 2024-09-30 0001744494 adn:MariaGregoriouMember 2023-12-31 0001744494 adn:EmorySDeCastroMember 2024-09-30 0001744494 adn:EmorySDeCastroMember 2024-12-31 0001744494 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-09-30 0001744494 adn:UltraCellLLCMember us-gaap:TradeNamesMember 2023-01-01 2023-12-31 0001744494 2023-01-01 2023-12-31 0001744494 us-gaap:PatentsMember 2023-12-31 0001744494 us-gaap:InProcessResearchAndDevelopmentMember 2023-12-31 0001744494 us-gaap:OrderOrProductionBacklogMember 2023-12-31 0001744494 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001744494 us-gaap:FiniteLivedIntangibleAssetsMember 2024-07-01 2024-09-30 0001744494 us-gaap:FiniteLivedIntangibleAssetsMember 2023-07-01 2023-09-30 0001744494 us-gaap:FiniteLivedIntangibleAssetsMember 2024-01-01 2024-09-30 0001744494 us-gaap:FiniteLivedIntangibleAssetsMember 2023-01-01 2023-09-30 0001744494 us-gaap:IntangibleAssetsAmortizationPeriodMember 2024-09-30 0001744494 us-gaap:LandBuildingsAndImprovementsMember 2024-09-30 0001744494 us-gaap:LandBuildingsAndImprovementsMember 2023-12-31 0001744494 adn:MachineryMember 2024-09-30 0001744494 adn:MachineryMember 2023-12-31 0001744494 us-gaap:EquipmentMember 2024-09-30 0001744494 us-gaap:EquipmentMember 2023-12-31 0001744494 adn:HoodParkMember 2024-09-30 0001744494 adn:HoodParkMember 2023-12-31 0001744494 2024-05-01 2024-05-07 0001744494 adn:SuppliersMember 2024-09-30 0001744494 adn:SuppliersMember 2023-12-31 0001744494 2021-02-05 0001744494 us-gaap:OtherNoncurrentAssetsMember 2024-09-30 0001744494 us-gaap:OtherNoncurrentAssetsMember 2023-12-31 0001744494 2023-01-09 0001744494 2021-03-08 0001744494 adn:PrivatePlacementWarrantMember us-gaap:IPOMember 2024-01-01 2024-09-30 0001744494 adn:PrivatePlacementWarrantMember 2024-09-30 0001744494 adn:PrivatePlacementWarrantMember 2023-12-31 0001744494 adn:H.C.WainwrightAndCo.LLCMember 2024-03-28 0001744494 adn:H.C.WainwrightAndCo.LLCMember 2024-04-15 0001744494 adn:H.C.WainwrightAndCo.LLCMember 2024-04-01 2024-04-15 0001744494 adn:StockholdersMember 2024-04-01 2024-04-29 0001744494 adn:BoardMember 2024-05-01 2024-05-13 0001744494 us-gaap:WarrantMember 2024-09-30 0001744494 us-gaap:WarrantMember 2021-10-01 2021-12-31 0001744494 us-gaap:WarrantMember 2021-12-31 0001744494 adn:PrivatePlacementWarrantsMember 2024-09-30 0001744494 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001744494 adn:EquityIncentivePlan2021Member 2024-09-30 0001744494 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001744494 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001744494 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001744494 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001744494 us-gaap:EmployeeStockOptionMember 2024-09-30 0001744494 us-gaap:RestrictedStockUnitsRSUMember adn:EquityIncentivePlan2021Member 2024-07-01 2024-09-30 0001744494 us-gaap:RestrictedStockUnitsRSUMember adn:EquityIncentivePlan2021Member 2024-01-01 2024-09-30 0001744494 us-gaap:RestrictedStockUnitsRSUMember adn:EquityIncentivePlan2021Member 2023-07-01 2023-09-30 0001744494 us-gaap:RestrictedStockUnitsRSUMember adn:EquityIncentivePlan2021Member 2023-01-01 2023-09-30 0001744494 us-gaap:RestrictedStockUnitsRSUMember adn:EquityIncentivePlan2021Member 2024-09-30 0001744494 us-gaap:EmployeeStockOptionMember 2023-12-31 0001744494 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001744494 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001744494 us-gaap:RestrictedStockUnitsRSUMember 2024-09-30 0001744494 adn:SalesOfGoodsMember 2024-07-01 2024-09-30 0001744494 adn:SalesOfGoodsMember 2023-07-01 2023-09-30 0001744494 adn:SalesOfGoodsMember 2024-01-01 2024-09-30 0001744494 adn:SalesOfGoodsMember 2023-01-01 2023-09-30 0001744494 us-gaap:ServiceMember 2024-07-01 2024-09-30 0001744494 us-gaap:ServiceMember 2023-07-01 2023-09-30 0001744494 us-gaap:ServiceMember 2024-01-01 2024-09-30 0001744494 us-gaap:ServiceMember 2023-01-01 2023-09-30 0001744494 us-gaap:TransferredAtPointInTimeMember 2024-07-01 2024-09-30 0001744494 us-gaap:TransferredAtPointInTimeMember 2023-07-01 2023-09-30 0001744494 us-gaap:TransferredAtPointInTimeMember 2024-01-01 2024-09-30 0001744494 us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0001744494 us-gaap:TransferredOverTimeMember 2024-07-01 2024-09-30 0001744494 us-gaap:TransferredOverTimeMember 2023-07-01 2023-09-30 0001744494 us-gaap:TransferredOverTimeMember 2024-01-01 2024-09-30 0001744494 us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0001744494 adn:CooperativeResearchAndDevelopmentAgreementMember 2020-08-31 0001744494 adn:CooperativeResearchAndDevelopmentAgreementMember 2020-08-01 2020-08-31 0001744494 us-gaap:CollaborativeArrangementMember 2024-07-01 2024-09-30 0001744494 us-gaap:CollaborativeArrangementMember 2024-01-01 2024-09-30 0001744494 us-gaap:CollaborativeArrangementMember 2023-07-01 2023-09-30 0001744494 us-gaap:CollaborativeArrangementMember 2023-01-01 2023-09-30 0001744494 srt:NorthAmericaMember 2024-07-01 2024-09-30 0001744494 srt:NorthAmericaMember 2023-07-01 2023-09-30 0001744494 srt:NorthAmericaMember 2024-01-01 2024-09-30 0001744494 srt:NorthAmericaMember 2023-01-01 2023-09-30 0001744494 srt:EuropeMember 2024-07-01 2024-09-30 0001744494 srt:EuropeMember 2023-07-01 2023-09-30 0001744494 srt:EuropeMember 2024-01-01 2024-09-30 0001744494 srt:EuropeMember 2023-01-01 2023-09-30 0001744494 srt:AsiaMember 2024-07-01 2024-09-30 0001744494 srt:AsiaMember 2023-07-01 2023-09-30 0001744494 srt:AsiaMember 2024-01-01 2024-09-30 0001744494 srt:AsiaMember 2023-01-01 2023-09-30 0001744494 2023-05-31 0001744494 us-gaap:SegmentDiscontinuedOperationsMember 2023-12-31 0001744494 us-gaap:SegmentDiscontinuedOperationsMember 2024-07-01 2024-09-30 0001744494 us-gaap:SegmentDiscontinuedOperationsMember 2023-07-01 2023-09-30 0001744494 us-gaap:SegmentDiscontinuedOperationsMember 2024-01-01 2024-09-30 0001744494 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-09-30 0001744494 adn:PurchaseAgreementMember adn:SeniorNoteMember 2024-11-01 2024-11-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft adn:Integer iso4217:EUR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 10-Q

 

 

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 001-38742

 

 

 

Advent Technologies Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   83-0982969
(State or other jurisdiction of
incorporation or organization)		   (I.R.S. Employer
Identification Number)

 

5637 La Ribera St., Suite A Livermore, CA   94550
(Address of principal executive offices)   (Zip code)

 

(925) 455-9400

(Registrant’s telephone number, including area code)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share  

ADN

   The Nasdaq Capital Market
Warrants   ADNWW   The Nasdaq Capital Market

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐   No  ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐   No ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

 

As of December 24, 2024, the registrant had 2,636,508 shares of common stock, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements, which reflect our current views with respect to, among other things, our operations and financial performance. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy and plans and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “could,” “target,” “predict,” “seek” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short- and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those referenced in the section titled “Risk Factors” in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Annual Report”) which could cause actual results to differ materially. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

 

Some of the key factors that could cause actual results to differ from our expectations include:

 

● our ability to maintain the listing of our shares of common stock and warrants on Nasdaq;

 

● our ability to raise financing in the future;

 

● our success in retaining or recruiting officers, key employees or directors;

 

● factors relating to our business, operations and financial performance, including:

 

○ our ability to control the costs associated with our operations;

 

○ our ability to grow and manage growth profitably;

 

○ our reliance on complex machinery for our operations and production;

 

○ the market’s willingness to adopt our technology;

 

○ our ability to maintain relationships with customers;

 

○ the potential impact of product recalls;

 

○ our ability to compete within our industry;

 

○ increases in costs, disruption of supply or shortage of raw materials;

 

○ risks associated with strategic alliances or acquisitions;

 

○ the impact of unfavorable changes in U.S. and international regulations;

 

 

 

 

○ the availability of and our ability to meet the terms and conditions for government grants and economic incentives; and

 

○ our ability to protect our intellectual property rights;

 

● market conditions and global and economic factors beyond our control;

 

● volatility of our stock price and potential share dilution;

 

● future exchange and interest rates; and

 

● other factors detailed within the 2023 Annual Report under the section entitled “Risk Factors.”

 

The forward-looking statements included in this Quarterly Report on Form 10-Q are made only as of the date of this report. You should not rely upon forward-looking statements as predictions of future events. We cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Quarterly Report on Form 10-Q to conform these statements to actual results or reflect interim developments.

 

As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. For a discussion of the risks involved in our business and investing in our common stock, see the section entitled “Risk Factors” within the 2023 Annual Report.

 

Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may vary in material respects from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements.

 

 

 

 

Advent Technologies Holdings, Inc.

 

Table of Contents

 

        Page
PART I—FINANCIAL INFORMATION
         
Item 1.   Unaudited Condensed Consolidated Financial Statements   1
    Unaudited Condensed Consolidated Balance Sheets   1
    Unaudited Condensed Consolidated Statements of Operations   2
    Unaudited Condensed Consolidated Statements of Comprehensive Loss   3
    Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity / (Deficit)   4
    Unaudited Condensed Consolidated Statements of Cash Flows   8
    Notes to Unaudited Condensed Consolidated Financial Statements   9
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   35
Item 3.   Quantitative and Qualitative Disclosures About Market Risk   52
Item 4.   Controls and Procedures   52
         
PART II—OTHER INFORMATION
         
Item 1.   Legal Proceedings   55
Item 1A.   Risk Factors   55
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds   55
Item 3.   Defaults Upon Senior Securities   55
Item 4.   Mine Safety Disclosures   55
Item 5.   Other Information   55
Item 6.   Exhibits   56
     
Signatures   57

 

i

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Unaudited Condensed Consolidated Financial Statements

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(Amounts in USD thousands, except share and per share amounts)

 

                 
    As of  
   

September 30,
2024

     December 31,
2023		  
    (Unaudited)        
ASSETS                
Current assets:                
Cash and cash equivalents   $ 192     $ 3,200  
Restricted cash, current     -       100  
Accounts receivable, net     274       63  
Contract assets     -       9  
Inventories     97       195  
Prepaid expenses and Other current assets     861       838  
Assets of discontinued operations     -       4,430  
Total current assets     1,424       8,835  
Non-current assets:                
Intangibles, net     77       79  
Property and equipment, net     5,310       20,086  
Right-of-use assets     279       3,157  
Restricted cash, non-current     -       750  
Other non-current assets     239       242  
Available for sale financial asset     -       -  
Assets of discontinued operations     -       1,588  
Total non-current assets     5,905       25,902  
Total assets   $ 7,329     $ 34,737  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Current liabilities:                
Trade and other payables   $ 16,420     $ 3,996  
Due to related parties     253       -  
Deferred income from grants, current     -       523  
Contract liabilities     1,230       414  
Loss contingency liabilities     5,162       -  
Other current liabilities     1,785       1,035  
Operating lease liabilities     111       2,138  
Income tax payable     183       179  
Liabilities of discontinued operations     -       3,628  
Total current liabilities     25,144       11,913  
Non-current liabilities:                
Bonds and other long-term debt, net     -       -  
Warrant liability     -       59  
Long-term operating lease liabilities     159       8,218  
Defined benefit obligation     99       83  
Deferred income from grants, non-current     -       320  
Other long-term liabilities     1       1  
Liabilities of discontinued operations     -       695  
Total non-current liabilities     259       9,376  
Total liabilities     25,403       21,289  
                 
Commitments and contingent liabilities                
                 
Stockholders’ equity                
Common stock ($0.0001 par value per share; Shares authorized: 500,000,000 at September 30, 2024 and December 31, 2023; Issued and outstanding: 2,636,508 and 2,580,159 at September 30, 2024 and December 31, 2023, respectively)     -       -  
Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at September 30, 2024 and December 31, 2023; nil issued and outstanding at September 30, 2024 and December 31, 2023)     -       -  
Additional paid-in capital     201,211       194,941  
Accumulated other comprehensive loss     (975 )     (2,334 )
Accumulated deficit     (218,310 )     (179,159 )
Total stockholders’ equity / (deficit)     (18,074 )     13,448  
Total liabilities and stockholders’ equity   $ 7,329     $ 34,737  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

1

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(Amounts in USD thousands, except share and per share amounts)

 

                                 
    Three months ended
September 30,
(Unaudited)		     Nine months ended
September 30,
(Unaudited)		  
    2024     2023     2024     2023  
Revenue, net   $ 128     $ 112     $ 3,520     $ 222  
Cost of revenues     (336 )     (807 )     (896 )     (1,336 )
Gross profit / (loss)     (208 )     (695 )     2,624       (1,114 )
Income from grants     137       242       1,399       788  
Research and development expenses     (411 )     (1,197 )     (2,521 )     (4,745 )
Administrative and selling expenses     (3,135 )     (8,000 )     (6,954 )     (10,786 )
Sublease income     -       139       145       404  
Amortization of intangibles     (1 )     (117 )     (3 )     (526 )
Credit loss – customer contracts     (4,309 )     (3 )     (4,309 )     (63 )
Impairment losses     -       -       -       (9,763 )
Operating loss     (7,927 )     (9,631 )     (9,619 )     (25,805 )
Fair value change of warrant liability     -       (134 )     59       355  
Finance income / (expenses), net     (14 )     (72 )     (300 )     (522 )
Foreign exchange gains / (losses), net     (1,672 )     (22 )     (1,837 )     107  
Loss contingency     -       -       (4,871 )     -  
Net gains / (losses) on disposal/write-offs of property, plant and equipment and intangible assets     -       -       (12,735 )     -  
Other income / (expenses), net     (2 )     (113 )     4       (869 )
Loss before income tax     (9,615 )     (9,972 )     (29,299 )     (26,734 )
Income taxes     -       81       55       204  
Net loss from continuing operations   $ (9,615 )   $ (9,891 )   $ (29,244 )   $ (26,530 )
Income (loss) from discontinued operations     (8,907 )     (1,955 )     (9,907 )     (19,135 )
Net loss   $ (18,522 )   $ (11,846 )   $ (39,151 )   $ (45,665 )
Net loss per share                                
Basic loss per share from continuing operations     (3.65 )     (4.92 )     (11.17 )     (14.39 )
Basic loss per share from discontinued operations     (3.38 )     (0.97 )     (3.78 )     (10.38 )
Basic loss per share     (7.03 )     (5.89 )     (14.95 )     (24.78 )
Basic weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Diluted loss per share from continuing operations     (3.65 )     (4.92 )     (11.17 )     (14.39 )
Diluted loss per share from discontinued operations     (3.38 )     (0.97 )     (3.78 )     (10.38 )
Diluted loss per share     (7.03 )     (5.89 )     (14.95 )     (24.78 )
Diluted weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

2

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

(Amounts in USD thousands)

 

                                 
    Three months ended
September 30,
(Unaudited)		     Nine months ended
September 30,
(Unaudited)		  
    2024     2023     2024     2023  
Net loss   $ (18,522 )   $ (11,846 )   $ (39,151 )   $ (45,665 )
Other comprehensive loss, net of tax effect:                                
Foreign currency translation adjustment     (116 )     (353 )     (217 )     (265 )
Other comprehensive loss from continuing operations     (18,638 )     (12,199 )     (39,368 )     (45,930 )
Other comprehensive loss from discontinued operations     (220 )     (220 )     (141 )     22  
Total other comprehensive loss   $ (18,858 )   $ (12,419 )   $ (39,509 )   $ (45,908 )

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

3

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY / (DEFICIT)

 

(Amounts in USD thousands, except share amounts)

 

                                                                                 
    Three Months Ended September 30, 2024  
    Preferred Stock
Series A		     Preferred Stock
Series Seed		     Common Stock     Additional
Paid-in		     Accumulated     Accumulated     Total
Stockholders’ Equity / 		 
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     OCI     (Deficit)  
Balance as of June 30, 2024 (Unaudited)     -     $ -       -     $ -       2,636,508     $ -     $ 199,265     $ (199,788 )   $ (2,356 )   $ (2,879 )
Issuance of common stock for cash (Unaudited)     -       -       -       -       -       -       -       -       -       -  
Stock issued under stock compensation plan (Unaudited)     -       -       -       -       -       -       -       -       -       -  
Stock based compensation expense (Unaudited)     -       -       -       -       -       -       1,946       -       -       1,946  
Disposal of subsidiaries (Unaudited)     -       -       -       -       -       -       -       -       1,717       1,717  
Net loss (Unaudited)     -       -       -       -       -       -       -       (18,522 )     -       (18,522 )
Other comprehensive gain (Unaudited)     -       -       -       -       -       -       -       -       (336 )     (336 )
Balance as of September 30, 2024 (Unaudited)     -     $ -       -     $ -       2,636,508     $ -     $ 201,211     $ (218,310 )   $ (975 )   $ (18,074 )

 

See accompanying notes to unaudited condensed consolidated financial statements

 

4

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY / (DEFICIT)

 

(Amounts in USD thousands, except share amounts)

 

       
    Three Months Ended September 30, 2023  
    Preferred Stock
Series A		     Preferred Stock
Series Seed		     Common Stock     Additional
Paid-in		     Accumulated     Accumulated     Total
Stockholders’		  
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     OCI     Equity  
Balance as of June 30, 2023 (Unaudited)     -     $ -       -     $ -       1,947,340     $ -     $ 183,914     $ (141,581 )   $ (2,274 )   $ 40,059  
Issuance of common stock (Unaudited)                                     113,711       -       2,250                       2,250  
Stock issued under stock compensation plan (Unaudited)     -       -       -       -       9,226       -       -       -       -       -  
Stock based compensation expense (Unaudited)     -       -       -       -       -       -       2,479       -       -       2,479  
Reclassification of private warrants (Unaudited)     -       -       -       -       -       -       213       -       -       213  
Net loss (Unaudited)     -       -       -       -       -       -       -       (11,846 )     -       (11,846 )
Other comprehensive gain (Unaudited)     -       -       -       -       -       -       -       -       (573 )     (573 )
Balance as of September 30, 2023 (Unaudited)     -     $ -       -     $ -       2,070,277     $ -     $ 188,856     $ (153,427 )   $ (2,847 )   $ 32,582  

 

See accompanying notes to unaudited condensed consolidated financial statements

 

5

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY / (DEFICIT)

 

(Amounts in USD thousands, except share amounts)

 

       
    Nine Months Ended September 30, 2024  
    Preferred Stock
Series A		     Preferred Stock
Series Seed		     Common Stock     Additional
Paid-in		     Accumulated     Accumulated     Total
Stockholders’ Equity /		  
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     OCI     (Deficit)  
Balance as of December 31, 2023     -     $ -       -     $ -       2,580,159     $ -     $ 194,941     $ (179,159 )   $ (2,334 )   $ 13,448  
Issuance of common stock for cash (Unaudited)     -       -       -       -       56,349       -       282       -       -       282  
Stock issued under stock compensation plan (Unaudited)     -       -       -       -       -       -       -       -       -       -  
Stock based compensation expense (Unaudited)     -       -       -       -       -       -       5,988       -       -       5,988  
Disposal of subsidiaries (Unaudited)     -       -       -       -       -       -       -       -       1,717       1,717  
Net loss (Unaudited)     -       -       -       -       -       -       -       (39,151 )     -       (39,151 )
Other comprehensive loss (Unaudited)     -       -       -       -       -       -       -       -       (358 )     (358 )
Balance as of September 30, 2024 (Unaudited)     -     $ -       -     $ -       2,636,508     $ -     $ 201,211     $ (218,310 )   $ (975 )   $ (18,074 )

 

See accompanying notes to unaudited condensed consolidated financial statements

 

6

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY / (DEFICIT)

 

(Amounts in USD thousands, except share amounts)

 

       
    Nine Months Ended September 30, 2023  
    Preferred Stock
Series A		     Preferred Stock
Series Seed		     Common Stock     Additional
Paid-in		     Accumulated     Accumulated     Total
Stockholders’		  
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     OCI     Equity  
Balance as of December 31, 2022     -     $ -       -     $ -       1,723,924     $ -     $ 174,514     $ (107,762 )   $ (2,604 )   $ 64,148  
Issuance of common stock (Unaudited)     -       -       -       -       314,695       -       6,429                       6,429  
Stock issued under stock compensation plan (Unaudited)                                     31,658       -       -                       -  
Stock based compensation expense (Unaudited)     -       -       -       -       -       -       7,368       -       -       7,368  
Reclassification of private warrants (Unaudited)     -       -       -       -       -       -       545       -       -       545  
Net loss (Unaudited)     -       -       -       -       -       -       -       (45,665 )     -       (45,665 )
Other comprehensive loss (Unaudited)     -       -       -       -       -       -       -       -       (243 )     (243 )
Balance as of September 30, 2023 (Unaudited)     -     $ -       -     $ -       2,070,277     $ -     $ 188,856     $ (153,427 )   $ (2,847 )   $ 32,582  

 

See accompanying notes to unaudited condensed consolidated financial statements

 

7

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(Amounts in USD thousands)

 

                 
    Nine months ended
September 30,
(Unaudited)		  
    2024     2023  
Cash Flows from Operating Activities:                
Net loss   $ (39,151 )   $ (45,665 )
Adjustments to reconcile net loss to net cash flows used in operating activities:                
Loss from discontinued operations     6,062       -  
Depreciation of property and equipment     1,157       1,596  
Amortization of intangible assets     3       526  
Impairment loss of tangible and intangible assets and goodwill     -       9,763  
Provision for litigation expenses     4,871       -  
Credit loss allowance     4,309       (12,271 )
Fair value gain of warrant liability     (59 )     (355 )
Stock-based compensation expense     5,988       7,368  
Issuance of commitment shares     -       1,186  
Benefit for current and deferred income taxes     (55 )     (204 )
Net losses on disposal/write-offs of property, plant and equipment and intangible assets     12,735       182  
Provision for inventories     250       -  
Net periodic cost of defined benefit obligation     14       18  
Changes in operating assets and liabilities:                
Decrease/(increase) in accounts receivable     3,054       520  
Decrease/(increase) in contract assets     9       10  
Decrease/(increase) in inventories     (149 )     278  
Decrease in prepaid expenses and other current assets     637       (174 )
Decrease in other non-current assets     (2,751 )     7,106  
(Decrease)/increase in trade payables     12,117       (5,244 )
(Decrease)/increase in due to related parties     253       -  
Decrease in deferred income from grants     (837 )     203  
Increase in loss contingency liability     292       -  
(Decrease)/increase in contract liabilities     812       (85 )
(Decrease)/increase in other current liabilities     735       (343 )
Operating lease asset and liabilities     (7,208 )     (655 )
Net Cash provided by / (used in) Operating Activities   $ 3,088     $ (36,240 )
                 
Cash Flows from Investing Activities:                
Proceeds from sale of property and equipment     300       -  
Purchases of property and equipment     (28 )     (2,952 )
Advances for the acquisition of property and equipment     -       (1,255 )
Acquisition of subsidiaries     -       (1,864 )
Net Cash provided by / (used in) Investing Activities   $ 272     $ (6,071 )
                 
Cash Flows from Financing Activities:                
Proceeds of issuance of common stock and paid-in capital     282       5,488  
Net Cash provided by Financing Activities   $ 282     $ 5,488  
                 
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents from continuing operations   $ 3,642     $ (36,823 )
Effect of exchange rate changes on cash, cash equivalent, restricted cash and restricted cash equivalents     274       5  
Net cash provided by / (used in) discontinued operations:                
Cash provided by / (used in) operating activities     (8,317 )     9,903  
Cash provided by / (used in) investing activities     -       (275 )
Cash provided by / (used in) financing activities     543       -  
Net cash provided by / (used in) discontinued operations     (7,774 )     9,628  
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents     (3,858 )     (27,190 )
Cash, cash equivalents, restricted cash and restricted cash equivalents at the beginning of the period     4,050       33,619  
Cash, cash equivalents, restricted cash and restricted cash equivalents at the end of the period   $ 192     $ 6,429  
                 
Reconciliation to Condensed Consolidated Balance Sheets:                
Cash and cash equivalents   $ 192     $ 3,661  
Restricted cash, current     -       2,018  
Restricted cash, non-current     -       750  
Cash, cash equivalents, restricted cash and restricted cash equivalents   $ 192     $ 6,429  
                 
Non-cash Financing Activities:                
Issuance of common stock and paid-in capital   $ -     $ 769  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

8

 

 

ADVENT TECHNOLOGIES HOLDINGS, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Basis of presentation

 

Overview

 

Advent Technologies Holdings, Inc. and its subsidiaries (collectively referred to as “Advent” and the “Company”) is an advanced materials and technology development company operating in the fuel cell, methanol, and hydrogen technology space. Advent is a world-leading company in the development of the HT-PEM technology (with more than 150 patents issued, pending, or licensed worldwide). The HT-PEM fuel cell technology developed by Advent enables off-grid power systems to produce clean power from various green fuels (hydrogen, methanol, bio and eMethanol, and renewable natural gas) and to function with higher efficiency at extreme ambient temperatures and in general extreme environmental conditions (humidity, air pollution). Advent’s main operations focus on developing and manufacturing the Membrane Electrode Assembly (MEA), which is the core electrochemical element and the most critical component of the fuel cell. The MEA largely determines lifetime, power density, efficiency, and overall cost of installation and operation for all applications. Advent is working with world-leading market-leading OEMs with the goal of bringing to the market complete fuel cell systems for a range of applications in the stationary power markets (backup, off-grid, and portable power) and the heavy-duty mobility markets (automotive, aviation, marine).

 

Advent has its headquarters in Livermore, California, and the Company has MEA and fuel cell product development facilities in Livermore, California and Patras, Greece. Previously, the Company’s headquarters were located in Boston, Massachusetts. During 2023, the Company decided to consolidate certain of its German operations with its operations in Greece. During June 2024, the Company closed its facilities in Boston, MA, and no longer maintains its facilities in Denmark and the Philippines due to the bankruptcy of Advent Technologies A/S in July 2024.

 

On February 4, 2021 (“Closing Date”), AMCI Acquisition Corp. (“AMCI”), consummated the business combination (the “Business Combination”) pursuant to that certain merger agreement (the “Agreement and Plan of Merger”), dated October 12, 2020, by and among AMCI, AMCI Merger Sub Corp., a Delaware corporation and newly formed wholly-owned subsidiary of AMCI (“Merger Sub”), AMCI Sponsor LLC (the “Sponsor”), solely in the capacity as the representative from and after the effective time of the Business Combination for the stockholders of AMCI, Advent Technologies, Inc., a Delaware corporation (“Legacy Advent”), and Vassilios Gregoriou, solely in his capacity as the representative from and after the effective time for the Legacy Advent stockholders (the “Seller Representative”), as amended by Amendment No. 1 and Amendment No. 2 to the Agreement and Plan of Merger, dated as of October 19, 2020 and December 31, 2020, respectively, by and among AMCI, Merger Sub, Sponsor, Legacy Advent, and Seller Representative. In connection with the closing of the Business Combination (the “Closing”), AMCI acquired 100% of the stock of Legacy Advent (as it existed immediately prior to the Closing) and its subsidiaries.

 

On the Closing Date, and in connection with the closing of the Business Combination, AMCI changed its name to Advent Technologies Holdings, Inc. Legacy Advent was deemed the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (“ASC”) 805. This determination was primarily based on Legacy Advent’s stockholders prior to the Business Combination having a majority of the voting interests in the combined company, Legacy Advent’s operations comprising the ongoing operations of the combined company, Legacy Advent’s board of directors comprising a majority of the board of directors of the combined company, and Legacy Advent’s senior management comprising the senior management of the combined company. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Advent issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI are stated at historical cost, with no goodwill or other intangible assets recorded.

 

9

 

 

While AMCI was the legal acquirer in the Business Combination, because Legacy Advent was deemed the accounting acquirer, the historical financial statements of Legacy Advent became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the consolidated financial statements included in this report reflect (i) the historical operating results of Legacy Advent prior to the Business Combination; (ii) the results of the Company (combined results of AMCI and Legacy Advent) following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Advent at their historical cost; and (iv) Company’s equity structure for all periods presented.

 

In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to Legacy Advent’s stockholders in connection with the recapitalization transaction. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Advent Preferred Stock (“Preferred Series A” and “Preferred Series Seed”) and Legacy Advent common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination Agreement. Activity within the statement of changes in stockholders’ equity / (deficit) for the issuances of Legacy Advent’s Preferred Stock, were also retroactively converted to Legacy Advent common stock.

 

On February 18, 2021, Advent Technologies, Inc. entered into a Membership Interest Purchase Agreement with Bren-Tronics, Inc. (“Bren-Tronics”) and UltraCell, LLC (“UltraCell”), a Delaware limited liability company and a direct wholly owned subsidiary of Bren-Tronics.

 

UltraCell LLC was renamed Advent Technologies LLC following its acquisition by the Company.

 

On June 25, 2021, the Company entered into a Share Purchase Agreement, with F.E.R. fischer Edelstahlrohre GmbH, a limited liability company incorporated under the Laws of Germany (the “Seller”) to acquire all of the issued and outstanding equity interests in SerEnergy A/S, a Danish stock corporation and a wholly-owned subsidiary of the Seller (“SerEnergy”) and fischer eco solutions GmbH, a German limited liability company and a wholly-owned subsidiary of the Seller (“FES”) together with certain outstanding shareholder loan receivables.

 

SerEnergy and FES were renamed to Advent Technologies A/S and Advent Technologies GmbH, respectively, following their acquisition by the Company on August 31, 2021.

 

The unaudited condensed consolidated financial statements of the Company have been prepared to reflect the consolidation of the companies listed below:

 

                   
    Country of   Ownership Interest   Statements of Operations
Company Name   Incorporation   Direct   Indirect   2024   2023
Advent Technologies, Inc.   USA   100%   -   01/01 – 9/30   01/01 – 9/30
Advent Technologies S.A.   Greece   -   100%   01/01 – 9/30   01/01 – 9/30
Advent Technologies LLC   USA   -   100%   01/01 – 9/30   01/01 – 9/30
Advent Technologies GmbH   Germany   100%   -   01/01 – 9/30   01/01 – 9/30

 

On July 25, 2024, Advent Technologies A/S was declared bankrupt by the court in Aalborg, Denmark. The petition was brought by IDA, the union of engineers for €402,000. As the Company did not have the ability to pay the full amount due, the Danish court declared Advent Technologies A/S bankrupt. Advent Technologies A/S and its wholly owned subsidiary Advent Green Energy Philippines, Inc. will be liquidated by the court appointed trustee to settle all claims under the bankruptcy. The Company anticipates it will receive no residual assets. As a result of their bankruptcy, Advent Technologies A/S and Advent Green Energy Philippines, Inc. (collectively referred to as the “Discontinued Subsidiaries”) have been presented as discontinued operations in the accompanying financial statements.

 

10

 

 

Unaudited Condensed Consolidated Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”). The unaudited financial information reflects, in the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s audited consolidated financial statements as of and for the year ended December 31, 2023, included in the Annual Report on Form 10-K filed with the SEC on August 13, 2024.

 

We reclassified certain prior year amounts in our consolidated financial statements to conform to the current year presentation. All reclassifications have been applied consistently to the periods presented.

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated.

 

Share and per share amounts are presented on a post-conversion basis for all periods presented, unless otherwise specified.

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company considers that the going concern basis is appropriate for the preparation of its unaudited condensed consolidated financial statements, as it is pursuing additional fund raising as disclosed below and has no intentions to proceed with liquidation. The going concern basis of presentation assumes that the Company will continue in operation one year from the date these unaudited condensed consolidated financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. As such, the accompanying unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and their carrying amounts, or the amount and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date that the unaudited condensed consolidated financial statements are issued. The Company’s ability to meet its liquidity needs will largely depend on its ability to generate cash in the future. During the nine months ended September 30, 2024, the Company provided $3.1 million of cash in operating activities (excluding discontinued operations), and the Company’s ability to generate cash in the future is subject to general economic, financial, competitive, legislative, regulatory, and other factors that are beyond the Company’s control. Furthermore, the Company has suffered recurring operating losses and has a negative net working capital position of $23.0 million as of September 30, 2024. In addition, as of the issuance date of these unaudited condensed consolidated financial statements the Company is overdue in a number of its obligations which could give the right to creditors at any time from the issuance date of these consolidated financial statements to raise legal action against the Company which in turn could potentially lead to liquidation action against the Company and/or its subsidiaries. The transition to profitability and positive cash flow is highly dependent upon the successful development, approval, and commercialization of the Company’s products and the achievement of a revenue level adequate to support its cost structure and the Company can give no assurances that this will occur. Based on the Company’s current operating plan, the Company believes that its cash and cash equivalents as of September 30, 2024, of $0.2 million and $0.5 million as of December 26, 2024, are not sufficient to fund operations and capital expenditures for the twelve months following the filing of this Quarterly Report on Form 10-Q, and the Company will need to obtain additional funding in the very near term, otherwise the Company may immediately substantially curtail or terminate its operations.

 

11

 

 

The Company performed a cash flow projection on a monthly basis for the twelve-month period following the issuance of the consolidated financial statements. With regards to the cash flow projections, the projected inflows from revenues and grants will be insufficient to cover the projected outflows, as such, the Company will continue to have a negative net working capital position and a delay in the projected timing of the short term financing and inflows and/or an immediate demand by creditors of repayment of the long outstanding payables may result in the Company being insolvent and short of cash at any specific time over the coming weeks and over the next twelve months.

 

The highlights of the projections are as follows:

 

The Company projects cash inflows from contracted revenues and grants for which it has already signed agreements with third parties and estimates projected outflows assuming the effective implementation of the Company’s plans to reduce monthly expenditures gradually during 2024.

 

In addition, the projections do not include any cash outflows relating to commitments and contingencies as disclosed in Note 19 to the unaudited condensed consolidated financial statements, since the Company believes that any cash outflows relating to these commitments will not materialize based on the Company’s plans to agree the termination of such contracts with its suppliers and a contingent loss as outcome of the pending arbitration it is not probable.

 

Until such time as the Company generates sufficient revenue to fund its operations (if ever), the Company plans to finance its operations and repay its existing and future liabilities and other obligations through the sale of equity and/or debt securities and, to the extent available, short-term and long-term loans.

 

With regards to the projected revenues and grants, a delay in the projected timing of inflows may result in the Company remaining insolvent and short of cash at any specific time over the next twelve months. Also, there is no guarantee that the Company’s plans to reduce monthly expenditures will be successful.

 

If the Company is unable to obtain sufficient funding, it could be required to delay its development efforts, limit activities, and further reduce research and development costs, which could adversely affect its business prospects and delivery of contractual obligations. A cash shortfall at any point in time over the next twelve months could result in the Company failing to meet its overdue and current obligations which could trigger action against the Company and/or its subsidiaries for liquidation by employees, authorities, or creditors. Because of the uncertainty in securing additional funding, delays in growth of revenue, failure to materialize cost-cutting efforts and the insufficient amount of cash and cash equivalents as of the consolidated financial statement filing date, management has concluded that substantial doubt exists with respect to the Company’s ability to continue as a going concern for one year from the date the unaudited condensed consolidated financial statements are issued.

 

2. Summary of Significant Accounting Policies

 

There have been no significant changes from the significant accounting policies disclosed in Note 2 of the “Notes to Consolidated Financial Statements” included in the Annual Report Form 10-K filed with the SEC on August 13, 2024.

 

The Company did not apply any new accounting policies during the nine-month period ended September 30, 2024 other than those noted below.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an on-going basis, management evaluates the estimates and judgments, including those related to the selection of useful lives for tangible assets, expected future cash flows from long-lived assets to support impairment tests, the carrying value of goodwill, provisions necessary for accounts receivables and inventory write downs, provisions for legal disputes, and contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates under different assumptions and/or conditions.

 

12

 

 

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

 

Cash and cash equivalents are highly liquid investments with original maturities of three months or less. Cash and cash equivalents consist of cash on hand, deposits held on call with banks and investments in money market funds with original maturities of three months or less at the date of acquisition. As of December 31, 2023, the Company has cash and cash equivalents which are restricted of $0.9 million. The restricted cash equivalent was a letter of credit required by the Company’s lease agreement for the Hood Park facility in Boston, MA. The letter of credit is required for the duration of the lease agreement which commenced in October 2022 and then was terminated in June 2024 resulting in the release of the letter of credit in the benefit of the landlord.

 

The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported in the consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows:

 

               
 

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Cash and cash equivalents   $ 192     $ 3,200  
Restricted cash, current     -       100  
Restricted cash, non-current     -       750  
Cash, cash equivalents, restricted cash and restricted cash equivalents   $ 192     $ 4,050  

 

Credit Losses

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which amends the requirement on the measurement and recognition of expected credit losses for financial assets held. Furthermore, amendments ASU 2019-10 and ASU 2019-11 provided additional clarification for implementing ASU 2016-13. ASU 2016-13 is effective for the Company beginning January 1, 2023, with early adoption permitted. The Company adopted the standard on January 1, 2023, in accordance with the adoption dates for private entities applicable to it under its emerging growth company status at that time and the standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements and related disclosures. The Company is exposed to credit losses primarily through sales of its products. The Company assesses each customer’s ability to pay and a credit loss estimate by conducting a credit review which includes consideration of established credit rating or an internal assessment of the customer’s creditworthiness based on an analysis of their payment history when a credit rating is not available. The Company monitors credit exposure through active review of customer balances. The Company’s expected loss methodology for accounts receivable is developed through consideration of factors including, but not limited to, historical collection experience, current customer credit ratings, current customer financial condition, current and future economic and market conditions, and age of the receivables. Charges related to credit losses are included in administrative and selling expenses and are recorded in the period that the outstanding receivables are determined to be doubtful. Account balances are written-off against the allowance when they are deemed uncollectible.

 

During the three months ended September 30, 2024, certain receivables totaling $4.3 million from Advent Technologies A/S were fully reserved as expected credit losses.

 

Inventories

 

Inventories, which consist of raw materials, work-in-process and finished goods are stated at the lower of cost or net realizable value using the first-in, first-out cost method. Cost includes the cost of purchased materials, inbound freight charges, external and internal processing and applicable labor and overhead costs. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.

 

The Company periodically reviews quantities of inventories on hand and compares these amounts to the expected use of each product. Inventories are reviewed to determine if valuation allowances are required for obsolescence (excess, obsolete, and slow-moving inventory). This review includes analyzing inventory levels of individual parts considering the current design of our products and production requirements as well as the expected inventory requirements for maintenance on installed power platforms. The Company records a charge to cost of revenue for the amount required to reduce the carrying value of inventory to the net realizable value.

 

13

 

 

Fair Value Measurements

 

The Company follows the accounting guidance in ASC 820 for its fair value measurements of financial assets and liabilities measured at fair value on a recurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

 

The accounting guidance requires fair value measurements be classified and disclosed in one of the following three categories:

 

● Level 1: Quoted prices in active markets for identical assets or liabilities.

 

● Level 2: Observable inputs other than Level 1 prices, for similar assets or liabilities that are directly or indirectly observable in the marketplace.

 

● Level 3: Unobservable inputs which are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

 

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

Convertible Bond Loan

 

On May 25, 2022, Advent Technologies S.A (“Advent SA”) and UNI.FUND Mutual Fund (“UNIFUND”) entered into an agreement to finance Cyrus SA (“Cyrus”) with a convertible bond loan (“Bond Loan”) of €1.0 million. As a part of this transaction, Advent SA offered €0.3 million in bond loans with an annual interest rate of 8.00%. The term of the loan is three years and there is a surcharge of 2.5% for overdue interest.

 

Cyrus business relates to the research and experimental development in natural sciences and mechanics, the construction of pumps and hydrogen compressors and the wholesale of compressors. Hydrogen compressors are a critical part of the Hydrogen Refueling Stations (HRS) to be used by transport applications. Cyrus has developed a prototype Metal Hydride Compressor which offers unique advantages. The proceeds from the Bond Loan are to cover Cyrus’s working capital needs in the context of its operation and the product development.

 

Mandatory conversion of the Bond Loan will occur in the event of qualified financing which is equivalent to a share capital increase by Cyrus in the first three years from the execution of the Bond Loan agreement with a total amount over €3 million which is covered by third parties unrelated to the basic shareholders or by investors related to them.

 

The Company classifies the Bond Loan as an available for sale financial asset on the consolidated balance sheets. The Company recognizes interest income within the consolidated statement of operations. For the three and nine months ended September 30, 2024, the Company recognized $7 thousand and $21 thousand of interest income related to the Bond Loan within the consolidated statements of operations, respectively. For the three and nine months ended September 30, 2023, the Company recognized $6 thousand and $19 thousand of interest income related to the Bond Loan within the consolidated statements of operations, respectively.

 

The Company initially measured the available for sale Bond Loan at the transaction price plus any applicable transaction costs. The Bond Loan is remeasured to its fair value at each reporting period and upon settlement. The estimated fair value of the Bond Loan is determined using Level 3 inputs by using a discounted cash flow model. The change in fair value is recognized within the consolidated statements of comprehensive loss. As of September 30, 2024, the Company continues to fully reserve the Bond Loan as an expected credit loss. The Company did not recognize any unrealized gain / (loss) during the three and nine months ended September 30, 2024, or 2023.

 

14

 

 

Warrant Liability

 

As a result of the Business Combination, the Company assumed a warrant liability (the “Warrant Liability”) related to previously issued 131,343 warrants, each exercisable to purchase one share of common stock at an exercise price of $345.00 per share, originally sold to AMCI Sponsor LLC (the “Sponsor”) in a private placement consummated in connection with AMCI’s initial public offering (the “Private Placement Warrants”) and the 13,333 warrants, each exercisable to purchase one share of Common Stock at an exercise price of $345.00 per share, converted from the Sponsor’s non-interest bearing loan to the Company of $0.4 million in connection with the closing of the Business Combination (the “Working Capital Warrants”) (Note 13). The Private Placement Warrants and the Working Capital Warrants have substantially the same terms as the 734,309 warrants, each exercisable to purchase one share of Common Stock at an exercise price of $345.00 per share, issued by AMCI in its initial public offering (the “Public Warrants”).

 

The following tables summarize the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023.

 

               
   

As of
September 30,
2024

(Unaudited)

  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ -     $ -  
    $ -     $ -  

 

    As of
December 31,
2023		  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ 59     $ 59  
    $ 59     $ 59  

 

The carrying amounts of the Company’s remaining financial instruments reflected on the consolidated balance sheets and which consist of cash and cash equivalents, accounts receivables, net, other current assets, trade and other payables, and other current liabilities, approximate their respective fair values due to their short-term nature.

 

15

 

 

Changes in the fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2024 and 2023 were as follows:

 

                               
Available for Sale Financial Asset
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 326     $ -     $ 320  
Estimated fair value of available for sale financial asset acquired     -       -       -       -  
Foreign exchange fluctuations     -       (10 )     -       (4 )
Change in estimated fair value     -       -       -       -  
Estimated fair value (end of period)   $ -     $ 316     $ -     $ 316  

 

Warrant Liability
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 177     $ 59     $ 998  
Change in estimated fair value     -       135       (59 )     (355 )
Reclassification of private placement warrants     -       (213 )     -       (545 )
Estimated fair value (end of period)   $ -     $ 99     $ -     $ 99  

 

The Warrant Liability is remeasured to its fair value at each reporting period and upon settlement. The change in fair value is recognized in “Fair value change of warrant liability” on the consolidated statements of operations.

 

3. Related party disclosures

 

Balances with related parties

 

          
   September 30,
2024		   December 31,
2023		 
(Amounts in thousands)  (Unaudited)     
Due to related parties          
Vassilios Gregoriou  $75   $- 
Maria Gregoriou   50    - 
Emory S. De Castro   128    - 
Total  $253   $- 

 

The outstanding balances as of September 30, 2024 due to the Company’s executives and officers relate to short-term promissory notes with the Company. The notes are due by August 31, 2026 and bear interest at a rate of 5.00% per annum.

 

Transactions with related parties

 

Related parties’ transactions are in the normal course of operations and are measured at the amount of consideration established and agreed to by related parties.

 

16

 

 

4. Accounts receivable, net

 

Accounts receivable consist of the following:

 

               
  September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accounts receivable from third party customers   $ 2,142     $ 348  
Less: Allowance for credit losses     (1,868 )     (285 )
Accounts receivable, net   $ 274     $ 63  

 

5. Inventories

 

Inventories consist of the following:

 

               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Raw materials and supplies   $ 4,967     $ 4,864  
Work-in-process     228       90  
Finished goods     264       259  
Total   $ 5,459     $ 5,213  
Provision for inventory     (5,362 )     (5,018 )
Total   $ 97     $ 195  

 

The changes in the provision for inventory is as follows:

 

                               
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Balance at beginning of period   $ (5,175 )   $ (46 )   $ (5,018 )   $ (45 )
Additions during the period     (11 )     (449 )     (250 )     (449 )
Exchange differences     (176 )     2       (94 )     1  
Balance at end of period   $ (5,362 )   $ (493 )   $ (5,362 )   $ (493 )

 

17

 

 

6. Prepaid expenses and other current assets

 

Prepaid expenses are analyzed as follows:

 

               
   

September 30,
2024

    

December 31,

2023

  
(Amounts in thousands)   (Unaudited)        
Prepaid insurance expenses   $ 410     $ 155  
Prepaid research expenses     13       36  
Other prepaid expenses     125       27  
Total   $ 548     $ 218  

 

Prepaid insurance expenses as of September 30, 2024 and December 31, 2023 mainly include prepayments to insurers for directors’ and officers’ insurance services for liabilities that may arise in their capacity as directors and officers of a public entity.

 

Prepaid research expenses as of September 30, 2024 and December 31, 2023 mainly relate to prepayments for expenses under the Cooperative Research and Development Agreement as discussed in Note 16.

 

Other prepaid expenses as of September 30, 2024 and December 31, 2023 mainly include prepayments for professional fees and purchases, which also include costs to fulfill a contract with customers which are expected to be recognized within 2024, upon delivery of services to these customers.

 

Other current assets are analyzed as follows:

 

               
   

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
VAT receivable   $ 56     $ 267  
Withholding tax     -       -  
Grant receivable     185       181  
Purchases under receipt     -       1  
Guarantees     -       -  
Other receivables     72       91  
Accrued sublease income     -       80  
Accrued interest income     -       -  
Total   $ 313     $ 620  

 

18

 

 

7. Intangible Assets

 

Information regarding our intangible assets, including assets recognized from our acquisitions, as of September 30, 2024 and December 31, 2023 is as follows:

 

                               
    As of September 30, 2024 (Unaudited)  
(Amounts in thousands)   Gross
Carrying
Amount		     Accumulated
Amortization		     Cumulative
Impairment		     Net
Carrying
Amount		  
Finite-lived intangible assets:                                
Software     237       (160 )     -       77  
Total intangible assets   $ 237     $ (160 )   $ -     $ 77  

 

    As of December 31, 2023  
(Amounts in thousands)   Gross
Carrying
Amount		     Accumulated
Amortization		     Cumulative
Impairment		     Net
Carrying
Amount		  
Indefinite-lived intangible assets:                                
Trade name “UltraCell”   $ 406     $ -     $ (406 )   $ -  
Total indefinite-lived intangible assets   $ 406     $ -     $ (406 )   $ -  
Finite-lived intangible assets:                                
Patents     21,221       (3,247 )     (17,974 )     -  
Process know-how (IPR&D)     2,612       (1,017 )     (1,595 )     -  
Order backlog     266       (266 )     -       -  
Software     233       (154 )     -       79  
Total finite-lived intangible assets   $ 24,332     $ (4,684 )   $ (19,569 )   $ 79  
Total intangible assets   $ 24,738     $ (4,684 )   $ (19,975 )   $ 79  

 

The Company did not record any additions to indefinite-lived intangible assets during the three and nine months ended September 30, 2024 and 2023.

 

The amortization expense for the intangible assets for the three months ended September 30, 2024 and 2023 was nil and $0.1 million, respectively. The amortization expense for the intangible assets for the nine months ended September 30, 2024 and 2023 was $2.0 thousand and $0.5 million, respectively.

 

All remaining intangible assets, other than software, from the UltraCell and SerEnergy and FES acquisitions were fully impaired during the year ended December 31, 2023.

 

Amortization expense is recorded on a straight-line basis. Assuming constant foreign currency exchange rates and no change in the gross carrying amount of the intangible assets, future amortization expense related to the Company’s intangible assets subject to amortization as of September 30, 2024 is expected to be as follows:

 

       
(Amounts in thousands)      
Fiscal Year Ended December 31,        
2024   $ 7  
2025     28  
2026     42  
2027     -  
2028     -  
Thereafter     -  
Total   $ 77  

 

19

 

 

8. Property, plant and equipment, net

 

The Company’s property, plant and equipment, net, consisted of the following:

 

               
    September 30,
2024		    

December 31,

2023

  
(Amounts in thousands)   (Unaudited)        
Land, Buildings & Leasehold Improvements   $ 1,014     $ 12,632  
Machinery     6,176       10,908  
Equipment     1,911       2,591  
    $ 9,101     $ 26,131  
Less: accumulated depreciation     (1,407 )     (3,661 )
Less: impairment     (2,384 )     (2,384 )
Total   $ 5,310     $ 20,086  

 

During the three and nine months ended September 30, 2024, additions to property, plant and equipment of nil and $28 thousand, respectively, for equipment. During the three and nine months ended September 30, 2023, additions to property, plant and equipment were $5.1 million and $9.0 million, respectively, primarily consisting of machines and assets related to the construction of the Hood Park facility. Additionally, on April 27, 2023, the Company entered into an agreement with ETTEL S.A. to purchase land in Kozani, Greece in the amount of €0.8 million.

 

During the nine months ended September 30, 2024, the Company disposed of leasehold improvements, sold machinery and disposed of other equipment with an aggregate net book value of $13.6 million for net proceeds of $0.9 million resulting in a loss of $12.7 million.

 

On June 29, 2024, in an effort to reduce costs, the Company decided to abandon the facility at Hood Park and was able to find a new tenant to occupy the space. The Company and the landlord agreed to accelerate the expiration of the lease to occur on June 30, 2024. The Company had a letter of credit in the amount of $750 thousand in favor of the landlord and that letter of the credit was released to the landlord in satisfaction of any claims against the Company. During the nine months ended September 30, 2024, the Company wrote off $9.8 million of leasehold improvements and $0.5 million of furniture as part of the exit of Hood Park. As of December 31, 2023, the Company had $10.4 million of leasehold improvements and $0.5 million of furniture that will be forfeited as part of the exit of Hood Park.

 

On May 7, 2024, the Company entered into an agreement to sell some of its coating machines (part of its property, plant and equipment) from the Hood Park facility for $0.9 million resulting in a loss of $2.5 million. On May 8, 2024, the Company received an initial deposit of $0.3 million and the remaining $0.6 million in July 2024. The remaining machinery and equipment from Hood Park were relocated and is planned for use at the Company’s other locations.

 

Depreciation expense during the three months ended September 30, 2024 and 2023 was $0.2 million and $0.9 million, respectively. Depreciation expense for the nine months ended September 30, 2024 and 2023 was $1.0 million and $2.1 million, respectively.

 

There are no collaterals or other commitments on the Company’s property, plant and equipment.

 

20

 

 

9. Other non-current assets

 

Other non-current assets as of September 30, 2024 and December 31, 2023 are mostly comprised of guarantees to suppliers of $0.2 million and $0.2 million, respectively.

 

10. Trade and other payables

 

Trade and other payables as of September 30, 2024 and December 31, 2023 include balances of suppliers and consulting service providers of $16.4 million and $4.0 million, respectively.

 

The increase in trade and other payables for the three months ended September 30, 2024 is driven by an $11.6 million payable between the Company and one of its Discontinued Subsidiaries which was previously eliminated as intercompany activity.

 

11. Other current liabilities

 

As of September 30, 2024 and December 31, 2023, other current liabilities consist of the following:

 

               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accrued expenses(1)   $ 563     $ 653  
Other short-term payables     802       44  
Taxes and duties payable     299       255  
Provision for unused vacation     4       4  
Social security funds     108       70  
Overtime provision     9       9  
Total   $ 1,785     $ 1,035  

 

 
(1) Accrued expenses are analyzed as follows:

 

               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accrued expenses for legal and consulting fees   $ 243     $ 219  
Accrued payroll fees     39       139  
Other accrued expenses     281       295  
Total   $ 563     $ 653  

 

Other accrued expenses mainly consist of accrual of staff expenses and audit fees.

 

21

 

 

12. Leases

 

The Company enters into operating lease agreements for the use of real estate and certain other equipment. The Company determines if an arrangement contains a lease at inception, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The impacts of accounting for operating leases are included in Right-of-use assets, Operating lease liabilities, and Long-term operating lease liabilities in the Company’s consolidated balance sheets.

 

On February 5, 2021, the Company entered into a lease agreement by and among the Company, in its capacity as tenant, and BP Hancock LLC, a Delaware limited liability company, in its capacity as landlord. The lease provides for the rental by the Company of office space at 200 Clarendon Street, Boston, MA 02116 for use as the Company’s executive offices. Under the terms of the lease, the Company leases 6,041 square feet at an initial fixed annual rent of $0.5 million. The term of the lease is for five years (unless terminated as provided in the lease) and commenced on April 1, 2021. The Company provided security in the form of a security deposit in the amount of $0.1 million which is included in Other non-current assets on the consolidated balance sheet as of December 31, 2023. On April 17, 2024, the landlord terminated the lease for past due rent totaling $0.2 million and seized the security deposit of $0.1 million.

 

On January 9, 2023, the Company entered into a sublease agreement by and among the Company, in its capacity as sublandlord, BP Hancock LLC, a Delaware limited liability company, in its capacity as landlord, and Hughes Boston, Inc. (“Hughes”), in its capacity as subtenant. The sublease provides for the rental by Hughes of office space at 200 Clarendon Street, Boston, MA 02116. Under the terms of the sublease, Hughes subleases 6,041 square feet at an initial fixed annual rent of $0.6 million and will increase 3.0% on each anniversary of the sublease commencement date. The term of the sublease is through March 2026 (unless terminated as provided in the sublease) and the sublease commencement date was February 1, 2023. The sublease was terminated on April 17, 2024 in connection with the termination of the lease agreement with BP Hancock LLC, in its capacity as landlord.

 

During the three months ended September 30, 2024, and September 30, 2023, the Company recognized nil and $0.1 million, respectively, in rent income. During the nine months ended September 30, 2024 and September 30, 2023, the Company recognized $0.1 million and $0.1 million in rent income, respectively. Rent income is included within sublease income in the unaudited condensed consolidated statement of operations

 

Additionally, the Company’s subsidiaries, Advent Technologies S.A. and Advent Technologies LLC, have in place rental agreements for the lease of office and factory spaces.

 

On March 8, 2021, the Company entered into a lease for 21,401 square feet as a product development and manufacturing center at Hood Park in Charlestown, MA. Under the terms of the lease, the Company will pay an initial fixed annual rent of $1.5 million. The lease has a term of eight years and five months, with an option to extend for five years, and commenced in October 2022. The Company is obliged to provide security in the form of a security deposit in the amount of $0.8 million before commencement of the lease.

 

On April 1, 2024, the Company agreed with the landlord of the Hood Park facility for a 4-month rate abatement period (March through June 2024) and extend the term of the lease for 4 additional months. On June 29, 2024, in an effort to reduce costs, the Company decided to abandon the facility at Hood Park and was able to find a new tenant to occupy the space. The Company and the landlord agreed to accelerate the expiration of the lease to occur on June 30, 2024. The Company had a letter of credit in the amount of $750 thousand in favor of the landlord and that letter of the credit was released to the landlord in satisfaction of any claims against the Company.

 

Rental expense for all operating leases was nil and $0.3 million for the three months ended September 30, 2024, and 2023, respectively. For the three months ended September 30, 2024, and 2023, rental expense for short-term leases was nil and $0.3 million, respectively.

 

Rental expense for all operating leases was $4.7 million and $1.7 million for the nine months ended September 30, 2024, and 2023, respectively. For the nine months ended September 30, 2024, and 2023, rental expense for short-term leases was $0.01 million and $0.4 million, respectively.

 

22

 

 

As of September 30, 2024, and December 31, 2023, the right of use assets, net associated with operating leases was $0.3 million and $3.2 million, respectively.

 

As of September 30, 2024, undiscounted maturities of operating lease liabilities remaining are as follows (amounts in thousands):

 

       
    Operating
Leases		  
Fiscal Year Ended December 31,        
2024   $ 35  
2025     140  
2026     107  
2027     4  
2028     -  
Thereafter     -  
Total undiscounted lease payments   $ 286  
Less: imputed interest     (16 )
Total discounted lease payments   $ 270  
Less: current portion     (111 )
Long-term lease liabilities   $ 159  

 

13. Private Placement Warrants and Working Capital Warrants

 

In connection with the Business Combination, the Company assumed 131,343 Private Placement Warrants issued upon AMCI’s initial public offering. In addition, upon the closing of the Business Combination, the working capital loan provided by AMCI’s Sponsor to AMCI was converted into 13,333 Working Capital Warrants, which were also assumed. The terms of the Working Capital Warrants are the same as those of the Private Placement Warrants.

 

As of September 30, 2024 and December 31, 2023, the Company had an aggregate of 65,671 Private Placement Warrants and Working Capital Warrants outstanding. Each Private Placement Warrant and Working Capital Warrant entitles the registered holder to purchase one share of Common Stock at a price of $345.00 per share, subject to adjustment, at any time commencing 30 days after the completion of the Business Combination. The Public Warrants expire five years after the closing of the Business Combination or earlier upon redemption or liquidation.

 

The Private Placement Warrants and Working Capital Warrants are identical to the Public Warrants, except that the Private Placement Warrants and Working Capital Warrants and the common stock issuable upon the exercise of those warrants were not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Working Capital Warrants are exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If those warrants are held by someone other than the initial purchasers or their permitted transferees, they will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. As of September 30, 2024, an aggregate of 65,671 Private Placement Warrants and Working Capital Warrants are held by its initial purchasers.

 

According to the provisions of the Private Placement Warrants and Working Capital Warrants warrant agreements, the exercise price and number of shares of common stock issuable upon exercise of those warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. Private Placement Warrants and Working Capital Warrants are classified as liabilities in accordance with the Company’s evaluation of the provisions of ASC 815-40-15, which provides that a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant with a fixed exercise price and fixed number of underlying shares.

 

23

 

 

14. Stockholders’ Equity

 

Shares Authorized

 

As of September 30, 2024, the Company had authorized a total of 501,000,000 shares for issuance with 500,000,000 shares designated as common stock, par value $0.0001 per share, and 1,000,000 shares designated as preferred stock, par value $0.0001 per share.

 

Common Stock

 

From February 2, 2024, through March 28, 2024, 24,976 shares of common stock were issued in connection with the At the Market Offering with H.C. Wainwright & Co., LLC for net proceeds of $0.1 million

 

From April 1, 2024, through April 15, 2024, 31,373 shares of common stock were issued in connection with the At the Market Offering with H.C. Wainwright & Co., LLC for net proceeds of $0.2 million.

 

As of September 30, 2024, and December 31, 2023, there were 2,636,508 and 2,580,159 shares of issued and outstanding common stock with a par value of $0.0001 per share, respectively.

 

Reverse Stock Split

 

On April 29, 2024 and April 30, 2024, our stockholders and Board, respectively, approved a reverse stock split of our Common Stock, at a ratio of 1-for-30 (the “Reverse Stock Split”), as of the Effective Date. The Effective Date of the Reverse Stock Split with the Secretary of the Commonwealth of Massachusetts was 5:00 p.m. on May 13, 2024 and May 14, 2024 in the marketplace.

 

On May 13, 2024, the Company completed a 1-for-30 reverse stock split.

 

On the Effective Date, the total number of shares of our Common Stock held by each shareholder was converted automatically into the number of whole shares of Common Stock equal to (i) the number of issued and outstanding shares of Common Stock held by such shareholder immediately prior to the Reverse Stock Split, divided by (ii) 30.

 

No fractional shares were issued in connection with the Reverse Stock Split, and stockholders who would otherwise be entitled to a fractional share received a proportional cash payment in April 2024. The Reverse Stock Split did not have any effect on the stated par value of the Company’s Common Stock. The rights and privileges of the holders of shares of Common Stock will be unaffected by the Reverse Stock Split.

 

The Company is authorized to issue 501,000,000 shares of Common Stock and that number did not change as a result of the Reverse Stock Split.

 

The consolidated financial statements and footnote disclosures have been updated to reflect the retrospective effect of the reverse stock split for all periods presented.

 

24

 

 

At the Market Offering Agreement

 

On June 2, 2023, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (the “Agent”), to create an at-the-market equity program under which it may sell up to $50 million of shares of the Company’s common stock (the “Shares”) from time to time through the Agent (the “ATM Offering”). Under the ATM Agreement, the Agent will be entitled to a commission at a fixed rate of 3.0% of the gross proceeds from each sale of Shares under the ATM Agreement.

 

Sales of the Shares, if any, under the ATM Agreement may be made in transactions that are deemed to be “at-the-market equity offerings” as defined in Rule 415 under the Securities Act, including sales made by means of ordinary brokers’ transactions, including on the Nasdaq Capital Market, at prevailing market prices at the time of sale or as otherwise agreed with the Agent. The Company has no obligation to sell, and the Agent is not obligated to buy or sell, any of the Shares under the Agreement and may at any time suspend offers under the Agreement or terminate the Agreement. The ATM Offering will terminate upon the termination of the ATM Agreement as permitted therein. The Shares will be issued pursuant to the Company’s previously filed Registration Statement on Form S-3 (File No. 333-271389) that was declared effective on May 2, 2023, and a prospectus supplement and accompanying prospectus relating to the ATM Offering filed with the SEC on June 2, 2023.

 

Deferred offering costs associated with the ATM Agreement are reclassified to additional paid in capital on a pro-rata basis when the Company completes offerings under the ATM Agreement. Any remaining deferred costs will be expensed to the statements of operations should the planned offering be terminated.

 

Public Warrants

 

In connection with the Business Combination, the Company assumed the Public Warrants issued upon AMCI’s initial public offering.

 

As of December 31, 2020, the Company had 735,069 Public Warrants outstanding. Each Public Warrant entitles the registered holder to purchase one share of common stock at a price of $345.00 per share, subject to adjustment, at any time commencing 30 days after the completion of the Business Combination. The Public Warrants will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. During the second quarter of 2021, certain warrant holders exercised their option to purchase an additional 760 shares at $345.00 per share. These exercises generated $262,177 additional proceeds to the Company and increased the Company’s shares outstanding by 760 shares. During 2023, one original Private Warrant Holder sold all their Private Placement Warrants resulting in a reclassification to Public Warrants. Following these exercises, as of September 30, 2024, the Company’s Public Warrants amounted to 813,314.

 

Once the warrants become exercisable, the Company may redeem the Public Warrants:

 

– in whole and not in part;

 

– at a price of $0.01 per warrant;

 

– upon not less than 30 days’ prior written notice of redemption;

 

– if, and only if, the reported last sale price of the Company’s Common Stock equals or exceeds $540.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders; and

 

– if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying such warrants.

 

25

 

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Common Stock at a price below its exercise price. In addition, the warrant agreement provides that in case of a tender offer or exchange that involves 50% or more of the Company’s stockholders, the Public Warrants may be settled in cash, equity securities or other assets depending on the kind and amount received per share by the holders of the common stock in such consolidation or merger that affirmatively make such election.

 

The Public Warrants are classified in equity in accordance with the Company’s evaluation of the provisions of ASC 480 and ASC 815. The Company analyzed the terms of the Public Warrants and concluded that there are no terms that provide that the warrant is not indexed to the issuer’s common stock. The Company also analyzed the tender offer provision discussed above and considering that upon the Closing of the Business Combination the Company has a single class of common shares, concluded that the exception discussed in ASC 815-40-25 applies, and thus equity classification is not precluded.

 

Stock-Based Compensation Plans

 

2021 Equity Incentive Plan

 

The Company’s Board of Directors (sometimes referred to herein as the “Board”) and stockholders previously approved the 2021 Equity Incentive Plan (the “Plan”) to reward certain employees and directors of the Company. The Plan has been established to advance the interests of the Company by providing for the grant to Participants of Stock and Stock-based Awards. The maximum number of shares of Common Stock that may be delivered in satisfaction of Awards under the Plan is 569,273 shares. On April 29, 2024, the stockholders voted to increase the number of shares of Common Stock issuable under the Company’s 2021 Equity Incentive Plan from 230,530 to 569,306.

 

Stock Options

 

Pursuant to and subject to the terms of the Plan the Company entered into separate Stock Option Agreements with each participant according to which each participant is granted an option (the “Stock Option”) to purchase up to a specific number of shares of common stock set forth in each agreement with an exercise price equal to the market price of Company’s common stock at the date of grant. The Company did not grant Stock Options during the three and nine months ended September 30, 2024.

 

Stock Options are granted to each participant in connection with their employment with the Company. The Stock Options vest on a graded basis over four years. The Company has a policy of recognizing compensation cost on a straight-line basis over the total requisite service period for the stock options. The Company recognized compensation cost of $0.6 million and $2.0 million in respect of Stock Options granted, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2024, respectively. The Company recognized compensation cost of $0.8 million and $2.5 million in respect of Stock Options granted, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2023, respectively. The Company also has a policy of accounting for forfeitures when they occur.

 

26

 

 

The following table summarizes the activities for our unvested stock options for the nine months ended September 30, 2024:

 

               
    Number of
options		    

Weighted
Average
Grant Date

Fair Value

  
Unvested as of December 31, 2023     57,894     $ 124.24  
Vested     (21,920 )   $ 134.19  
Forfeited     (11,948 )   $ 96.94  
Unvested as of September 30, 2024     24,026     $ 128.75  

 

As of September 30, 2024, there was $1.4 million of unrecognized compensation cost related to unvested Stock Options. This amount is expected to be recognized over the remaining vesting period of Stock Options.

 

Restricted Stock Units

 

Pursuant to and subject to the terms of the Plan the Company entered into separate Restricted Stock Units (“RSUs”) with each participant. On the grant date of RSUs, the Company grants to each participant a specific number of RSUs as set forth in each agreement, giving each participant the conditional right to receive without payment one share of common stock. The RSUs are granted to each participant in connection with their ongoing employment with the Company. The Company has in place Restricted Stock Unit Agreements that vest within one year and Restricted Stock Unit Agreements that vest on a graded basis over four years. The Company has a policy of recognizing compensation cost on a straight-line basis over the total requisite service period. The Company recognized compensation cost of $1.4 million and $4.0 million in respect of RSUs, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2024, respectively. The Company recognized compensation cost of $1.6 million and $4.9 million in respect of RSUs, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2023, respectively. The Company also has a policy of accounting for forfeitures when they occur. The Company did not grant RSUs during the nine months ended September 30, 2024.

 

The following table summarizes the activities for our unvested RSUs for the nine months ended September 30, 2024:

 

               
    Number of
Shares		     Weighted
Average
Grant Date
Fair Value		  
Unvested as of December 31, 2023     67,894     $ 200.1  
Vested     (29,503 )   $ 198.95  
Forfeited     (14,275 )   $ 126.55  
Unvested as of September 30, 2024     24,116     $ 244.63  

 

As of September 30, 2024, there was $2.5 million of unrecognized compensation cost related to unvested RSUs. This amount is expected to be recognized over the remaining vesting period of Restricted Stock Unit Agreements.

 

27

 

 

15. Revenue

 

Revenue is analyzed as follows:

 

                               
   

Three Months Ended

September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
Sales of goods   $ 128     $ 112     $ 1,852     $ -  
Sales of services     -       -       1,668       222  
Total revenue from contracts with customers   $ 128     $ 112     $ 3,520     $ 222  

 

The timing of revenue recognition is analyzed as follows:

 

 

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
Timing of revenue recognition                                
Revenue recognized at a point in time   $ 128     $ 112     $ 3,520     $ 222  
Revenue recognized over time     -       -       -       -  
Total revenue from contracts with customers   $ 128     $ 112     $ 3,520     $ 222  

 

As of September 30, 2024, and December 31, 2023, Advent recognized contract assets of nil and $9 thousand, respectively, on the consolidated balance sheets.

 

As of September 30, 2024, and December 31, 2023, Advent recognized contract liabilities of $1.2 million and $0.4 million, respectively, in the consolidated balance sheets. During the nine months ended September 30, 2024, the Company recognized the amount of $0.1 million in revenues.

 

16. Collaborative Arrangements

 

Cooperative Research and Development Agreement

 

In August 2020, the Company entered into a Cooperative Research and Development Agreement (“CRADA”) with Triad National Security, LLC (“TRIAD”), Alliance for Sustainable Energy LLC (“ASE”), and Brookhaven Science Associates (“BSA”). The purpose of this project is to build a fuel cell prototype that moves this technology closer to commercial readiness which was sanctioned by the Los Alamos National Laboratory and the National Renewable Energy Laboratory. The Government’s estimated total contribution, which is provided through TRIAD’s, ASE’s, and BSA’s respective contracts with the Department of Energy is $1.2 million, subject to available funding. As a part of the CRADA, the Company is required to contribute $1.2 million in cash and $0.6 million of in-kind contributions, such as personnel salaries. The cash payments are capitalized and amortized on a straight-line basis over the life of the contract. In-kind contributions are expensed as incurred. To date, the Company has not recognized any revenue from the CRADA. In December 2022, the term of the agreement was extended until March 3, 2024. In January 2024, the term of the agreement was extended until September 3, 2024.

 

Expenses from Collaborative Arrangements

 

For the three and nine months ended September 30, 2024, an amount of nil and $0.1 million has been recognized in research and development expenses on the unaudited condensed consolidated statements of operations, respectively. For the three and nine months ended September 30, 2023, an amount of $0.2 million and $1.5 million has been recognized in research and development expenses on the consolidated statements of operations, respectively.

 

28

 

 

17. Income Taxes

 

To calculate the interim tax provision, at the end of each interim period the Company estimates the annual effective tax rate and applies that to its ordinary quarterly earnings. The effect of changes in the enacted tax laws or rates is recognized in the interim period in which the change occurs. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and judgments including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in foreign jurisdictions, permanent differences between book and tax amounts, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, additional information is obtained, or the tax environment changes.

 

During the three and nine months ended September 30, 2024, the Company recorded income tax benefit of nil and $0.1 million, respectively, mainly related to net operating loss carryforwards. During the three and nine months ended September 30, 2023, the Company recorded income tax benefits of $80 thousand and $0.2 million, respectively, mainly related to the Company’s recoverability assessment of research and development tax credits in Denmark. As of September 30, 2024, and December 31, 2023, the Company provided a valuation allowance to offset the deferred tax asset related to the net operating loss carryforwards in Denmark.

 

18. Segment Reporting and Information about Geographical Areas

 

Reportable Segments

 

The Company develops and manufactures high-temperature proton exchange membranes (“HT-PEM” or “HT-PEMs”) and fuel cell systems for the off-grid and portable power markets and plans to expand into the mobility market. The Company’s current revenue is derived from the sale of fuel cell systems and from the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets. The research and development activities are viewed as another product line that contributes to the development, design, production and sale of fuel cell products; however, it is not considered a separate operating segment. The Company has identified one business segment.

 

Geographic Information

 

The following table presents revenues, by geographic location (based on the location of the entity selling the product) for the three and nine months ended September 30, 2024 and 2023:

 

                               
   

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
North America   $ 128     $ 63     $ 3,052     $ 173  
Europe     -       49       468       49  
Asia     -       -       -       -  
Total net sales   $ 128     $ 112     $ 3,520     $ 222  

 

19. Commitments and contingencies

 

Litigation

 

The Company is subject to legal and regulatory actions that arise from time to time in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events.

 

29

 

 

On June 7, 2023, the Company was served a Request for Arbitration from F.E.R. fischer Edelstahlrohre GmbH (“F.E.R.”), pursuant to the arbitration provisions of the Share Purchase Agreement dated June 25, 2021 whereby the Company acquired SerEnergy and FES, which acquisition closed on August 31, 2021. The arbitration was held in Frankfurt am Main, Germany in accordance with the Arbitration Rules of the German Arbitration Institute, and the parties presented closing arguments in May 2024. F.E.R. is asserting that it is due approximately €4.5 million based on the cap and corresponding value of the share consideration at the date of closing. On August 16, 2024, the Company was informed that an arbitration decision and award was decided in favor of F.E.R. in the amount of approximately €4.5 million. On November 18, 2024, the Company filed a motion with the Higher Regional Court of Frankfurt to set aside the arbitral award. At this time, the Company cannot accurately predict the outcome of this matter, however, has recorded a loss contingency in the amount of $4.9 million, accrued interest expense of $0.3 million for a total of $5.2 million accrued loss liability as of September 30, 2024.

 

There is no other material pending or threatened litigation against the Company that remains outstanding as of September 30, 2024, that is considered probable or reasonably possible.

 

Guarantee letters

 

The Company had contingent liabilities in relation to performance guarantee letters and other guarantees provided to third parties that arise from its normal business activity and from which no substantial charges are expected to arise. As of September 30, 2024 and December 31, 2023, the Company did not hold any letters of guarantee.

 

Contractual obligations

 

In December 2021, the Company entered into a supply agreement by and among the Company, in its capacity as Customer, and BASF New Business GmbH, in its capacity as Seller. The supply agreement provides for the purchase by the Company of 21,000m2 (Minimum Quantity) of membrane from BASF during the contract duration from January 1, 2022 until December 31, 2025. The Company has not purchased any additional quantities in 2024 under this agreement and on July 12, 2024, has formally requested to terminate the supply contract.

 

In June 2022, the Company entered into a supply agreement by and among the Company, in its capacity as Customer, and Shin-Etsu Polymer Singapore Pte, Ltd (“Shin-Etsu”), in its capacity as Seller. The supply agreement provides for the purchase by the Company of 318,400 pieces (Minimum Quantity) of bipolar plates from Shin-Etsu during the contract duration from June 1, 2022 until June 30, 2024. In May 2023, the Company amended the supply agreement with Shin-Etsu to reduce the Minimum Quantity of bipolar plates to 75,400 pieces. In January 2024, the Company amended the supply agreement with Shin-Etsu to shift the timing of the monthly minimum requirements and extend the agreement until September 2024. The Company has not made any purchases under the amended agreement in 2024, the contract is currently on hold pending negotiations with Shin Etsu. Under the contract, Shin- Etsu can claim Advent to buy the remaining purchase requirement with the agreed purchases by the end of September 2024. The Company has not purchased any additional quantities in 2024 under this agreement and has formally requested to terminate the supply contract.

 

The following table summarizes our contractual obligations as of September 30, 2024:

 

                       
Fiscal Year Ended December 31,   Quantity (pieces)     Quantity (m2)    

Price

(Amounts in thousands)

  
2024     57,600       6,174       2,304  
2025     -       8,000       2,150  
Total     57,600       14,174     $ 4,454  

 

The Company has not accrued for these unrecognized commitment obligations as of September 30, 2024, and December 31, 2023.

 

30

 

 

20. Net loss per share

 

Net loss per share is computed by dividing net loss by the weighted-average number of shares of Common Stock outstanding during the year.

 

The following table sets forth the computation of the basic and diluted net loss per share for the three and nine months ended September 30, 2024 and 2023:

 

                               
   

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands, except share and per share amounts)   2024     2023     2024     2023  
Numerator:                                
Net loss from continuing operations   $ (9,615 )   $ (9,891 )   $ (29,244 )   $ (26,530 )
Net loss from discontinued operations   $ (8,907 )   $ (1,955 )   $ (9,907 )   $ (19,135 )
Net loss   $ (18,522 )   $ (11,846 )   $ (39,151 )   $ (45,665 )
Denominator:                                
Basic weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Diluted weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Net loss per share:                                
Basic loss per share from continuing operations   $ (3.65 )   $ (4.92 )   $ (11.17 )   $ (14.39 )
Basic loss per share from discontinued operations   $ (3.38 )   $ (0.97 )   $ (3.78 )   $ (10.38 )
Basic loss per share   $ (7.03 )   $ (5.89 )   $ (14.95 )   $ (24.78 )
Diluted loss per share from continuing operations   $ (3.65 )   $ (4.92 )   $ (11.17 )   $ (14.39 )
Diluted loss per share from discontinued operations   $ (3.38 )   $ (0.97 )   $ (3.78 )   $ (10.38 )
Diluted loss per share   $ (7.03 )   $ (5.89 )   $ (14.95 )   $ (24.78 )

 

Basic net loss per share is computed by dividing net loss for the periods presented by the weighted-average number of shares of Common Stock outstanding during these periods.

 

Diluted net loss per share is computed by dividing the net loss, by the weighted average number of shares of Common Stock outstanding for the periods, adjusted for the dilutive effect of shares of Common Stock equivalents resulting from the assumed exercise of the Public Warrants, Private Placements Warrants, Working Capital Warrants, Stock Options and RSUs. The treasury stock method was used to calculate the potential dilutive effect of these Common Stock equivalents.

 

As the Company incurred losses for the three and nine months ended September 30, 2024 and 2023, the effect of including any potential shares of Common Stock in the denominator of diluted per-share computations would have been anti-dilutive; therefore, basic and diluted losses per share are the same.

 

31

 

 

21. Discontinued Operations

 

The following table presents a reconciliation of the carrying amounts of the major classes of assets and liabilities of discontinued operations to the total assets and liabilities of discontinued operations as presented in the condensed consolidated balance sheet.

 

       
(Amounts in thousands)   December 31,
2023		  
Assets        
Cash and cash equivalents   $ 362  
Accounts receivable, net     128  
Contract assets     12  
Inventories, net     2,512  
Prepaid expenses and other current assets     1,416  
Property, plant and equipment, net     1,463  
Right-of-use assets     59  
Other non-current assets     66  
Total Assets   $ 6,018  

 

         
(Amounts in thousands)   December 31,
2023		  
Liabilities        
Trade payables   $ 1,091  
Deferred income from grants, current     7  
Contract liabilities     1,601  
Other current liabilities     881  
Operating lease liabilities     48  
Lease liabilities – long-term     12  
Other long-term liabilities     683  
Total Liabilities   $ 4,323  

 

During the three and nine months ended September 30, 2024, and 2023, the Company’s operating results for the discontinued entities (Advent Technologies A/S and Advent Green Energy Philippines, Inc.):

 

                               
    Three months ended
September 30,
(Unaudited)		     Nine months ended
September 30,
(Unaudited)		  
(Amounts in USD in thousands)   2024     2023     2024     2023  
Revenue, net   $ (135 )   $ 1,152     $ 728     $ 3,131  
Cost of revenues     (102 )     (1,649 )     (716 )     (4,509 )
Gross profit / (loss)     (237 )     (497 )     12       (1,378 )
Income from grants     (541 )     254       310       902  
Research and development expenses     -       (934 )     -       (3,410 )
Administrative and selling expenses     (2,067 )     (916 )     (4,167 )     (14,951 )
Credit loss – customer contracts     -       67       -       -  
Operating loss     (2,845 )     (2,026 )     (3,845 )     (18,837 )
Finance income / (expenses), net     -       72       -       640  
Foreign exchange gains / (losses), net     -       10       -       (1 )
Other income / (expenses), net     -       (11 )     -       (13 )
Net assets / (liabilities) – Advent Technologies A/S and Advent Green Energy Philippines, Inc.     6,278       -       6,278       -  
Payable to Advent Technologies A/S     (12,340 )              (12,340 )      -  
Loss before income tax     (8,907 )     (1,954 )     (9,907 )     (18,211 )
Income taxes     -       (1 )     -       (924 )
Net loss   $ (8,907 )   $ (1,955 )   $ (9,907 )   $ (19,135 )

 

32

 

 

22. Subsequent Events

 

On October 15, 2024, the Company reported that as disclosed previously, on May 24, 2024, and August 28, 2024, the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notified the Company that, as of the date of such notification, it no longer met the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1)(the “Rule”) because it had not yet filed its Quarterly Reports on Form 10-Q for the periods ended March 31, and June 30, 2024 (the “Form 10-Qs”). On October 15, 2024, the Company received a letter from the Staff indicating that based on the October 15, 2024 filings of the Quarterly Reports on Form 10-Qs for the periods ended March 31, and June 30, 2024, the Staff has determined that the Company complies with the Rule. Accordingly, this matter is now closed. 

 

On October 18, 2024, the Company received a letter from the Staff of Nasdaq notifying the Company that because the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024, reported stockholders’ equity of ($2,879,000), and as of the date of such letter, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations, the Company was no longer compliant with Nasdaq’s Listing Rule requiring the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing.

 

As a result, as of October 18, 2024, under Nasdaq Rules the Company had 45 calendar days to submit a plan to regain compliance. If the Company’s plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance.

 

On October 24, 2024, the Board of the Company approved the termination of the employment of Vassilios Gregoriou, the Chief Executive Officer, Acting Chief Financial Officer, for cause, effective immediately.

 

Further to said termination, in connection with Mr. Gregoriou’s termination, the Company’s Board of Directors appointed Mr. Gary Herman, who is currently serving as a member of the Board, to the additional role of interim chief executive officer, effective immediately, until a new Chief Executive Officer is appointed. Mr. Herman, 60, is a seasoned investor with many years of investment and business experience. From 2005 to 2020 he co-managed the Strategic Turnaround Equity Partners, LP (Cayman) fund and its affiliates. From January 2011 to August 2013, he was a managing member of Abacoa Capital Management, LLC, which managed Abacoa Capital Master Fund, Ltd., focused on a Global-Macro investment strategy. From 2005 to 2020, Mr. Herman was affiliated with Arcadia Securities LLC, a New York-based broker-dealer. From 1997 to 2002, he was an investment banker with Burnham Securities, Inc. From 1993 to 1997, he was a managing partner of Kingshill Group, Inc., a merchant banking and financial firm with offices in New York and Tokyo. Mr. Herman has a B.S. from the University at Albany with a major in Political Science and minors in Business and Music. Mr. Herman has many years of experience serving on the boards of public and private companies. He presently sits on the boards of Siyata Mobile, Inc. (NASDAQ: SYTA), Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), SRM Entertainment, Inc. (NASDAQ: SRM), LQR House, Inc. (NASDAQ: LQR), SusGlobal Energy Corp. (OTCQB: SNRG) and XS Financial, Inc. (CSE: XS).

 

There are no family relationships between Mr. Herman and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

On October 29, 2024, the Board of the Company approved the termination of the employment of Christos Kaskavelis, Chief Strategy Officer of the Company, for cause, effective immediately.

 

On November 8, 2024, the Company terminated the Securities Purchase Agreement it had previously entered into on July 30, 2024 (the “SPA”) with an institutional investor (the “Investor”) pursuant to which, at the closing, the Company was contemplated to have issued to the Investor a senior promissory note in the principal amount of $1,000,000 (the “Senior Note”). The Investor had also committed to provide the Company with a one-year revolving line of credit to the Company for an aggregate maximum principal amount of $2,000,000, contingent upon the Company’s filing of a Registration Statement on Form S-1 with the SEC with respect to an underwritten or “best efforts” public offering by the Company of its common stock, and/or common stock equivalents registered under the Securities Act of 1933, as amended (the “Securities Act”) for proceeds to the Company of not less than $5,000,000. This transaction is referred to herein as the “Financing.” Inasmuch as the Investor failed to comply with the terms of the SPA and did not provide any funds to the Company to ultimately complete the Financing, the Board voted to terminate the SPA and potential Financing. The Company had initially disclosed the SPA and Financing on its Current Report on Form 8-K filed with the SEC on August 5, 2024.

 

33

 

 

Effective as of November 4, 2024, the Company appointed Messrs. Seth M. Lukash and Joseph P. Celia to the Board as Class II directors. Mr. Lukash will serve on the compensation and audit committees, and as chair of the audit committee. Mr. Celia will serve on the audit and compensation committees and as a chair of the compensation committee.

 

Mr. Seth Lukash, 78, is a seasoned corporate director, officer, and investor. For 30 years he was a CEO for various technology and manufacturing companies. He was CEO and President of Tridex, Inc. (n/k/a TransAct Technologies (Nasdaq: TACT) a manufacturer of printers and peripherals to the banking, lottery/gaming, and retail sales markets. Mr. Lukash was Chairman and CEO of Progressive Software, a large provider of application software to the restaurant and hospitality industry. After the sale and divestiture of these companies he advised several technology companies. He has served as an advisor to OEM Capital a boutique investment banking firm and Strategic Turnaround Equity Partners, LP, a fund focused on investments in undervalued public companies. For the past two years he has advised an AI start-up with their organization and structuring for additional financing. He started his finance career as a research analyst for Carter Berlind & Weil. Mr. Lukash is a graduate of the University of Miami with a BA in Finance.

 

Mr. Joseph P. Celia, 60, is a technology industry veteran with 30 years of experience with an impressive track record in building strategic partnerships, driving new business initiatives, and penetrating new markets. His dynamic and results-oriented approach in sales leadership within the rapidly evolving tech sector has consistently led to significant achievements. Mr. Celia has held executive and senior-level sales management positions at some of the tech industry’s most respected organizations, including Hewlett Packard, Motorola, 3Com, Symbol Technologies, Bradford Networks, Accton Technology, and FIS Global. Mr. Celia has a BS from Northeastern University in Computer Technology.

 

In connection with his appointment, the Board has determined that Mr. Lukash (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); (ii) is an “independent director” as contemplated by Nasdaq Listing Rule 5605(b)(1); and (iii) is an “audit committee financial expert,” as defined in Item 407(d)(5)(ii) of Regulation S-K. In connection with his appointment, the Board has determined that Mr. Celia (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); and (ii) is an “independent director” as contemplated by Nasdaq Listing Rule 5605(b)(1).

 

There are no arrangements or understandings between any of the new Directors and any other person pursuant to which each was selected as a director, and there have been no transactions since the beginning of the Company’s last fiscal year, nor are there any currently proposed transactions, regarding the new Directors that are required to be disclosed by Item 404(a) of Regulation S-K promulgated under the Exchange Act.

 

34

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on August 13, 2024 (“2023 Annual Report”).

 

Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the “Item 1A. Risk Factors” section of this Quarterly Report on Form 10-Q and the “Item 1A. Risk Factors” section of our 2023 Annual Report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

 

Overview

 

Advent Technologies Holdings, Inc. and its subsidiaries (collectively referred to as “Advent” and the “Company”) is an advanced materials and technology development company operating in the fuel cell, methanol, and hydrogen technology space. Advent is a world-leading company in the development of the HT-PEM technology (with more than 150 patents issued, pending, or licensed worldwide). The HT-PEM fuel cell technology developed by Advent enables off-grid power systems to produce clean power from various green fuels (hydrogen, methanol, bio and eMethanol, and renewable natural gas) and to function with higher efficiency at extreme ambient temperatures and in general extreme environmental conditions (humidity, air pollution). Advent’s main operations focus on developing and manufacturing the Membrane Electrode Assembly (MEA), which is the core electrochemical element and the most critical component of the fuel cell. The MEA largely determines lifetime, power density, efficiency, and overall cost of installation and operation for all applications. Advent is working with world-leading market-leading OEMs with the goal of bringing to the market complete fuel cell systems for a range of applications in the stationary power markets (backup, off-grid, and portable power) and the heavy-duty mobility markets (automotive, aviation, marine).

 

Advent’s core product offerings are fuel cell stacks and the Membrane Electrode Assembly (MEA) at the center of the fuel cell. The Advent MEA, which derives its key benefits from the properties of Advent’s engineered membrane and electrode technology, enables a high power-density, longer-lasting and ultimately lower-cost fuel cell product.

 

Advent’s principal operations have been to develop and manufacture MEAs, and to design fuel cell stacks and complete fuel cell systems for a range of applications in the stationary power, portable power, automotive, aviation, energy storage and sensor markets. Advent has its headquarters in Livermore, California, and product development facilities in Livermore, California and Patras, Greece.

 

The majority of Advent’s current revenue derives from Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) with world-leading OEMs for the development of joint products. The ultimate goal is that OEMs will bring to the market with Advent-inside technology (the Advent MEA and/or the Advent Fuel Cell Stack). The Company has also extensive know-how and IP in the development of full fuel cell systems that it intends to license out to OEMs and Tier1s through technology license agreements. Advent has also secured grant funding for a range of projects from research agencies and other organizations. Advent expects to continue to be eligible for grant funding based on its product development activities over the foreseeable future.

 

Business Developments

 

Management and Board Changes

 

On October 24, 2024, the Board approved the termination of the employment of Vassilios Gregoriou, the Chief Executive Officer, Acting Chief Financial Officer, for cause, effective immediately.

 

35

 

 

Further to the said termination, in connection with Mr. Gregoriou’s termination, the Board appointed Mr. Gary Herman, who is currently serving as a member of the Board, to the additional role of interim chief executive officer, effective immediately, until a new Chief Executive Officer is appointed. Mr. Herman, 60, is a seasoned investor with many years of investment and business experience. From 2005 to 2020 he co-managed the Strategic Turnaround Equity Partners, LP (Cayman) fund and its affiliates. From January 2011 to August 2013, he was a managing member of Abacoa Capital Management, LLC, which managed Abacoa Capital Master Fund, Ltd., focused on a Global-Macro investment strategy. From 2005 to 2020, Mr. Herman was affiliated with Arcadia Securities LLC, a New York-based broker-dealer. From 1997 to 2002, he was an investment banker with Burnham Securities, Inc. From 1993 to 1997, he was a managing partner of Kingshill Group, Inc., a merchant banking and financial firm with offices in New York and Tokyo. Mr. Herman has a B.S. from the University at Albany with a major in Political Science and minors in Business and Music. Mr. Herman has many years of experience serving on the boards of public and private companies. He presently sits on the boards of Siyata Mobile, Inc. (NASDAQ: SYTA), Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), SRM Entertainment, Inc. (NASDAQ: SRM), LQR House, Inc. (NASDAQ: LQR), SusGlobal Energy Corp. (OTCQB: SNRG) and XS Financial, Inc. (CSE: XS).

 

There are no family relationships between Mr. Herman and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

On October 29, 2024, the Board of the Company approved the termination of the employment of Christos Kaskavelis, Chief Strategy Officer of the Company, for cause, effective immediately.

 

Effective as of November 4, 2024, the Company appointed Messrs. Seth M. Lukash and Joseph P. Celia to the Board as Class II directors. Mr. Lukash will serve on the compensation and audit committees, and as chair of the audit committee. Mr. Celia will serve on the audit and compensation committees, respectively.

 

Mr. Seth Lukash, 78, is a seasoned corporate director, officer, and investor. For 30 years he was a CEO for various technology and manufacturing companies. He was CEO and President of Tridex, Inc. (n/k/a TransAct Technologies (NASDAQ: TACT) a manufacturer of printers and peripherals to the banking, lottery/gaming, and retail sales markets. Mr. Lukash was Chairman and CEO of Progressive Software, a large provider of application software to the restaurant and hospitality industry. After the sale and divestiture of these companies he advised several technology companies. He has served as an advisor to OEM Capital a boutique investment banking firm and Strategic Turnaround Equity Partners, LP, a fund focused on investments in undervalued public companies. For the past two years he has advised an AI start-up with their organization and structuring for additional financing. He started his finance career as a research analyst for Carter Berlind & Weil. Mr. Lukash is a graduate of the University of Miami with a BA in Finance.

 

Mr. Joseph P. Celia, 60, is a technology industry veteran with 30 years of experience with an impressive track record in building strategic partnerships, driving new business initiatives, and penetrating new markets. His dynamic and results-oriented approach in sales leadership within the rapidly evolving tech sector has consistently led to significant achievements. Mr. Celia has held executive and senior-level sales management positions at some of the tech industry’s most respected organizations, including Hewlett Packard, Motorola, 3Com, Symbol Technologies, Bradford Networks, Accton Technology, and FIS Global. Mr. Celia has a BS from Northeastern University in Computer Technology.

 

In connection with his appointment, the Board has determined that Mr. Lukash (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); (ii) is an “independent director” as contemplated by Nasdaq Listing Rule 5605(b)(1); and (iii) is an “audit committee financial expert,” as defined in Item 407(d)(5)(ii) of Regulation S-K. In connection with his appointment, the Board has determined that Mr. Celia (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); and (ii) is an “independent director” as contemplated by Nasdaq Listing Rule 5605(b)(1).

 

There are no arrangements or understandings between any of the new Directors and any other person pursuant to which each was selected as a director, and there have been no transactions since the beginning of the Company’s last fiscal year, nor are there any currently proposed transactions, regarding the new Directors that are required to be disclosed by Item 404(a) of Regulation S-K promulgated under the Exchange Act.

 

36

 

 

RHyno Project awarded €34.5 Million by EU Innovation Fund

 

On November 4, 2024, the Company announced that the Advent Renewable Hydrogen Innovative Technologies (RHyno) project initiated by its Greek subsidiary, Advanced Energy Technologies, SA was approved for the full amount of its requested grant in the amount of €34.5 million by the EU Innovation Fund. The Company is in the process of preparing the grant agreement per the instructions provided to it by the European Climate, Infrastructure and Environment Executive Agency (CINEA), which is expected to be signed in the first quarter of 2025.

 

The RHyno project involves the establishment of infrastructure for developing and manufacturing innovative fuel cells, electrolysers, and their key components including the Company’s ground-breaking Membrane Electrode Assembly technology at a megawatt (MW) scale. RHyno aims to pioneer the use of innovative materials to enhance power density and lifespan while significantly reducing the weight and volume of power systems through a streamlined balance of plant.

 

The state-of-the-art manufacturing facility is designed to optimize production processes, boost efficiency, and industrialize fuel cell and electrolyser technologies. These advancements are essential for decarbonizing carbon intense industries, such as the aviation, maritime and heavy-duty automotive sectors, with further potential for spillover to other sectors, positioning Advent at the forefront of the clean energy transition.

 

Green HiPo Project approved by EU not expected to receive funding

 

On June 16, 2022, Advent announced the receipt of a notification from the Greek State informing the Company that the IPCEI Green HiPo was submitted for ratification by the EU for funding. On July 15, 2022, Advent received official ratification from the European Commission of the EU. The Green HiPo project is designed to bring the development, design, and manufacture of HT-PEM fuel cells and electrolysers for the production of power and green hydrogen to the Western Macedonia region of Greece.

 

In February 2024, the Company received a formal invitation from the Greek State for €24 million grant for the Green HiPo IPCEI project, however, due to the two-year delay in receiving a signed agreement from the Greek Ministry of Economy and Finance and the uncertainty in the Company’s ability to secure the additional €36 million in funding, the Company does not expect any disbursement of the state aid package in the near future.

 

On September 16, 2024, Advent Technologies SA (“ATSA”), a subsidiary of the Company, received a letter from the Greek Ministry of Finance (the “Letter”) indicating that the Company is no longer eligible to receive funding under the previously awarded grant with respect to the Important Projects of Common European Interest (“IPCEI”) proposed project, Green HiPo, due to the Company’s current financial condition. ATSA has filed an appeal as permitted by the Letter.

 

Airbus Term Sheet to Launch a Joint Benchmarking Project

 

On November 6, 2023, Advent announced that it entered into a term sheet with Airbus, a global leader in aeronautics, space, and related services, for a joint benchmarking project regarding an optimized Ion Pair™ Membrane Electrode Assembly (“MEA”) for hydrogen fuel cells. Airbus will provide financial support to the project and its extensive knowledge of the aviation industry. Advent will invest in people, materials, hardware, and third-party research centers, to contribute to the goals of the project. The multi-million dollar collaboration is currently expected to take place over two years.

 

The goal of the project is to accelerate the development of Advent’s MEA and benchmark the Ion Pair MEA against aviation requirements and current/expected technological limits. HT-PEM MEAs operating at temperatures higher than 180°C (360°F) aim to solve one of the largest challenges in aviation fuel cell use: thermal management. High-temperature fuel cells allow increased performance, increased passenger carrying capability, and increased range compared to low-temperature fuel cell stack technology. Advent believes that HT-PEM is a superior option not only for aviation, but also for heavy-duty trucks, the automotive industry and marine use.

 

37

 

 

At the Market Offering Agreement

 

On June 2, 2023, Advent entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (the “Agent”), to create an at-the-market equity program under which it may sell up to $50 million of shares of Advent’s Common Stock from time to time through the Agent (the “ATM Offering”). Under the ATM Agreement, the Agent will be entitled to a commission at a fixed rate of 3.0% of the gross proceeds from each sale of shares under the ATM Agreement.

 

Sales of Common Stock, if any, under the ATM Agreement may be made in transactions that are deemed to be “at-the-market equity offerings” as defined in the Securities Act, including sales made by means of ordinary brokers’ transactions, including on the Nasdaq Capital Market, at prevailing market prices at the time of sale or as otherwise agreed with the Agent. Advent has no obligation to sell, and the Agent is not obligated to buy or sell, any of the Common Stock under the Agreement and may at any time suspend offers under the Agreement or terminate the Agreement. The ATM Offering will terminate upon the termination of the ATM Agreement as permitted therein. As of September 30, 2024, the Agent had sold an aggregate of 232,672 shares for total consideration to the Company of $1.7 million.

 

Common Stock was issued pursuant to Advent’s previously filed Registration Statement on Form S-3 (File No. 333-271389) that was declared effective on May 2, 2023, and a prospectus supplement and accompanying prospectus relating to the ATM Offering filed with the SEC on June 2, 2023.

 

Hood Park Facility

 

In March 2023, Advent announced that it had opened its new R&D and manufacturing facility at Hood Park in Boston, Massachusetts. On June 29, 2024, in an effort to reduce costs, the Company decided to abandon the facility at Hood Park and was able to find a new tenant to occupy the space. The Company and the landlord agreed to accelerate the expiration of the lease to occur on June 30, 2024. The Company had a letter of credit in the amount of $750 thousand in favor of the landlord and that letter of the credit was released to the landlord in satisfaction of any claims against the Company.

 

Collaboration with the Department of Energy

 

The efforts with the constellation of Department of Energy National Laboratories (Los Alamos National Laboratory, LANL; Brookhaven National Laboratory, BNL; National Renewable Energy Laboratory, NREL) continue to gain momentum. This group of leading scientists and engineers is working closely with Advent’s development and manufacturing teams and are furthering the understanding of breakthrough materials that will advance HT-PEM fuel cells. This next generation HT-PEM appears to be well suited for heavy duty transportation, marine, and aeronautical applications, as well as delivering benefits in cost and lifetime for stationary power systems used in telecom and other remote power markets.

 

Agreements with Hyundai Motor Company (“Hyundai”)

 

On April 6, 2022, Advent announced the signing of a technology assessment, sales, and development agreement with Hyundai, a leading multinational automotive manufacturer offering a range of world-class vehicles and mobility services in over 200 countries. Advent and Hyundai aim to deliver green energy solutions to current high carbon applications, using fuel cell technology. Under the agreement, Hyundai will provide catalysts to Advent for evaluation in its proprietary MEAs, while Advent intends to support Hyundai in fulfilling its fuel cell project needs, through:

 

● Developing inks and structures using Hyundai catalysts, which will then be evaluated by Hyundai. Following evaluation, Hyundai will determine whether their own or standard catalysts will be used for this project.

 

● Supplying MEAs throughout the development/commercialization cycle (“Advent MEAs”) for testing, evaluation, and optimization under conditions set by Hyundai.

 

● Assisting Hyundai with the use and specifications of MEAs as well as their implementation into Hyundai’s designs.

 

38

 

 

On March 23, 2023, Hyundai announced a successful technology assessment with Advent and following its success, Advent and Hyundai entered into a Joint Development Agreement (“JDA”). Under the agreement, Hyundai and Advent will work together to further develop HMC-Advent Ion Pair™ MEA, establish commercial criteria for MEA supply, and evaluate Advent’s advanced fuel cell technology for Hyundai’s heavy-duty and/or stationary application. Additionally, the parties will introduce advanced cooling technologies for mobility HT-PEM fuel cell stacks. Advent will work closely as Hyundai evaluates these stack cooling technologies and ensure optimal performance under different operating conditions.

 

This partnership builds upon a commitment from both companies to develop sustainable energy solutions for carbon-intensive applications. Hyundai aims to accelerate the establishment of a hydrogen-based society based on its vision, Progress for Humanity, and this JDA aligns with that vision. The synergy generated by combining the two companies’ advanced technology in this JDA is expected to revolutionize the global MEA market by providing significant improvement in lifetime and an increase in power density versus current HT-PEM MEAs.

 

Selection of Wearable Fuel Cell for the DOD 2021 Validation Program

 

On March 31, 2021, we announced that Advent’s 50 W Reformed Methanol Wearable Fuel Cell Power System (“Honey Badger”) had been selected by the DoD National Defense Center for Energy and Environment (“NDCEE”) to take part in its demonstration/validation program for 2021. The NDCEE is a DOD program that addresses high-priority environmental, safety, occupational health, and energy technological challenges that are demonstrated and validated at active installations for military application. The Company believes Advent’s Honey Badger 50™ (“HB50”) fuel cell is the only fuel cell that is part of this program that supports the U.S. Army’s goal of having a technology-enabled force by 2028.

 

Launch of the Honey Badger 50™ Fuel Cell System

 

On August 4, 2022, we announced the launch of our HB50 power system, a compact portable fuel cell system and quiet power supply for use in off-grid field applications such as military and rescue operations. The launch of Advent’s portable power system coincided with the Company’s fulfilment of its first shipment order from the U.S. Department of Defense. The HB50 power system can be fueled by biodegradable methanol, allowing near silent generation of up to 50W of continuous power with clean emissions. Designed for covert operations, HB50 can easily power radio and satellite communications gear, remote fixed and mobile surveillance systems, and laptop computers along with more general battery charging needs. HB50 is a unique technology that can provide 65% of weight savings versus batteries over a typical 72-hour mission. The weight savings benefit increases further for longer missions.

 

HB50’s unique design allows it to be used in soldier-worn configurations or operated inside a portable backpack or vehicle while charging batteries and powering soldier systems, while its thermal features allow it to operate within an ambient temperature range of -20°C to +55°C. Aside from its optimized compatibility with Integrated Visual Augmentation System (“IVAS”), HB50 can also power devices such as high frequency radios like the model 117G, as well as B-GAN and StarLink terminals. HB50’s durability allows it to be easily deployed in challenging conditions and climates while supporting mission mobility for three to seven days without the need to re-supply.

 

Since Honey Badger’s fuel cell technology can run on hydrogen or liquid fuels, the system can operate at a fraction of the weight of traditional military-grade batteries to meet the U.S. Department of Defense’s continuously evolving needs for ‘on-the-go’ electronics needs. As military adoption and use of IVAS equipment continues to evolve, the highly portable lightweight power solutions like Honey Badger and HB50 will become a mission critical necessity.

 

In September 2023, Advent secured a new $2.2 million contract with the U.S. DOD. This milestone achievement comes under the General Technical Services prime contract and will play a crucial role in supporting the demanding defense mission requirements of the U.S. Army. This contract is the continuation of a series of past contracts with the U.S. DOD and its primary objective is to further optimize Advent’s proprietary Honey Badger 50™ portable fuel cell system by integrating the Company’s innovative Ion Pair MEA technology. Upon the completion of this new 12-month contract, Advent and the U.S. DOD aim to reinforce their long-term collaboration by focusing on the manufacturing process of the enhanced HB50 fuel cell system, that will enable high-volume production manufacturing capacity. MEAs form the heart of the fuel cell, and their performance determines the lifetime, efficiency, weight, and to a large extent, the cost of the end electrochemistry products. Advent’s Ion Pair MEA technology is anticipated to significantly enhance HB50’s performance, resulting in higher power density and improved compact packaging, making it an ideal solution for off-grid field applications, including military and rescue operations.

 

39

 

 

In December 2023, Advent secured a new $2.8 million contract with the U.S. DOD. Under this new defense contract which comes under the umbrella of the Envision Innovative Solutions (“EIS’’), Advent will develop advanced manufacturing processes to enable a substantial increase in the production capacity while maintaining quality of the HB50 system. This new project is aligned with Advent’s and the DOD’s shared objective to strengthen their long-term collaboration and transform HB50 into a portable and clean source of power.

 

Advent Technologies A/S declared bankrupt

 

On July 25, 2024, Advent Technologies A/S was declared bankrupt by the court in Aalborg, Denmark. The petition was brought by IDA, the union of engineers with a claim for €402,000. As the Company did not have the ability to pay the full amount due, the Danish court declared Advent Technologies A/S bankrupt. Advent Technologies A/S and its wholly-owned subsidiary Green Energy Philippines, Inc. will be liquidated by the court appointed trustee to settle all claims under the bankruptcy. The Company anticipates it will receive no residual assets. The remainder of the Company’s legal entities have no plans to declare bankruptcy and will continue as going concern entities.

 

Key Factors Affecting Our Results

 

Advent believes that its performance and future success depend on several factors that present significant opportunities for Advent but also pose risks and challenges, including those discussed below.

 

Increased Customer Demand

 

Based on conversations with existing customers and incoming inquiries from new customers, Advent anticipates substantial increased demand for its fuel cell systems and MEAs from a wide range of customers as it scales up its production facilities and testing capabilities, and as the awareness of its MEA capabilities becomes widely known in the industry. In order for Advent to be able to capitalize this opportunity the Company will need to accomplish the MEA performance targets and also partner with OEMs that can bring end products to the market based on Advent’s technology. Advent is focusing its efforts on enabling these OEMs and working with them closely.

 

Successful development of the Advanced MEA product

 

Advent’s future success depends in large part on the increasing integration of the hydrogen and efuel (eMethanol, renewable natural gas) fuel cell into the energy transition globally over the next decade. In order to become cost-competitive with existing renewable power generation and energy storage technology and achieve widespread adoption, fuel cells will need to achieve substantial improvement in the cost/kW performance ratio delivered to prospective fuel cell customers, predominantly OEMs, System Integrators and major energy companies. Advent expects to play an important enabling role in the adoption of hydrogen and methanol fuel cells, as its MEA technology is the critical determining factor in the cost/kW performance ratio of the fuel cells. In partnership with the Los Alamos National Laboratory, Advent is currently developing its next generation MEA technology (“Advent MEA”) which is anticipated to deliver as much as three times the power output of its current MEA product. While Advent is already projecting being able to pass through cost benefits to its customers through economies of scale as it increases MEA production, the successful development of the Advent MEA will be an important factor in delivering the required improvement in cost/kw performance to Advent’s customers.

 

Basis of Presentation

 

Advent’s consolidated financial statements have been prepared in accordance with U.S. GAAP. Advent has determined that it operates in one reportable segment. See Note 1 “Basis of Presentation” in the accompanying consolidated financial statements for more information.

 

Components of Results of Operations

 

Revenue

 

Revenues consist of sales of goods (MEAs, membranes, fuel cell stacks, fuel cell systems and electrodes) and servicing of those systems, as well as engineering fees and revenue from Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) with world-leading OEMs for the development of joint products. Advent expects revenues to increase materially and be weighted towards JDAs and TAAs over time.

 

40

 

 

Cost of Revenues

 

Cost of revenues consists of consumables, raw materials, processing costs and direct labor costs associated with the assembly, manufacturing, and servicing of MEAs, membranes, fuel cell stacks and systems and electrodes. Advent expects cost of revenues to increase substantially in line with increased production. Advent recognizes cost of revenues in the period that revenues are recognized.

 

Income from Grants

 

Income from grants consists of cash subsidies received from research agencies and other national and international organizations in support of Advent’s research and development activities. Advent expects to continue to be eligible for grant income and remains in discussion with a number of prospective grantors in relation to a number of product development activities.

 

Research and Development Expenses

 

Research and development expenses consist of costs associated with Advent’s research and development activities, such as laboratory costs and sample material costs.

 

Administrative and Selling Expenses

 

Administrative and selling expenses consist of travel expenses, indirect labor costs, fees paid to consultants, third parties and service providers, taxes and duties, legal and audit fees, depreciation, business development salaries and limited marketing activities, and incentive and stock-based compensation expense. Advent expects administrative and selling expenses to increase in line with production and revenue as the business scales up, and as a result of operating as a public company, including compliance with the rules and regulations of the SEC, legal, audit, additional insurance expenses, investor relations activities and other administrative and professional services.

 

Amortization of intangibles

 

Amortization expense of $1 thousand and $0.1 million was recognized in relation to these intangibles for the three months ended September 30, 2024 and 2023, respectively. Amortization expense of $3 thousand and $0.5 million was recognized in relation to these intangibles for the nine months ended September 30, 2024 and 2023, respectively. The reduction in the amortization expense is due to significant impairment charges that were recognized in 2023.

 

Impairment Losses

 

We recognized impairment losses in the second quarter of 2023, primarily related to goodwill and other intangible assets from the UltraCell and SerEnergy and FES acquisitions.

 

Other Income / (Expenses), net

 

Other income / (expenses) consist of additional de minimis incidental income / (expenses) incurred by the business. These income / (expenses) are expected to remain at a de minimis level in the future.

 

Change in Fair Value of Warrant Liability

 

The change in fair value of warrant liability amounting to nil and $0.1 million for the three and nine months ended September 30, 2024, respectively, represents the change in fair value of the Private Placement Warrants and Working Capital Warrants. The change in fair value of warrant liability amounting to $(0.1) million and $0.4 million for the three and nine months ended September 30, 2023, respectively, represents the change in fair value of the Private Placement Warrants and Working Capital Warrants.

 

41

 

 

Finance income / (expenses), net

 

Finance income / (expenses) consist mainly of bank and interest charges.

 

Foreign Exchange Gains / (Losses), net

 

Foreign exchange gains / (losses) consists of foreign exchange gains or losses on transactions denominated in foreign currencies and on translation of monetary items denominated in foreign currencies. As Advent scales up, our foreign exchange exposure is likely to increase given its revenues are denominated in both euros and dollars, and a portion of our costs are denominated in euros and Danish krone.

 

Income taxes

 

During the three and nine months ended September 30, 2024, the Company recorded income tax benefit of nil and $0.1 million, respectively, mainly related to net operating loss carryforwards. During the three and nine months ended September 30, 2023, we recorded income tax benefits of $0.1 million and $0.2 million, respectively.

 

Results of Operations

 

Comparison of the Three Months Ended September 30, 2024 to Three Months Ended September 30, 2023

 

The following table sets forth a summary of our consolidated results of operations for the three months ended September 30, 2024 and 2023, and the changes between periods.

 

    Three months ended
September 30,
(Unaudited)		        
(Amounts in thousands, except share and per share amounts)   2024     2023     $ change     % change  
Revenue, net   $ 128     $ 112     $ 16       14.3 %
Cost of revenues     (336 )     (807 )     471       (58.4 )%
Gross loss     (208 )     (695 )     487       (70.1 )%
Income from grants     137       242       (105 )     (43.4 )%
Research and development expenses     (411 )     (1,197 )     786       (65.7 )%
Administrative and selling expenses     (3,135 )     (8,000 )     4,865       (60.8 )%
Sublease income     -       139       (139 )     N/A  
Amortization of intangibles     (1 )     (117 )     116       (99.1 )%
Credit loss – customer contracts     (4,309 )     (3 )     (4,306 )     N/A  
Operating loss     (7,927 )     (9,631 )     1,704       (17.7 )%
Fair value change of warrant liability     -       (134 )     134       (100.0 )%
Finance income / (expenses), net     (14 )     (72 )     58       (80.6 )%
Foreign exchange gains / (losses), net     (1,672 )     (22 )     (1,650 )     7,500.0 %
Loss contingency     -       -       -       N/A  
Other income / (expenses), net     (2 )     (113 )     111       (98.2 )%
Loss before income tax     (9,615 )     (9,972 )     357       (3.6 )%
Income tax     -       81       (81 )     (100.0 )%
Net loss from continuing operations     (9,615 )     (9,891 )     276       (2.8 )%
Income (loss) from discontinued operations     (8,907 )     (1,955 )     (6,952 )     355.6 %
Net loss   $ (18,522 )   $ (11,846 )     (6,676 )     56.4 %
Net loss per share                                
Basic loss per share from continuing operations     (3.65 )     (4.92 )     1.27       N/A  
Basic loss per share from discontinued operations     (3.38 )     (0.97 )     (2.41 )     N/A  
Basic loss per share     (7.03 )     (5.89 )     (1.14 )     N/A  
Basic weighted average number of shares     2,636,508       2,012,382       N/A       N/A  
Diluted loss per share from continuing operations     (3.65 )     (4.92 )     1.27       N/A  
Diluted loss per share from discontinued operations     (3.38 )     (0.97 )     (2.41 )     N/A  
Diluted loss per share     (7.03 )     (5.89 )     (1.14 )     N/A  
Diluted weighted average number of shares     2,636,508       2,012,382       N/A       N/A  

 

42

 

 

Revenue, net

 

Our total revenue remained consistent at $0.1 million for the three months ended September 30, 2024 and 2023.

 

Cost of Revenues

 

Cost of revenues decreased by approximately $0.5 million from approximately $0.8 million in the three months ended September 30, 2023 to approximately $0.3 million in the three months ended September 30, 2024. The decrease in cost of revenues was related to the decrease in sales and the focus on providing services under Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) and a shift from product sales during the period.

 

Income from Grants

 

Our income from grants was consistent at $0.1 million and $0.2 million in the three months ended September 30, 2024 and 2023, respectively.

 

Research and Development Expenses

 

Research and development expenses were approximately $0.4 million and $1.2 million in the three months ended September 30, 2024 and 2023, respectively, primarily related to internal research and development costs, as well as our cooperative research and development agreement with the U.S. Department of Energy.

 

Administrative and Selling Expenses

 

Administrative and selling expenses were approximately $3.1 million in the three months ended September 30, 2024, and $8.0 million in the three months ended September 30, 2023. The decrease was primarily due to staff departures and cost reductions implemented throughout 2024 and 2023.

 

Sublease income

 

The Company earned sublease income of nil and $0.1 million in the three months ended September 30, 2024 and 2023, respectively. The sublease was terminated in April 2024.

 

Change in fair value of Warrant Liability

 

The change in fair value of warrant liability amounting to nil and $0.1 million was due to the change in fair value of the Private Placement Warrants and Working Capital Warrants for the three months ended September 30, 2024 and 2023, respectively.

 

Other Income / (Expenses), Net

 

Other income / (expenses) of $(0.1) million for the three months ended September 30, 2023 primarily relate to the Lincoln Park Purchase Agreement.

 

43

 

 

Comparison of the Nine Months Ended September 30, 2024 to Nine Months Ended September 30, 2023

 

The following table sets forth a summary of our consolidated results of operations for the nine months ended September 30, 2024 and 2023, and the changes between periods.

 

    Nine months ended
September 30,
(Unaudited)		        
(Amounts in thousands, except share and per share amounts)   2024     2023     $ change     % change  
Revenue, net   $ 3,520     $ 222     $ 3,298       1,485.6 %
Cost of revenues     (896 )     (1,336 )     440       (32.9 )%
Gross loss     2,624       (1,114 )     3,738       (335.5 )%
Income from grants     1,399       788       611       77.5 %
Research and development expenses     (2,521 )     (4,745 )     2,224       (46.9 )%
Administrative and selling expenses     (6,954 )     (10,786 )     3,832       (35.5 )%
Sublease income     145       404       (259 )     (64.1 )%
Amortization of intangibles     (3 )     (526 )     523       (99.4 )%
Credit loss – customer contracts     (4,309 )     (63 )     (4,246 )     6,739.7 %
Impairment losses     -       (9,763 )     9,763       N/A  
Operating loss     (9,619 )     (25,805 )     16,186       (62.7 )%
Fair value change of warrant liability     59       355       (296 )     (83.4 )%
Finance income / (expenses), net     (300 )     (522 )     222       (42.5 )%
Foreign exchange gains / (losses), net     (1,837 )     107       (1,944 )     (1,816.8 )%
Loss contingency     (4,871 )     -       (4,871 )     N/A  
Net gains / (losses) on disposal/write-offs of property, plant and equipment and intangible assets     (12,735 )     -       (12,735 )     N/A  
Other income / (expenses), net     4       (869 )     873       (100.5 )%
Loss before income tax     (29,299 )     (26,734 )     (2,565 )     9.6 %
Income tax     55       204       (149 )     (73.0 )%
Net loss from continuing operations     (29,244 )     (26,530 )     (2,714 )     10.2 %
Income (loss) from discontinued operations     (9,907 )     (19,135 )     9,228       (48.2 )%
Net loss   $ (39,151 )   $ (45,665 )   $ 6,514       (14.3 )%
Net loss per share                                
Basic loss per share from continuing operations     (11.17 )     (14.39 )     3.23       N/A  
Basic loss per share from discontinued operations     (3.78 )     (10.38 )     6.60       N/A  
Basic loss per share     (14.95 )     (24.78 )     9.82       N/A  
Basic weighted average number of shares     2,618,601       1,843,154       N/A       N/A  
Diluted loss per share from continuing operations     (11.17 )     (14.39 )     3.23       N/A  
Diluted loss per share from discontinued operations     (3.78 )     (10.38 )     6.60       N/A  
Diluted loss per share     (14.95 )     (24.78 )     9.82       N/A  
Diluted weighted average number of shares     2,618,601       1,843,154       N/A       N/A  

 

Revenue, net

 

Our total revenue increased by approximately $3.3 million from approximately $0.2 million in the nine months ended September 30, 2023 to approximately $3.5 million in the nine months ended September 30, 2024. The increase was driven by our services provided under Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) in the nine months ended September 30, 2024.

 

Cost of Revenues

 

Cost of revenues decreased by approximately $0.4 million from approximately $1.3 million in the nine months ended September 30, 2023 to approximately $0.9 million in the nine months ended September 30, 2024. The decrease in cost of revenues was related to the focus on providing services under Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) and a shift from product sales during the period.

 

44

 

 

Income from Grants

 

Our income from grants increased by approximately $0.6 million from approximately $0.8 million in the nine months ended September 30, 2023 to approximately $1.4 million in the nine months ended September 30, 2024. The increase was driven by our services provided in Greece in the three months ended September 30, 2024.

 

Research and Development Expenses

 

Research and development expenses were approximately $2.5 million and $4.7 million in the nine months ended September 30, 2024 and 2023, respectively, primarily related to internal research and development costs, as well as our cooperative research and development agreement with the U.S. Department of Energy.

 

Administrative and Selling Expenses

 

Administrative and selling expenses were approximately $7.0 million in the nine months ended September 30, 2024, and $10.8 million in the nine months ended September 30, 2023. The expenses are primarily derived from payroll, stock based compensation, rent, legal fees and contractor costs.

 

Sublease income

 

The Company earned sublease income of $0.1 million and $0.4 million in the nine months ended September 30, 2024 and 2023, respectively. The sublease was terminated in April 2024.

 

Impairment Losses

 

We recognized impairment losses of $9.8 million in the nine months ended September 30, 2023, primarily related to goodwill and other intangible assets from the UltraCell and SerEnergy and FES acquisitions.

 

Change in Fair Value of Warrant Liability

 

The change in fair value of warrant liability amounting to $0.1 million and $0.4 million was due to the change in fair value of the Private Placement Warrants and Working Capital Warrants for the nine months ended September 30, 2024 and 2023, respectively.

 

Finance income / (expenses), net

 

Finance income / (expenses) of $0.3 million and $0.5 million for the nine months ended September 30, 2024 and 2023, respectively.

 

Foreign exchange gains / (losses), net

 

The Company recognized $(1.8) million of losses due to foreign exchange for the nine months ended September 30, 2024. The Company recognized $0.1 million of gains due to foreign exchange for the nine months ended September 30, 2023.

 

Other Income / (Expenses), Net

 

Other income / (expenses) of $0.1 million for the nine months ended September 30, 2024. Other income / (expenses) of $(0.9) million for the nine months ended September 30, 2023, primarily relate to the Lincoln Park Purchase Agreement.

 

Loss contingency

 

The Company accrued a loss contingency of $4.9 million related to the Fischer litigation for the nine months ended September 30, 2024.

 

Net gains / (losses) on disposal/write-offs of property, plant and equipment and intangible assets

 

The Company recorded net losses of $12.7 million related to the exit of Hood Park and the sale of the coating machines for the nine months ended September 30, 2024.

 

Liquidity and Capital Resources

 

At September 30, 2024 and for the nine months then ended, the Company had $0.2 million in cash and cash equivalents, provided $3.1 million of cash in operating activities, had $2.1 million in current assets and $25.1 million in current liabilities, leaving the Company a working capital deficit of $(23.0) million.

 

45

 

 

A major financial challenge and significant risk facing the Company is a lack of positive cash flow and liquidity. The Company’s ability to meet its liquidity needs will largely depend on its ability to raise capital in the very short term and generate cash in the future. If the Company is unable to obtain sufficient funding, it could be required to delay its development efforts, limit activities, and further reduce research and development costs, which could adversely affect its business prospects and delivery of contractual obligations. A cash shortfall at any point in time over the next twelve months could result in the Company failing to meet its overdue and current obligations which could trigger action against the Company and/or its subsidiaries for liquidation by employees, authorities, or creditors. Because of the uncertainty in securing additional funding, delays in growth of revenue, failure to materialize cost-cutting efforts and the insufficient amount of cash and cash equivalents as of the consolidated financial statement filing date, management has concluded that substantial doubt exists with respect to the Company’s ability to continue as a going concern for one year from the date the consolidated financial statements are issued.

 

The following table sets forth a summary of our consolidated cash flows for the nine months ended September 30, 2024 and 2023, and the changes between periods.

 

    Nine Months Ended
September 30,
(unaudited)		        
(Amounts in thousands)   2024     2023     $ change     % change  
Net Cash used in Operating Activities   $ 3,088     $ (36,240 )   $ 39,328       (108.5 )%
                                 
Cash Flows from Investing Activities:                                
Proceeds from sale of property and equipment     300       -       300       N/A  
Purchases of property and equipment     (28 )     (2,952 )     2,924       (99.1 )%
Advances for the acquisition of property and equipment     -       (1,255 )     1,255       N/A  
Acquisition of subsidiaries     -       (1,864 )     1,864       N/A  
Net Cash provided by / (used in) Investing Activities   $ 272     $ (6,071 )   $ 6,343       (104.5 )%
                                 
Cash Flows from Financing Activities:                                
Proceeds from issuance of common stock and paid-in capital     282       5,488       (5,206 )     (94.9 )%
Net cash provided by Financing Activities   $ 282     $ 5,488     $ (5,206 )     (94.9 )%
                                 
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents from continuing operations   $ 3,642     $ (36,823 )   $ 40,465       (109.9 )%
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents     274       5       269       5,380.0 %
Net cash provided by / (used in) discontinued operations:                                
Cash provided by / (used in) operating activities     (8,317 )     9,903       (18,220 )     (184.0 )%
Cash provided by / (used in) investing activities     -       (275 )     275       N/A  
Cash provided by / (used in) financing activities     543       -       543       N/A  
Net cash provided by / (used in) discontinued operations     (7,774 )     9,628       (17,402 )     (180.7 )%
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents     (3,858 )     (27,190 )     23,332       (85.8 )%
Cash, cash equivalents, restricted cash and restricted cash equivalents at the beginning of year     4,050       33,619       (29,569 )     (88.0 )%
Cash, cash equivalents, restricted cash and restricted cash equivalents at the end of period   $ 192     $ 6,429     $ (6,237 )     (97.0 )%

 

Cash flows used in Operating Activities

 

Advent’s cash flows from operating activities reflect the income statement position adjusted for working capital movements in current assets and liabilities. As Advent grows, it expects that operating cash flows will be affected by increased working capital needs to support growth in personnel-related expenditures and fluctuations in accounts receivable, inventory, accounts payable and other current assets and liabilities.

 

Net cash provided by / (used in) operating activities was approximately $3.1 million and $(36.2) million for the nine months ended September 30, 2024 and 2023, respectively, which related to outflows in connection with administrative and selling expenses, research and development expenses, and costs associated with insurances services and other personnel costs.

 

46

 

 

Cash Flows provided by / (used in) Investing Activities

 

Advent’s cash flows provided by / (used in) investing activities was approximately $0.3 million and $(6.1) million for the nine months ended September 30, 2024 and 2023, respectively, and which mostly related to the sale and acquisition of plant and equipment, respectively.

 

Cash Flows provided by Financing Activities

 

Advent’s cash flows provided by financing activities was approximately $0.3 million for the nine months ended September 30, 2024, which represents the net proceeds of issuance of common stock and paid-in capital in connection with the At the Market Offering with H.C. Wainwright & Co., LLC.

 

Advent’s cash flows from financing activities was approximately $5.5 million for the nine months ended September 30, 2023, which related to the net cash proceeds from the sale of shares under the Lincoln Park facility.

 

Reverse Stock Split

 

On April 29, 2024 and April 30, 2024, our stockholders and Board, respectively, approved a reverse stock split of our Common Stock, at a ratio of 1-for-30 (the “Reverse Stock Split”), as of the Effective Date. The Effective Date of the Reverse Stock Split with the Secretary of the Commonwealth of Massachusetts was 5:00 p.m. on May 13, 2024 and May 14, 2024 in the marketplace.

 

On the Effective Date, the total number of shares of our Common Stock held by each shareholder was converted automatically into the number of whole shares of Common Stock equal to (i) the number of issued and outstanding shares of Common Stock held by such shareholder immediately prior to the Reverse Stock Split, divided by (ii) 30.

 

No fractional shares were issued in connection with the Reverse Stock Split, and stockholders who would otherwise be entitled to a fractional share received a proportional cash payment in April 2024.

 

The Company is authorized to issue 501,000,000 shares of Common Stock and that number did not change as a result of the Reverse Stock Split.

 

The Reverse Stock Split did not have any effect on the stated par value of our Common Stock. The rights and privileges of the holders of shares of Common Stock are unaffected by the Reverse Stock Split. All of our options, warrants and convertible securities outstanding immediately prior to the Reverse Stock Split have been appropriately adjusted by dividing the number of shares of Common Stock into which the options, warrants and convertible securities are exercisable or convertible by 30.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. As of September 30, 2024 and December 31, 2023, Advent recognized contract assets of nil and $9 thousand, respectively, on the consolidated balance sheets.

 

Advent recognizes contract liabilities when we receive customer payments or have the unconditional right to receive consideration in advance of the performance obligations being satisfied on our contracts. We receive payments from customers based on the terms established in our contracts. Contract liabilities are classified as either current or long-term liabilities in the consolidated balance sheets based on the timing of when we expect to recognize the related revenue. As of September 30, 2024 and December 31, 2023, Advent recognized contract liabilities of $1.2 million and $0.4 million, respectively, in the consolidated balance sheets.

 

Off-Balance Sheet Commitments and Arrangements

 

Since the date of our incorporation, Advent has not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

 

47

 

 

Critical Accounting Policies and Estimates

 

Advent’s consolidated financial statements have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires Advent to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet date, as well as the reported expenses incurred during the reporting period. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to Advent’s financial statements.

 

Revenue Recognition from January 1, 2019

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), as amended, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. We adopted ASU No. 2014-09 on January 1, 2019, using the modified retrospective approach to all contracts not completed at the date of initial application.

 

In accordance with ASC 606, revenue is recognized when control of the promised goods or services are transferred to a customer in an amount that reflects the consideration that Advent expects to receive in exchange for those services. We apply the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its arrangements:

 

● identify the contract with a customer,

 

● identify the performance obligations in the contract,

 

● determine the transaction price,

 

● allocate the transaction price to performance obligations in the contract, and

 

● recognize revenue as the performance obligation is satisfied.

 

With significant and recurring customers, we negotiate written master agreements as framework agreements (general terms and conditions of trading), following individual purchase orders. For customers with no master agreements, the approved purchase orders form the contract. Effectively, contracts under the revenue standard have been assessed to be the purchase orders agreed with customers.

 

We have assessed that each product sold is a single performance obligation because the promised goods are distinct on their own and within the context of the contract. In cases where the agreement includes customization services for the contracted products, we are providing integrated services; therefore, the goods are not separately identifiable, but are inputs to produce and deliver a combined output and form a single performance obligation within the context of the contract. Furthermore, we assessed whether it acts as a principal or agent in each of its revenue arrangements and has concluded that in all sales transactions it acts as a principal. Additionally, we, taking into consideration the guidance and indicative factors provided by ASC 606, concluded that it provides assurance type warranties (warranty period is up to two years) as it does not provide a service to the customer beyond fixing defects that existed at the time of sale. We, based on historical performance, current circumstances, and projections of trends, estimated that no allowance for returns as per warranty policy should be recognized, at the time of sale, accounted for under ASC 460, Guarantees.

 

Under ASC 606, we estimate the transaction price, including variable consideration, at the commencement of the contract and recognize revenue over the contract term, rather than when fees become fixed or determinable. In other words, where contracts with customers include variable consideration (i.e. volume rebates), we estimate at contract inception the variable consideration and adjust the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Furthermore, no material rights or significant financing components have been identified in our contracts. Payment terms generally include advance payment requirements. The time between a customer’s payment and completion of the performance obligation is less than one year. Payment terms are in the majority fixed and do not include variable consideration, except from volume rebates.

 

48

 

 

Revenue from satisfaction of performance obligations is recognized based on identified transaction price. The transaction price reflects the amount to which we have rights under the present contract. It is allocated to the distinct performance obligations based on standalone selling prices of the services promised in the contract. In cases of more than one performance obligation, we allocate transaction price to the distinct performance obligations in proportion to their observable stand-alone selling prices and recognize revenue as those performance obligations are satisfied.

 

In the majority of cases of product sales, revenue is recognized at a point in time when the customer obtains control of the respective goods that is, when the products are shipped from our facilities as control passes to the customer in accordance with agreed contracts and the stated shipping terms. In cases where the contract includes customization services, in which one performance obligation is identified, revenue is recognized over time as our performance does not create an asset with alternative use and we have an enforceable right to payment for performance completed to date. We use the input method (i.e., cost-to-cost method) to measure progress towards complete satisfaction of the performance obligation.

 

Income from grants and related deferred income

 

Grants include cash subsidies received from various institutions and organizations. Grants are recognized as other income. Such amounts are recognized in the consolidated statements of operations when all conditions attached to the grants are fulfilled.

 

Condition to the grants would not be fulfilled unless related costs have been characterized as eligible by the grantors, are actually incurred and there is certainty that costs are allowable. These grants are recognized as deferred income when received and recorded in income when the eligible and allowable related costs and expenses are incurred. Under all grant programs, a coordinator is specified. The coordinator, among other, receives the funding from the grantor and proceeds to its distribution to the parties agreed in the process specified in the program. We assessed whether it acts as a principal or agent in its role as a coordinator for specific grants and has concluded that in all related transactions it acts as an agent.

 

Income Taxes

 

Advent follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. This method also requires the recognition of future tax benefits, such as net operating loss carry forwards, to the extent that it is more likely than not that such benefits will be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Valuation allowances are reassessed periodically to determine whether it is more likely than not that the tax benefits will be realized in the future and if any existing valuation allowance should be released.

 

Part of the Advent’s business activities are conducted through its subsidiaries outside of U.S. Earnings from these subsidiaries are generally indefinitely reinvested in the local businesses. Further, local laws and regulations may also restrict certain subsidiaries from paying dividends to their parents. Consequently, Advent generally does not accrue income taxes for the repatriation of such earnings in accordance with ASC 740, “Income Taxes.” To the extent that there are excess accumulated earnings that we intend to repatriate from any such subsidiaries, we recognize deferred tax liabilities on such foreign earnings.

 

Advent assesses its income tax positions and records tax benefits for all years subject to examination based on the evaluation of the facts, circumstances, and information available at each reporting date. For those tax positions with a greater than 50 percent likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information, Advent records a tax benefit. For those income tax positions that are not likely to be sustained, no tax benefit is recognized in the consolidated financial statements. Advent recognizes interest and penalties related to uncertain tax positions as part of the provision for income taxes.

 

49

 

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. For those income tax positions that are not likely to be sustained, no tax benefit is recognized in the consolidated financial statements. Advent recognizes interest and penalties related to uncertain tax positions as part of the provision for income taxes.

 

For the three months ended September 30, 2024 and 2023, net income tax (expenses) benefits of nil and $81 thousand, respectively, have been recorded in the consolidated statements of operations. For the nine months ended September 30, 2024 and 2023, net income tax (expenses) benefits of $55 thousand and $0.2 million, respectively, have been recorded in the consolidated statements of operations. Advent is currently not aware of any issues under review that could result in significant accruals or material deviation from its position. Advent is subject to income tax examinations by major taxing authorities.

 

Advent and its U.S. subsidiaries may be subject to potential examination by U.S. federal, state and city, while Advent’s subsidiaries outside U.S. may be subject to potential examination by their taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with the U.S. federal, state and city, and tax laws in the countries where business activities of Advent’s subsidiaries are conducted. On December 22, 2017, the Tax Cuts and Jobs Act of 2017 was signed into legislation. As part of the legislation, the U.S. corporate income tax rate was reduced from 35% to 21%, among other changes.

 

Warrant Liability

 

Advent accounts for the 878,985 warrants (comprising of 813,314 Public Warrants and 65,671 Private Placement Warrants) issued in connection with the initial public offering and the 13,333 Working Capital Warrants issued at the consummation of the Business Combination in accordance with ASC 815-40-15-7D. If the warrants do not meet the criteria for equity treatment, they must be recorded as liabilities. We have determined that only the Private Placement Warrants and Working Capital Warrants must be recorded as liabilities and accordingly, we classify these warrant instruments as liabilities at their fair value and adjusts the instruments to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The fair value of the Private Placement Warrants and the Working Capital Warrants has been determined using either the quoted price, if available, or was based on a modified Black-Scholes-Merton model. The fair value of the Private Placement Warrants and the Working Capital Warrants has been determined based on a modified Black-Scholes-Merton model for the three and nine months ended September 30, 2024 and 2023.

 

Recent Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by Advent as of the specified effective date. Unless otherwise discussed, Advent believes that the impact of recently issued standards that are not yet effective will not have a material impact on Advent’s financial position or results of operations under adoption.

 

See Note 2 in the condensed consolidated financial statements included elsewhere in this report for more information about recent accounting pronouncements, the timing of their adoption and Advent’s assessment, to the extent Advent has made one, of their potential impact on Advent’s financial condition and results of operations.

 

Supplemental Non-GAAP Measures and Reconciliations

 

In addition to providing measures prepared in accordance with GAAP, we present certain supplemental non-GAAP measures. These measures are EBITDA, Adjusted EBITDA and Adjusted Net Income / (Loss), which we use to evaluate our operating performance, for business planning purposes and to measure our performance relative to that of our peers. These non-GAAP measures do not have any standardized meaning prescribed by GAAP and therefore may differ from similar measures presented by other companies and may not be comparable to other similarly titled measures. We believe these measures are useful in evaluating the operating performance of Advent’s ongoing business. These measures should be considered in addition to, and not as a substitute for net income, operating expense and income, cash flows and other measures of financial performance and liquidity reported in accordance with GAAP. The calculation of these non-GAAP measures has been made on a consistent basis for all periods presented.

 

50

 

 

EBITDA and Adjusted EBITDA

 

These supplemental non-GAAP measures are provided to assist readers in determining our operating performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. We also believe EBITDA and Adjusted EBITDA are frequently used by securities analysts and investors when comparing our results with those of other companies. EBITDA differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include interest, income taxes, depreciation of property, plant and equipment, and amortization of intangible assets. Adjusted EBITDA adjusts EBITDA for items such as one-time transaction costs, asset impairment charges, and fair value changes in the warrant liability.

 

The following tables show a reconciliation of net loss to EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2024 and 2023.

 

EBITDA and Adjusted EBITDA   Three months ended
September 30,
(Unaudited)		           Nine months ended
September 30,
(Unaudited)		        
(in Millions of US dollars)   2024     2023     $ change     2024     2023     $ change  
Net loss   $ (9.61 )   $ (9.89 )     0.28     $ (29.24 )   $ (26.53 )     (2.71 )
Depreciation of property and equipment   $ 0.17     $ 0.73       (0.56 )   $ 1.22     $ 1.60       (0.38 )
Amortization of intangibles   $ -     $ 0.12       (0.12 )   $ -     $ 0.53       (0.53 )
Finance income / (expenses), net   $ 0.01     $ 0.07       (0.06 )   $ 0.30     $ 0.52       (0.22 )
Loss contingency   $ -     $ -       -     $ 4.87     $ -       4.87  
Other income / (expenses), net   $ 0.00     $ 0.11       (0.11 )   $ 0.00     $ 0.87       (0.87 )
Foreign exchange differences, net   $ 1.67     $ 0.02       1.65     $ 1.84     $ (0.11 )     1.95  
Income taxes   $ -     $ (0.08 )     0.08     $ (0.06 )   $ (0.20 )     0.14  
EBITDA   $ (7.76 )   $ (8.92 )     1.16     $ (21.07 )   $ (23.32 )     2.25  
Net change in warrant liability   $ -     $ 0.13       (0.13 )   $ (0.06 )   $ (0.36 )     0.30  
Impairment losses   $ -     $ -       -     $ -     $ 9.76       (9.76 )
Adjusted EBITDA   $ (7.76 )   $ (8.79 )     1.03     $ (21.13 )   $ (13.92 )     (7.21 )

 

Adjusted Net Loss

 

This supplemental non-GAAP measure is provided to assist readers in determining our financial performance. We believe this measure is useful in assessing our actual performance by adjusting our results from continuing operations for changes in warrant liability and one-time transaction costs. Adjusted Net Loss differs from the most comparable GAAP measure, net loss, primarily because it does not include one-time transaction costs, asset impairment charges and warrant liability changes. The following table shows a reconciliation of net income/(loss) for three and nine months ended September 30, 2024 and 2023.

 

Adjusted Net Loss   Three months ended
September 30,
(Unaudited)		           Nine months ended
September 30,
(Unaudited)		        
(in Millions of US dollars)   2024     2023     $ change     2024     2023     $ change  
Net loss   $ (9.61 )   $ (9.89 )     0.28     $ (29.24 )   $ (26.53 )     (2.71 )
Net change in warrant liability   $ -     $ 0.13       (0.13 )   $ (0.06 )   $ (0.36 )     0.30  
Impairment losses   $ -     $ -       -     $ -     $ 9.76       (9.76 )
Adjusted Net Loss   $ (9.61 )   $ (9.76 )     0.15     $ (29.30 )   $ (17.13 )     (12.17 )

 

51

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Advent is exposed to a variety of market and other risks, including the effects of changes in interest rates and inflation, as well as risks to the availability of funding sources, hazard events and specific asset risks.

 

Interest Rate Risk

 

Advent holds cash and cash equivalents for working capital, investment and general corporate purposes. As of September 30, 2024, Advent had an unrestricted cash balance of approximately $0.2 million, consisting of operating and savings accounts which are not affected by changes in the general level of U.S. interest rates. Advent is not expected to be materially exposed to interest rate risk in the future as it intends to take on limited debt finance.

 

Inflation Risk

 

Advent does not believe that inflation currently has a material effect on its business. To mitigate cost increases caused by inflation, Advent has taken steps such as searching for alternative supplies at a lower cost and pre-buying materials and supplies at a more advantageous price in advance of its intended use.

 

Foreign Exchange Risk

 

Advent has costs and revenues denominated in Euros, Danish krone and Philippine pesos, and therefore is exposed to fluctuations in exchange rates. To date, Advent has not entered into any hedging transactions to mitigate the effect of foreign exchange due to the relatively low exposure. As we increase in scale, we expect to continue to realize a portion of our revenues and costs in foreign currencies, and therefore expect to put in place appropriate foreign exchange risk mitigation features in due course.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Interim Chief Executive Officer (currently also serving as Interim Chief Financial Officer) has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Report on Form 10-Q.

 

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

As described below, based on the evaluation of our disclosure controls and procedures as of the end of the period covered by this Report on Form 10-Q, management identified material weaknesses in our internal control over financial reporting. As a result of the material weaknesses, our Interim Chief Executive Officer (currently also serving as Interim Chief Financial Officer) has concluded that, as of September 30, 2024, our disclosure controls and procedures were not effective to provide reasonable assurance that information required to be disclosed in the reports we file and submit under the Exchange Act is recorded, processed, summarized, and reported as and when required.

 

52

 

 

Notwithstanding these material weaknesses identified, our management, including our Interim Chief Executive Officer (currently also serving as Interim Chief Financial Officer), has concluded that our financial statements included in this Report on Form 10-Q present fairly, in all material respects, our financial position, results of operations, and cash flows for the periods presented in accordance with U.S. GAAP.

 

Management’s Quarterly Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) of the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP, and includes those policies and procedures that:

 

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management assessed the effectiveness of our internal control over financial reporting as of September 30, 2024, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013).

 

Based on this assessment and the evaluation of those criteria, management, including our Interim Chief Executive Officer (currently also serving as Interim Chief Financial Officer), concluded that our internal control over financial reporting was not effective as of September 30, 2024, due to the material weaknesses described below.

 

A material weakness (as defined in Rule 12b-2 under the Exchange Act) is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Entity-Level Control Environment

 

The entity-level control environment did not adequately support the prevention, detection or correction of material misstatements. We identified deficiencies in all five components of the entity-level control environment, including the control environment, control activities, information and communication, monitoring and risk assessment that aggregated into material weaknesses. Overall, we did not sufficiently establish internal control policies and procedures in our material business processes related to the financial reporting process.

 

Financial Statement Close and Reporting Process

 

We did not adequately design and execute controls that addressed the relevant financial statement assertions over the close and reporting process including review controls, journal entries and adjustments during the period-end reporting, changes to general ledger master data. We lacked in certain instances sufficient and appropriate documentation, reconciliation controls and segregation of duties controls.

 

53

 

 

IT Processes

 

Internal controls that address the IT risks of applications were not adequately designed and implemented. Management did not adequately perform controls or retain sufficient and appropriate evidence over 1) user access controls 2) application change controls and 3) the timeliness of segregation of duties access monitoring procedures.

 

To mitigate the potential impact of material weaknesses, and prior to filing this report, we performed additional analysis and other post-closing procedures to determine that our consolidated financial statements are prepared in accordance with U.S. GAAP. These material weaknesses did not result in any material misstatements and there were no changes to previously released financial statements. Notwithstanding our material weaknesses, we have concluded that the financial statements and other financial information included in this Report on Form 10-Q fairly present in all material respects our financial position, results of operations, and cash flows for the periods presented in conformity with U.S. GAAP.

 

Remediation Plan

 

Following the identification of the material weaknesses in our internal control over financial reporting as of September 30, 2024, and with the oversight of the Audit Committee of our Board, we will commence remediation efforts to enhance our control environment.

 

  ● Hiring and augmenting our team with knowledgeable and qualified IT, accounting, and finance professionals.

 

  ● Enhancing the robustness and effectiveness of our IT systems and control environment.

 

  ● Enhancing related policies and process documentation, implementing new controls or redesigning existing ones, and improving the skills of process owners.

 

  ● Training process owners, evaluating the adoption of revised policies and procedures, and monitoring results.

 

  ● Increasing the frequency and independence of testing the design and operating effectiveness of controls.

 

Management is committed to successfully implementing the remediation plan as promptly as possible. Our plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. See “Risk Factors—Risks Related to Our Operations and Business — We have identified material weaknesses in our system of internal controls pursuant to Section 404 of the Sarbanes-Oxley Act of 2002. If not remediated, these material weaknesses could result in material misstatements in our consolidated financial statements. We may be unable to develop, implement and maintain appropriate controls in future periods.” within the 2023 Annual Report.

 

Changes in Internal Control over Financial Reporting

 

Financial Statement Close and Reporting Process

 

We did not adequately maintain accounting records at the consolidated level, resulting in a loss of access to underlying systems and records with the bankruptcy of Advent Technologies A/S in July 2024. The Company generated estimates using internal management reporting and bank statements as part of the September 30, 2024, close and reporting process.

 

Except as otherwise noted above and also under “Remediation Plan,” including the on-going remediation efforts described, there were no other changes in our internal control over financial reporting (as such term is defined in Exchange Act Rule 13a–15(f) and 15d-15(f)) during the quarter ended September 30, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our plans for remediating the material weaknesses, described above, will constitute changes in our internal control over financial reporting, prospectively, when such remediation plans are effectively implemented

 

54

 

 

PART II—OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are from time to time subject to various claims, lawsuits and other legal and administrative proceedings arising in the ordinary course of business. Some of these claims, lawsuits and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, non-monetary sanctions or relief. However, we do not consider any such claims, lawsuits or proceedings that are currently pending, individually or in the aggregate, to be material to our business with one exception:

 

On June 7, 2023, the Company was served a Request for Arbitration from F.E.R. fischer Edelstahlrohre GmbH (“F.E.R.”), pursuant to the arbitration provisions of the Share Purchase Agreement dated June 25, 2021 whereby the Company acquired SerEnergy and FES, which acquisition closed on August 31, 2021. The arbitration was held in Frankfurt am Main, Germany in accordance with the Arbitration Rules of the German Arbitration Institute, and the parties presented closing arguments in May 2024. F.E.R. is asserting that it is due approximately €4.5 million based on the cap and corresponding value of the share consideration at the date of closing. On August 16, 2024, the Company was informed that an arbitration decision and award was decided in favor of F.E.R. in the amount of approximately €4.5 million. On November 18, 2024, the Company filed a motion with the Higher Regional Court of Frankfurt to set aside the arbitral award. At this time, the Company cannot accurately predict the outcome of this matter, however, has recorded a loss contingency in the amount of $4.9 million, accrued interest expense of $0.3 million for a total of $5.2 million accrued loss liability as of September 30, 2024.

 

By letter dated September 14, 2023, a purported shareholder of the Company made a demand to inspect the Company’s books and records pursuant 8 Del. C. § 220 (“Demand”). The Demand purported to request access to books and records of the Company and its predecessor, AMCI Acquisition Corp. (“AMCI”), to investigate possible alleged breaches of fiduciary duties by AMCI’s board of directors and officers in connection with its merger with the Company on February 4, 2021. As of May 24, 2024, the purported shareholder entered into a tolling agreement with the Company and the former directors of AMCI that tolled all claims for the period January 29, 2024 through June 30, 2024. On June 5, 2024, the purported shareholder filed a putative class action complaint (“Complaint”) on behalf of in the Delaware Court of Chancery alleging claims of breach of fiduciary duty and unjust enrichment in connection with the SPAC transaction against former officers and directors of AMCI. The Company is not named as a defendant in the Complaint. The Company is not aware as to whether the Complaint has been served on the defendants.

 

Item 1A. Risk Factors.

 

In addition to the other information set forth in this Quarterly Report, for a discussion of risk factors that could significantly and negatively affect our business, financial condition, results of operations, cash flows and prospects, see the disclosure under the heading “Risk Factors” in our 2023 Annual Report. Such risks described are not the only risks facing us. Additional risks and uncertainties not currently known to us, or that our management currently deems to be immaterial, also may adversely affect our business, financial condition, results of operations, cash flows or prospects. There are no material changes to the risk factors described in the 2023 Annual Report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Default Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

55

 

 

Item 6. Exhibits

 

The following exhibits are being filed or furnished as part of this Quarterly Report on Form 10-Q:

 

Exhibit
Number

   Description
31.1*   Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a)
     
31.2*   Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a)
     
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350
     
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350
     
101.INS*   Inline XBRL Instance
     
101.SCH*   Inline XBRL Taxonomy Extension Schema
     
101.CAL*   Inline XBRL Taxonomy Extension Calculation
     
101.LAB*   Inline XBRL Taxonomy Extension Labels
     
101.PRE*   Inline XBRL Taxonomy Extension Presentation
     
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 
* Filed herewith.
** Furnished herewith

 

56

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: December 26, 2024 ADVENT TECHNOLOGIES HOLDINGS, INC.
   
  By: /s/ Gary Herman
    Gary Herman
    Interim Chief Financial Officer

 

57

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Gary Herman, certify that:

 

  1. I have reviewed this report on Form 10-Q of Advent Technologies Holdings, Inc.;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 26, 2024  
   
/s/ Gary Herman  
Gary Herman  
Interim Chief Executive Officer  

 

 

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Gary Herman, certify that:

 

  1. I have reviewed this report on Form 10-Q of Advent Technologies Holdings, Inc.;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 26, 2024  
   
/s/ Gary Herman  
Gary Herman  
Interim Chief Financial Officer  

 

 

 

Exhibit 32.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Gary Herman, Interim Chief Executive Officer of Advent Technologies Holdings, Inc. (the “Company”), hereby certifies that, to such officer’s knowledge:

 

  1. The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Report”), to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: December 26, 2024  
   
/s/ Gary Herman  
Gary Herman  
Interim Chief Executive Officer  

 

 

 

Exhibit 32.2

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Gary Herman, Interim Chief Financial Officer of Advent Technologies Holdings, Inc. (the “Company”), hereby certifies that, to such officer’s knowledge:

 

  1. The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Report”), to which this Certification is attached as Exhibit 32.2, fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: December 26, 2024  
   
/s/ Gary Herman  
Gary Herman  
Interim Chief Financial Officer  

 

 

v3.24.4
Cover - shares
 9 Months Ended
Sep. 30, 2024
Dec. 24, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 001-38742  
Entity Registrant Name Advent Technologies Holdings, Inc.  
Entity Central Index Key 0001744494  
Entity Tax Identification Number 83-0982969  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 5637 La Ribera St.  
Entity Address, Address Line Two Suite A  
Entity Address, City or Town Livermore  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94550  
City Area Code 925  
Local Phone Number 455-9400  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,636,508
Common Stock, par value $0.0001 per share    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol ADN  
Security Exchange Name NASDAQ  
Warrants    
Title of 12(b) Security Warrants  
Trading Symbol ADNWW  
Security Exchange Name NASDAQ  
v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 192 $ 3,200
Restricted cash, current 100
Accounts receivable, net 274 63
Contract assets 9
Inventories 97 195
Prepaid expenses and Other current assets 861 838
Assets of discontinued operations 4,430
Total current assets 1,424 8,835
Non-current assets:    
Intangibles, net 77 79
Property and equipment, net 5,310 20,086
Right-of-use assets 279 3,157
Restricted cash, non-current 750
Other non-current assets 239 242
Available for sale financial asset
Assets of discontinued operations 1,588
Total non-current assets 5,905 25,902
Total assets 7,329 34,737
Current liabilities:    
Trade and other payables 16,420 3,996
Due to related parties 253
Deferred income from grants, current 523
Contract liabilities 1,230 414
Loss contingency liabilities 5,162
Other current liabilities 1,785 1,035
Operating lease liabilities 111 2,138
Income tax payable 183 179
Liabilities of discontinued operations 3,628
Total current liabilities 25,144 11,913
Non-current liabilities:    
Bonds and other long-term debt, net
Warrant liability 59
Long-term operating lease liabilities 159 8,218
Defined benefit obligation 99 83
Deferred income from grants, non-current 320
Other long-term liabilities 1 1
Liabilities of discontinued operations 695
Total non-current liabilities 259 9,376
Total liabilities 25,403 21,289
Stockholders’ equity    
Common stock ($0.0001 par value per share; Shares authorized: 500,000,000 at September 30, 2024 and December 31, 2023; Issued and outstanding: 2,636,508 and 2,580,159 at September 30, 2024 and December 31, 2023, respectively)
Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at September 30, 2024 and December 31, 2023; nil 0 issued and outstanding at September 30, 2024 and December 31, 2023)
Additional paid-in capital 201,211 194,941
Accumulated other comprehensive loss (975) (2,334)
Accumulated deficit (218,310) (179,159)
Total stockholders’ equity / (deficit) (18,074) 13,448
Total liabilities and stockholders’ equity $ 7,329 $ 34,737
v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 2,636,508 2,580,159
Common stock, shares outstanding (in shares) 2,636,508 2,580,159
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue, net $ 128 $ 112 $ 3,520 $ 222
Cost of revenues (336) (807) (896) (1,336)
Gross profit / (loss) (208) (695) 2,624 (1,114)
Income from grants 137 242 1,399 788
Research and development expenses (411) (1,197) (2,521) (4,745)
Administrative and selling expenses (3,135) (8,000) (6,954) (10,786)
Sublease income 139 145 404
Amortization of intangibles (1) (117) (3) (526)
Credit loss – customer contracts (4,309) (3) (4,309) (63)
Impairment losses (9,763)
Operating loss (7,927) (9,631) (9,619) (25,805)
Fair value change of warrant liability (134) 59 355
Finance income / (expenses), net (14) (72) (300) (522)
Foreign exchange gains / (losses), net (1,672) (22) (1,837) 107
Loss contingency (4,871)
Net gains / (losses) on disposal/write-offs of property, plant and equipment and intangible assets (12,735)
Other income / (expenses), net (2) (113) 4 (869)
Loss before income tax (9,615) (9,972) (29,299) (26,734)
Income taxes 0 81 55 204
Net loss from continuing operations (9,615) (9,891) (29,244) (26,530)
Income (loss) from discontinued operations (8,907) (1,955) (9,907) (19,135)
Net loss $ (18,522) $ (11,846) $ (39,151) $ (45,665)
Net loss per share        
Basic loss per share from continuing operations $ (3.65) $ (4.92) $ (11.17) $ (14.39)
Basic loss per share from discontinued operations (3.38) (0.97) (3.78) (10.38)
Basic loss per share $ (7.03) $ (5.89) $ (14.95) $ (24.78)
Basic weighted average number of shares 2,636,508 2,012,382 2,618,601 1,843,154
Diluted loss per share from continuing operations $ (3.65) $ (4.92) $ (11.17) $ (14.39)
Diluted loss per share from discontinued operations (3.38) (0.97) (3.78) (10.38)
Diluted loss per share $ (7.03) $ (5.89) $ (14.95) $ (24.78)
Diluted weighted average number of shares 2,636,508 2,012,382 2,618,601 1,843,154
v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net loss $ (18,522) $ (11,846) $ (39,151) $ (45,665)
Other comprehensive loss, net of tax effect:        
Foreign currency translation adjustment (116) (353) (217) (265)
Other comprehensive loss from continuing operations (18,638) (12,199) (39,368) (45,930)
Other comprehensive loss from discontinued operations (220) (220) (141) 22
Total other comprehensive loss $ (18,858) $ (12,419) $ (39,509) $ (45,908)
v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Preferred Stock Series A [Member]
Preferred Stock Series Seed [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 174,514 $ (107,762) $ (2,604) $ 64,148
Beginning balance, shares at Dec. 31, 2022 1,723,924        
Issuance of common stock (Unaudited) 6,429     6,429
Issuance of common stock for cash, shares     314,695        
Stock issued under stock compensation plan (Unaudited)        
Stock issued under stock compensation plan, shares     31,658        
Stock based compensation expense (Unaudited) 7,368 7,368
Reclassification of private warrants (Unaudited) 545 545
Net loss (Unaudited) (45,665) (45,665)
Other comprehensive loss (Unaudited) (243) (243)
Ending balance, value at Sep. 30, 2023 188,856 (153,427) (2,847) 32,582
Ending balance, shares at Sep. 30, 2023 2,070,277        
Beginning balance, value at Jun. 30, 2023 183,914 (141,581) (2,274) 40,059
Beginning balance, shares at Jun. 30, 2023 1,947,340        
Issuance of common stock (Unaudited)     2,250     2,250
Issuance of common stock for cash, shares     113,711        
Stock issued under stock compensation plan (Unaudited)
Stock issued under stock compensation plan, shares     9,226        
Stock based compensation expense (Unaudited) 2,479 2,479
Reclassification of private warrants (Unaudited) 213 213
Net loss (Unaudited) (11,846) (11,846)
Other comprehensive loss (Unaudited) (573) (573)
Ending balance, value at Sep. 30, 2023 188,856 (153,427) (2,847) 32,582
Ending balance, shares at Sep. 30, 2023 2,070,277        
Beginning balance, value at Dec. 31, 2023 194,941 (179,159) (2,334) 13,448
Beginning balance, shares at Dec. 31, 2023 2,580,159        
Issuance of common stock (Unaudited) 282 282
Issuance of common stock for cash, shares     56,349        
Stock issued under stock compensation plan (Unaudited)
Stock based compensation expense (Unaudited) 5,988 5,988
Disposal of subsidiaries (Unaudited) 1,717 1,717
Net loss (Unaudited) (39,151) (39,151)
Other comprehensive loss (Unaudited) (358) (358)
Ending balance, value at Sep. 30, 2024 201,211 (218,310) (975) (18,074)
Ending balance, shares at Sep. 30, 2024 2,636,508        
Beginning balance, value at Jun. 30, 2024 199,265 (199,788) (2,356) (2,879)
Beginning balance, shares at Jun. 30, 2024 2,636,508        
Issuance of common stock (Unaudited)
Issuance of common stock for cash, shares            
Stock issued under stock compensation plan (Unaudited)
Stock based compensation expense (Unaudited) 1,946 1,946
Disposal of subsidiaries (Unaudited) 1,717 1,717
Net loss (Unaudited) (18,522) (18,522)
Other comprehensive loss (Unaudited) (336) (336)
Ending balance, value at Sep. 30, 2024 $ 201,211 $ (218,310) $ (975) $ (18,074)
Ending balance, shares at Sep. 30, 2024 2,636,508        
v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net loss $ (39,151) $ (45,665)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Loss from discontinued operations 6,062
Depreciation of property and equipment 1,157 1,596
Amortization of intangible assets 3 526
Impairment loss of tangible and intangible assets and goodwill 9,763
Provision for litigation expenses 4,871
Credit loss allowance 4,309 (12,271)
Fair value gain of warrant liability (59) (355)
Stock-based compensation expense 5,988 7,368
Issuance of commitment shares 1,186
Benefit for current and deferred income taxes (55) (204)
Net losses on disposal/write-offs of property, plant and equipment and intangible assets 12,735 182
Provision for inventories 250
Net periodic cost of defined benefit obligation 14 18
Changes in operating assets and liabilities:    
Decrease/(increase) in accounts receivable 3,054 520
Decrease/(increase) in contract assets 9 10
Decrease/(increase) in inventories (149) 278
Decrease in prepaid expenses and other current assets 637 (174)
Decrease in other non-current assets (2,751) 7,106
(Decrease)/increase in trade payables 12,117 (5,244)
(Decrease)/increase in due to related parties 253
Decrease in deferred income from grants (837) 203
Increase in loss contingency liability 292
(Decrease)/increase in contract liabilities 812 (85)
(Decrease)/increase in other current liabilities 735 (343)
Operating lease asset and liabilities (7,208) (655)
Net Cash provided by / (used in) Operating Activities 3,088 (36,240)
Cash Flows from Investing Activities:    
Proceeds from sale of property and equipment 300
Purchases of property and equipment (28) (2,952)
Advances for the acquisition of property and equipment (1,255)
Acquisition of subsidiaries (1,864)
Net Cash provided by / (used in) Investing Activities 272 (6,071)
Cash Flows from Financing Activities:    
Proceeds of issuance of common stock and paid-in capital 282 5,488
Net Cash provided by Financing Activities 282 5,488
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents from continuing operations 3,642 (36,823)
Effect of exchange rate changes on cash, cash equivalent, restricted cash and restricted cash equivalents 274 5
Net cash provided by / (used in) discontinued operations:    
Cash provided by / (used in) operating activities (8,317) 9,903
Cash provided by / (used in) investing activities (275)
Cash provided by / (used in) financing activities 543
Net cash provided by / (used in) discontinued operations (7,774) 9,628
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents (3,858) (27,190)
Cash, cash equivalents, restricted cash and restricted cash equivalents at the beginning of the period 4,050 33,619
Cash, cash equivalents, restricted cash and restricted cash equivalents at the end of the period 192 6,429
Reconciliation to Condensed Consolidated Balance Sheets:    
Cash and cash equivalents 192 3,661
Restricted cash, current 2,018
Restricted cash, non-current 750
Cash, cash equivalents, restricted cash and restricted cash equivalents 192 6,429
Non-cash Financing Activities:    
Issuance of common stock and paid-in capital $ 769
v3.24.4
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure [Table]        
Net Income (Loss) $ (18,522) $ (11,846) $ (39,151) $ (45,665)
v3.24.4
Insider Trading Arrangements
 9 Months Ended
Sep. 30, 2024
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.4
Basis of presentation
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of presentation

1. Basis of presentation

 

Overview

 

Advent Technologies Holdings, Inc. and its subsidiaries (collectively referred to as “Advent” and the “Company”) is an advanced materials and technology development company operating in the fuel cell, methanol, and hydrogen technology space. Advent is a world-leading company in the development of the HT-PEM technology (with more than 150 patents issued, pending, or licensed worldwide). The HT-PEM fuel cell technology developed by Advent enables off-grid power systems to produce clean power from various green fuels (hydrogen, methanol, bio and eMethanol, and renewable natural gas) and to function with higher efficiency at extreme ambient temperatures and in general extreme environmental conditions (humidity, air pollution). Advent’s main operations focus on developing and manufacturing the Membrane Electrode Assembly (MEA), which is the core electrochemical element and the most critical component of the fuel cell. The MEA largely determines lifetime, power density, efficiency, and overall cost of installation and operation for all applications. Advent is working with world-leading market-leading OEMs with the goal of bringing to the market complete fuel cell systems for a range of applications in the stationary power markets (backup, off-grid, and portable power) and the heavy-duty mobility markets (automotive, aviation, marine).

 

Advent has its headquarters in Livermore, California, and the Company has MEA and fuel cell product development facilities in Livermore, California and Patras, Greece. Previously, the Company’s headquarters were located in Boston, Massachusetts. During 2023, the Company decided to consolidate certain of its German operations with its operations in Greece. During June 2024, the Company closed its facilities in Boston, MA, and no longer maintains its facilities in Denmark and the Philippines due to the bankruptcy of Advent Technologies A/S in July 2024.

 

On February 4, 2021 (“Closing Date”), AMCI Acquisition Corp. (“AMCI”), consummated the business combination (the “Business Combination”) pursuant to that certain merger agreement (the “Agreement and Plan of Merger”), dated October 12, 2020, by and among AMCI, AMCI Merger Sub Corp., a Delaware corporation and newly formed wholly-owned subsidiary of AMCI (“Merger Sub”), AMCI Sponsor LLC (the “Sponsor”), solely in the capacity as the representative from and after the effective time of the Business Combination for the stockholders of AMCI, Advent Technologies, Inc., a Delaware corporation (“Legacy Advent”), and Vassilios Gregoriou, solely in his capacity as the representative from and after the effective time for the Legacy Advent stockholders (the “Seller Representative”), as amended by Amendment No. 1 and Amendment No. 2 to the Agreement and Plan of Merger, dated as of October 19, 2020 and December 31, 2020, respectively, by and among AMCI, Merger Sub, Sponsor, Legacy Advent, and Seller Representative. In connection with the closing of the Business Combination (the “Closing”), AMCI acquired 100% of the stock of Legacy Advent (as it existed immediately prior to the Closing) and its subsidiaries.

 

On the Closing Date, and in connection with the closing of the Business Combination, AMCI changed its name to Advent Technologies Holdings, Inc. Legacy Advent was deemed the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (“ASC”) 805. This determination was primarily based on Legacy Advent’s stockholders prior to the Business Combination having a majority of the voting interests in the combined company, Legacy Advent’s operations comprising the ongoing operations of the combined company, Legacy Advent’s board of directors comprising a majority of the board of directors of the combined company, and Legacy Advent’s senior management comprising the senior management of the combined company. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Advent issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI are stated at historical cost, with no goodwill or other intangible assets recorded.

 

While AMCI was the legal acquirer in the Business Combination, because Legacy Advent was deemed the accounting acquirer, the historical financial statements of Legacy Advent became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the consolidated financial statements included in this report reflect (i) the historical operating results of Legacy Advent prior to the Business Combination; (ii) the results of the Company (combined results of AMCI and Legacy Advent) following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Advent at their historical cost; and (iv) Company’s equity structure for all periods presented.

 

In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to Legacy Advent’s stockholders in connection with the recapitalization transaction. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Advent Preferred Stock (“Preferred Series A” and “Preferred Series Seed”) and Legacy Advent common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination Agreement. Activity within the statement of changes in stockholders’ equity / (deficit) for the issuances of Legacy Advent’s Preferred Stock, were also retroactively converted to Legacy Advent common stock.

 

On February 18, 2021, Advent Technologies, Inc. entered into a Membership Interest Purchase Agreement with Bren-Tronics, Inc. (“Bren-Tronics”) and UltraCell, LLC (“UltraCell”), a Delaware limited liability company and a direct wholly owned subsidiary of Bren-Tronics.

 

UltraCell LLC was renamed Advent Technologies LLC following its acquisition by the Company.

 

On June 25, 2021, the Company entered into a Share Purchase Agreement, with F.E.R. fischer Edelstahlrohre GmbH, a limited liability company incorporated under the Laws of Germany (the “Seller”) to acquire all of the issued and outstanding equity interests in SerEnergy A/S, a Danish stock corporation and a wholly-owned subsidiary of the Seller (“SerEnergy”) and fischer eco solutions GmbH, a German limited liability company and a wholly-owned subsidiary of the Seller (“FES”) together with certain outstanding shareholder loan receivables.

 

SerEnergy and FES were renamed to Advent Technologies A/S and Advent Technologies GmbH, respectively, following their acquisition by the Company on August 31, 2021.

 

The unaudited condensed consolidated financial statements of the Company have been prepared to reflect the consolidation of the companies listed below:

 

                   
    Country of   Ownership Interest   Statements of Operations
Company Name   Incorporation   Direct   Indirect   2024   2023
Advent Technologies, Inc.   USA   100%   -   01/01 – 9/30   01/01 – 9/30
Advent Technologies S.A.   Greece   -   100%   01/01 – 9/30   01/01 – 9/30
Advent Technologies LLC   USA   -   100%   01/01 – 9/30   01/01 – 9/30
Advent Technologies GmbH   Germany   100%   -   01/01 – 9/30   01/01 – 9/30

 

On July 25, 2024, Advent Technologies A/S was declared bankrupt by the court in Aalborg, Denmark. The petition was brought by IDA, the union of engineers for €402,000. As the Company did not have the ability to pay the full amount due, the Danish court declared Advent Technologies A/S bankrupt. Advent Technologies A/S and its wholly owned subsidiary Advent Green Energy Philippines, Inc. will be liquidated by the court appointed trustee to settle all claims under the bankruptcy. The Company anticipates it will receive no residual assets. As a result of their bankruptcy, Advent Technologies A/S and Advent Green Energy Philippines, Inc. (collectively referred to as the “Discontinued Subsidiaries”) have been presented as discontinued operations in the accompanying financial statements.

 

Unaudited Condensed Consolidated Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”). The unaudited financial information reflects, in the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s audited consolidated financial statements as of and for the year ended December 31, 2023, included in the Annual Report on Form 10-K filed with the SEC on August 13, 2024.

 

We reclassified certain prior year amounts in our consolidated financial statements to conform to the current year presentation. All reclassifications have been applied consistently to the periods presented.

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated.

 

Share and per share amounts are presented on a post-conversion basis for all periods presented, unless otherwise specified.

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company considers that the going concern basis is appropriate for the preparation of its unaudited condensed consolidated financial statements, as it is pursuing additional fund raising as disclosed below and has no intentions to proceed with liquidation. The going concern basis of presentation assumes that the Company will continue in operation one year from the date these unaudited condensed consolidated financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. As such, the accompanying unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and their carrying amounts, or the amount and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date that the unaudited condensed consolidated financial statements are issued. The Company’s ability to meet its liquidity needs will largely depend on its ability to generate cash in the future. During the nine months ended September 30, 2024, the Company provided $3.1 million of cash in operating activities (excluding discontinued operations), and the Company’s ability to generate cash in the future is subject to general economic, financial, competitive, legislative, regulatory, and other factors that are beyond the Company’s control. Furthermore, the Company has suffered recurring operating losses and has a negative net working capital position of $23.0 million as of September 30, 2024. In addition, as of the issuance date of these unaudited condensed consolidated financial statements the Company is overdue in a number of its obligations which could give the right to creditors at any time from the issuance date of these consolidated financial statements to raise legal action against the Company which in turn could potentially lead to liquidation action against the Company and/or its subsidiaries. The transition to profitability and positive cash flow is highly dependent upon the successful development, approval, and commercialization of the Company’s products and the achievement of a revenue level adequate to support its cost structure and the Company can give no assurances that this will occur. Based on the Company’s current operating plan, the Company believes that its cash and cash equivalents as of September 30, 2024, of $0.2 million and $0.5 million as of December 26, 2024, are not sufficient to fund operations and capital expenditures for the twelve months following the filing of this Quarterly Report on Form 10-Q, and the Company will need to obtain additional funding in the very near term, otherwise the Company may immediately substantially curtail or terminate its operations.

 

The Company performed a cash flow projection on a monthly basis for the twelve-month period following the issuance of the consolidated financial statements. With regards to the cash flow projections, the projected inflows from revenues and grants will be insufficient to cover the projected outflows, as such, the Company will continue to have a negative net working capital position and a delay in the projected timing of the short term financing and inflows and/or an immediate demand by creditors of repayment of the long outstanding payables may result in the Company being insolvent and short of cash at any specific time over the coming weeks and over the next twelve months.

 

The highlights of the projections are as follows:

 

The Company projects cash inflows from contracted revenues and grants for which it has already signed agreements with third parties and estimates projected outflows assuming the effective implementation of the Company’s plans to reduce monthly expenditures gradually during 2024.

 

In addition, the projections do not include any cash outflows relating to commitments and contingencies as disclosed in Note 19 to the unaudited condensed consolidated financial statements, since the Company believes that any cash outflows relating to these commitments will not materialize based on the Company’s plans to agree the termination of such contracts with its suppliers and a contingent loss as outcome of the pending arbitration it is not probable.

 

Until such time as the Company generates sufficient revenue to fund its operations (if ever), the Company plans to finance its operations and repay its existing and future liabilities and other obligations through the sale of equity and/or debt securities and, to the extent available, short-term and long-term loans.

 

With regards to the projected revenues and grants, a delay in the projected timing of inflows may result in the Company remaining insolvent and short of cash at any specific time over the next twelve months. Also, there is no guarantee that the Company’s plans to reduce monthly expenditures will be successful.

 

If the Company is unable to obtain sufficient funding, it could be required to delay its development efforts, limit activities, and further reduce research and development costs, which could adversely affect its business prospects and delivery of contractual obligations. A cash shortfall at any point in time over the next twelve months could result in the Company failing to meet its overdue and current obligations which could trigger action against the Company and/or its subsidiaries for liquidation by employees, authorities, or creditors. Because of the uncertainty in securing additional funding, delays in growth of revenue, failure to materialize cost-cutting efforts and the insufficient amount of cash and cash equivalents as of the consolidated financial statement filing date, management has concluded that substantial doubt exists with respect to the Company’s ability to continue as a going concern for one year from the date the unaudited condensed consolidated financial statements are issued.

 
v3.24.4
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

There have been no significant changes from the significant accounting policies disclosed in Note 2 of the “Notes to Consolidated Financial Statements” included in the Annual Report Form 10-K filed with the SEC on August 13, 2024.

 

The Company did not apply any new accounting policies during the nine-month period ended September 30, 2024 other than those noted below.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an on-going basis, management evaluates the estimates and judgments, including those related to the selection of useful lives for tangible assets, expected future cash flows from long-lived assets to support impairment tests, the carrying value of goodwill, provisions necessary for accounts receivables and inventory write downs, provisions for legal disputes, and contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates under different assumptions and/or conditions.

 

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

 

Cash and cash equivalents are highly liquid investments with original maturities of three months or less. Cash and cash equivalents consist of cash on hand, deposits held on call with banks and investments in money market funds with original maturities of three months or less at the date of acquisition. As of December 31, 2023, the Company has cash and cash equivalents which are restricted of $0.9 million. The restricted cash equivalent was a letter of credit required by the Company’s lease agreement for the Hood Park facility in Boston, MA. The letter of credit is required for the duration of the lease agreement which commenced in October 2022 and then was terminated in June 2024 resulting in the release of the letter of credit in the benefit of the landlord.

 

The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported in the consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows:

 

               
 

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Cash and cash equivalents   $ 192     $ 3,200  
Restricted cash, current     -       100  
Restricted cash, non-current     -       750  
Cash, cash equivalents, restricted cash and restricted cash equivalents   $ 192     $ 4,050  

 

Credit Losses

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which amends the requirement on the measurement and recognition of expected credit losses for financial assets held. Furthermore, amendments ASU 2019-10 and ASU 2019-11 provided additional clarification for implementing ASU 2016-13. ASU 2016-13 is effective for the Company beginning January 1, 2023, with early adoption permitted. The Company adopted the standard on January 1, 2023, in accordance with the adoption dates for private entities applicable to it under its emerging growth company status at that time and the standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements and related disclosures. The Company is exposed to credit losses primarily through sales of its products. The Company assesses each customer’s ability to pay and a credit loss estimate by conducting a credit review which includes consideration of established credit rating or an internal assessment of the customer’s creditworthiness based on an analysis of their payment history when a credit rating is not available. The Company monitors credit exposure through active review of customer balances. The Company’s expected loss methodology for accounts receivable is developed through consideration of factors including, but not limited to, historical collection experience, current customer credit ratings, current customer financial condition, current and future economic and market conditions, and age of the receivables. Charges related to credit losses are included in administrative and selling expenses and are recorded in the period that the outstanding receivables are determined to be doubtful. Account balances are written-off against the allowance when they are deemed uncollectible.

 

During the three months ended September 30, 2024, certain receivables totaling $4.3 million from Advent Technologies A/S were fully reserved as expected credit losses.

 

Inventories

 

Inventories, which consist of raw materials, work-in-process and finished goods are stated at the lower of cost or net realizable value using the first-in, first-out cost method. Cost includes the cost of purchased materials, inbound freight charges, external and internal processing and applicable labor and overhead costs. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.

 

The Company periodically reviews quantities of inventories on hand and compares these amounts to the expected use of each product. Inventories are reviewed to determine if valuation allowances are required for obsolescence (excess, obsolete, and slow-moving inventory). This review includes analyzing inventory levels of individual parts considering the current design of our products and production requirements as well as the expected inventory requirements for maintenance on installed power platforms. The Company records a charge to cost of revenue for the amount required to reduce the carrying value of inventory to the net realizable value.

 

Fair Value Measurements

 

The Company follows the accounting guidance in ASC 820 for its fair value measurements of financial assets and liabilities measured at fair value on a recurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

 

The accounting guidance requires fair value measurements be classified and disclosed in one of the following three categories:

 

● Level 1: Quoted prices in active markets for identical assets or liabilities.

 

● Level 2: Observable inputs other than Level 1 prices, for similar assets or liabilities that are directly or indirectly observable in the marketplace.

 

● Level 3: Unobservable inputs which are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

 

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

Convertible Bond Loan

 

On May 25, 2022, Advent Technologies S.A (“Advent SA”) and UNI.FUND Mutual Fund (“UNIFUND”) entered into an agreement to finance Cyrus SA (“Cyrus”) with a convertible bond loan (“Bond Loan”) of €1.0 million. As a part of this transaction, Advent SA offered €0.3 million in bond loans with an annual interest rate of 8.00%. The term of the loan is three years and there is a surcharge of 2.5% for overdue interest.

 

Cyrus business relates to the research and experimental development in natural sciences and mechanics, the construction of pumps and hydrogen compressors and the wholesale of compressors. Hydrogen compressors are a critical part of the Hydrogen Refueling Stations (HRS) to be used by transport applications. Cyrus has developed a prototype Metal Hydride Compressor which offers unique advantages. The proceeds from the Bond Loan are to cover Cyrus’s working capital needs in the context of its operation and the product development.

 

Mandatory conversion of the Bond Loan will occur in the event of qualified financing which is equivalent to a share capital increase by Cyrus in the first three years from the execution of the Bond Loan agreement with a total amount over €3 million which is covered by third parties unrelated to the basic shareholders or by investors related to them.

 

The Company classifies the Bond Loan as an available for sale financial asset on the consolidated balance sheets. The Company recognizes interest income within the consolidated statement of operations. For the three and nine months ended September 30, 2024, the Company recognized $7 thousand and $21 thousand of interest income related to the Bond Loan within the consolidated statements of operations, respectively. For the three and nine months ended September 30, 2023, the Company recognized $6 thousand and $19 thousand of interest income related to the Bond Loan within the consolidated statements of operations, respectively.

 

The Company initially measured the available for sale Bond Loan at the transaction price plus any applicable transaction costs. The Bond Loan is remeasured to its fair value at each reporting period and upon settlement. The estimated fair value of the Bond Loan is determined using Level 3 inputs by using a discounted cash flow model. The change in fair value is recognized within the consolidated statements of comprehensive loss. As of September 30, 2024, the Company continues to fully reserve the Bond Loan as an expected credit loss. The Company did not recognize any unrealized gain / (loss) during the three and nine months ended September 30, 2024, or 2023.

 

Warrant Liability

 

As a result of the Business Combination, the Company assumed a warrant liability (the “Warrant Liability”) related to previously issued 131,343 warrants, each exercisable to purchase one share of common stock at an exercise price of $345.00 per share, originally sold to AMCI Sponsor LLC (the “Sponsor”) in a private placement consummated in connection with AMCI’s initial public offering (the “Private Placement Warrants”) and the 13,333 warrants, each exercisable to purchase one share of Common Stock at an exercise price of $345.00 per share, converted from the Sponsor’s non-interest bearing loan to the Company of $0.4 million in connection with the closing of the Business Combination (the “Working Capital Warrants”) (Note 13). The Private Placement Warrants and the Working Capital Warrants have substantially the same terms as the 734,309 warrants, each exercisable to purchase one share of Common Stock at an exercise price of $345.00 per share, issued by AMCI in its initial public offering (the “Public Warrants”).

 

The following tables summarize the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023.

 

               
   

As of
September 30,
2024

(Unaudited)

  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ -     $ -  
    $ -     $ -  

 

    As of
December 31,
2023		  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ 59     $ 59  
    $ 59     $ 59  

 

The carrying amounts of the Company’s remaining financial instruments reflected on the consolidated balance sheets and which consist of cash and cash equivalents, accounts receivables, net, other current assets, trade and other payables, and other current liabilities, approximate their respective fair values due to their short-term nature.

 

Changes in the fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2024 and 2023 were as follows:

 

                               
Available for Sale Financial Asset
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 326     $ -     $ 320  
Estimated fair value of available for sale financial asset acquired     -       -       -       -  
Foreign exchange fluctuations     -       (10 )     -       (4 )
Change in estimated fair value     -       -       -       -  
Estimated fair value (end of period)   $ -     $ 316     $ -     $ 316  

 

Warrant Liability
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 177     $ 59     $ 998  
Change in estimated fair value     -       135       (59 )     (355 )
Reclassification of private placement warrants     -       (213 )     -       (545 )
Estimated fair value (end of period)   $ -     $ 99     $ -     $ 99  

 

The Warrant Liability is remeasured to its fair value at each reporting period and upon settlement. The change in fair value is recognized in “Fair value change of warrant liability” on the consolidated statements of operations.

 
v3.24.4
Related party disclosures
 9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
Related party disclosures

3. Related party disclosures

 

Balances with related parties

 

          
   September 30,
2024		   December 31,
2023		 
(Amounts in thousands)  (Unaudited)     
Due to related parties          
Vassilios Gregoriou  $75   $- 
Maria Gregoriou   50    - 
Emory S. De Castro   128    - 
Total  $253   $- 

 

The outstanding balances as of September 30, 2024 due to the Company’s executives and officers relate to short-term promissory notes with the Company. The notes are due by August 31, 2026 and bear interest at a rate of 5.00% per annum.

 

Transactions with related parties

 

Related parties’ transactions are in the normal course of operations and are measured at the amount of consideration established and agreed to by related parties.

 
v3.24.4
Accounts receivable, net
 9 Months Ended
Sep. 30, 2024
Receivables [Abstract]  
Accounts receivable, net

4. Accounts receivable, net

 

Accounts receivable consist of the following:

 

               
  September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accounts receivable from third party customers   $ 2,142     $ 348  
Less: Allowance for credit losses     (1,868 )     (285 )
Accounts receivable, net   $ 274     $ 63  

 
v3.24.4
Inventories
 9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
Inventories

5. Inventories

 

Inventories consist of the following:

 

               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Raw materials and supplies   $ 4,967     $ 4,864  
Work-in-process     228       90  
Finished goods     264       259  
Total   $ 5,459     $ 5,213  
Provision for inventory     (5,362 )     (5,018 )
Total   $ 97     $ 195  

 

The changes in the provision for inventory is as follows:

 

                               
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Balance at beginning of period   $ (5,175 )   $ (46 )   $ (5,018 )   $ (45 )
Additions during the period     (11 )     (449 )     (250 )     (449 )
Exchange differences     (176 )     2       (94 )     1  
Balance at end of period   $ (5,362 )   $ (493 )   $ (5,362 )   $ (493 )

 

 
v3.24.4
Prepaid expenses and other current assets
 9 Months Ended
Sep. 30, 2024
Prepaid Expenses And Other Current Assets  
Prepaid expenses and other current assets

6. Prepaid expenses and other current assets

 

Prepaid expenses are analyzed as follows:

 

               
   

September 30,
2024

    

December 31,

2023

  
(Amounts in thousands)   (Unaudited)        
Prepaid insurance expenses   $ 410     $ 155  
Prepaid research expenses     13       36  
Other prepaid expenses     125       27  
Total   $ 548     $ 218  

 

Prepaid insurance expenses as of September 30, 2024 and December 31, 2023 mainly include prepayments to insurers for directors’ and officers’ insurance services for liabilities that may arise in their capacity as directors and officers of a public entity.

 

Prepaid research expenses as of September 30, 2024 and December 31, 2023 mainly relate to prepayments for expenses under the Cooperative Research and Development Agreement as discussed in Note 16.

 

Other prepaid expenses as of September 30, 2024 and December 31, 2023 mainly include prepayments for professional fees and purchases, which also include costs to fulfill a contract with customers which are expected to be recognized within 2024, upon delivery of services to these customers.

 

Other current assets are analyzed as follows:

 

               
   

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
VAT receivable   $ 56     $ 267  
Withholding tax     -       -  
Grant receivable     185       181  
Purchases under receipt     -       1  
Guarantees     -       -  
Other receivables     72       91  
Accrued sublease income     -       80  
Accrued interest income     -       -  
Total   $ 313     $ 620  

 
v3.24.4
Intangible Assets
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

7. Intangible Assets

 

Information regarding our intangible assets, including assets recognized from our acquisitions, as of September 30, 2024 and December 31, 2023 is as follows:

 

                               
    As of September 30, 2024 (Unaudited)  
(Amounts in thousands)   Gross
Carrying
Amount		     Accumulated
Amortization		     Cumulative
Impairment		     Net
Carrying
Amount		  
Finite-lived intangible assets:                                
Software     237       (160 )     -       77  
Total intangible assets   $ 237     $ (160 )   $ -     $ 77  

 

    As of December 31, 2023  
(Amounts in thousands)   Gross
Carrying
Amount		     Accumulated
Amortization		     Cumulative
Impairment		     Net
Carrying
Amount		  
Indefinite-lived intangible assets:                                
Trade name “UltraCell”   $ 406     $ -     $ (406 )   $ -  
Total indefinite-lived intangible assets   $ 406     $ -     $ (406 )   $ -  
Finite-lived intangible assets:                                
Patents     21,221       (3,247 )     (17,974 )     -  
Process know-how (IPR&D)     2,612       (1,017 )     (1,595 )     -  
Order backlog     266       (266 )     -       -  
Software     233       (154 )     -       79  
Total finite-lived intangible assets   $ 24,332     $ (4,684 )   $ (19,569 )   $ 79  
Total intangible assets   $ 24,738     $ (4,684 )   $ (19,975 )   $ 79  

 

The Company did not record any additions to indefinite-lived intangible assets during the three and nine months ended September 30, 2024 and 2023.

 

The amortization expense for the intangible assets for the three months ended September 30, 2024 and 2023 was nil and $0.1 million, respectively. The amortization expense for the intangible assets for the nine months ended September 30, 2024 and 2023 was $2.0 thousand and $0.5 million, respectively.

 

All remaining intangible assets, other than software, from the UltraCell and SerEnergy and FES acquisitions were fully impaired during the year ended December 31, 2023.

 

Amortization expense is recorded on a straight-line basis. Assuming constant foreign currency exchange rates and no change in the gross carrying amount of the intangible assets, future amortization expense related to the Company’s intangible assets subject to amortization as of September 30, 2024 is expected to be as follows:

 

       
(Amounts in thousands)      
Fiscal Year Ended December 31,        
2024   $ 7  
2025     28  
2026     42  
2027     -  
2028     -  
Thereafter     -  
Total   $ 77  

 
v3.24.4
Property, plant and equipment, net
 9 Months Ended
Sep. 30, 2024
Property, Plant and Equipment [Abstract]  
Property, plant and equipment, net

8. Property, plant and equipment, net

 

The Company’s property, plant and equipment, net, consisted of the following:

 

               
    September 30,
2024		    

December 31,

2023

  
(Amounts in thousands)   (Unaudited)        
Land, Buildings & Leasehold Improvements   $ 1,014     $ 12,632  
Machinery     6,176       10,908  
Equipment     1,911       2,591  
    $ 9,101     $ 26,131  
Less: accumulated depreciation     (1,407 )     (3,661 )
Less: impairment     (2,384 )     (2,384 )
Total   $ 5,310     $ 20,086  

 

During the three and nine months ended September 30, 2024, additions to property, plant and equipment of nil and $28 thousand, respectively, for equipment. During the three and nine months ended September 30, 2023, additions to property, plant and equipment were $5.1 million and $9.0 million, respectively, primarily consisting of machines and assets related to the construction of the Hood Park facility. Additionally, on April 27, 2023, the Company entered into an agreement with ETTEL S.A. to purchase land in Kozani, Greece in the amount of €0.8 million.

 

During the nine months ended September 30, 2024, the Company disposed of leasehold improvements, sold machinery and disposed of other equipment with an aggregate net book value of $13.6 million for net proceeds of $0.9 million resulting in a loss of $12.7 million.

 

On June 29, 2024, in an effort to reduce costs, the Company decided to abandon the facility at Hood Park and was able to find a new tenant to occupy the space. The Company and the landlord agreed to accelerate the expiration of the lease to occur on June 30, 2024. The Company had a letter of credit in the amount of $750 thousand in favor of the landlord and that letter of the credit was released to the landlord in satisfaction of any claims against the Company. During the nine months ended September 30, 2024, the Company wrote off $9.8 million of leasehold improvements and $0.5 million of furniture as part of the exit of Hood Park. As of December 31, 2023, the Company had $10.4 million of leasehold improvements and $0.5 million of furniture that will be forfeited as part of the exit of Hood Park.

 

On May 7, 2024, the Company entered into an agreement to sell some of its coating machines (part of its property, plant and equipment) from the Hood Park facility for $0.9 million resulting in a loss of $2.5 million. On May 8, 2024, the Company received an initial deposit of $0.3 million and the remaining $0.6 million in July 2024. The remaining machinery and equipment from Hood Park were relocated and is planned for use at the Company’s other locations.

 

Depreciation expense during the three months ended September 30, 2024 and 2023 was $0.2 million and $0.9 million, respectively. Depreciation expense for the nine months ended September 30, 2024 and 2023 was $1.0 million and $2.1 million, respectively.

 

There are no collaterals or other commitments on the Company’s property, plant and equipment.

 
v3.24.4
Other non-current assets
 9 Months Ended
Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other non-current assets

9. Other non-current assets

 

Other non-current assets as of September 30, 2024 and December 31, 2023 are mostly comprised of guarantees to suppliers of $0.2 million and $0.2 million, respectively.

 
v3.24.4
Trade and other payables
 9 Months Ended
Sep. 30, 2024
Payables and Accruals [Abstract]  
Trade and other payables

10. Trade and other payables

 

Trade and other payables as of September 30, 2024 and December 31, 2023 include balances of suppliers and consulting service providers of $16.4 million and $4.0 million, respectively.

 

The increase in trade and other payables for the three months ended September 30, 2024 is driven by an $11.6 million payable between the Company and one of its Discontinued Subsidiaries which was previously eliminated as intercompany activity.

 
v3.24.4
Other current liabilities
 9 Months Ended
Sep. 30, 2024
Other Current Liabilities  
Other current liabilities

11. Other current liabilities

 

As of September 30, 2024 and December 31, 2023, other current liabilities consist of the following:

 

               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accrued expenses(1)   $ 563     $ 653  
Other short-term payables     802       44  
Taxes and duties payable     299       255  
Provision for unused vacation     4       4  
Social security funds     108       70  
Overtime provision     9       9  
Total   $ 1,785     $ 1,035  

 

 
(1) Accrued expenses are analyzed as follows:

 

               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accrued expenses for legal and consulting fees   $ 243     $ 219  
Accrued payroll fees     39       139  
Other accrued expenses     281       295  
Total   $ 563     $ 653  

 

Other accrued expenses mainly consist of accrual of staff expenses and audit fees.

 
v3.24.4
Leases
 9 Months Ended
Sep. 30, 2024
Leases  
Leases

12. Leases

 

The Company enters into operating lease agreements for the use of real estate and certain other equipment. The Company determines if an arrangement contains a lease at inception, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The impacts of accounting for operating leases are included in Right-of-use assets, Operating lease liabilities, and Long-term operating lease liabilities in the Company’s consolidated balance sheets.

 

On February 5, 2021, the Company entered into a lease agreement by and among the Company, in its capacity as tenant, and BP Hancock LLC, a Delaware limited liability company, in its capacity as landlord. The lease provides for the rental by the Company of office space at 200 Clarendon Street, Boston, MA 02116 for use as the Company’s executive offices. Under the terms of the lease, the Company leases 6,041 square feet at an initial fixed annual rent of $0.5 million. The term of the lease is for five years (unless terminated as provided in the lease) and commenced on April 1, 2021. The Company provided security in the form of a security deposit in the amount of $0.1 million which is included in Other non-current assets on the consolidated balance sheet as of December 31, 2023. On April 17, 2024, the landlord terminated the lease for past due rent totaling $0.2 million and seized the security deposit of $0.1 million.

 

On January 9, 2023, the Company entered into a sublease agreement by and among the Company, in its capacity as sublandlord, BP Hancock LLC, a Delaware limited liability company, in its capacity as landlord, and Hughes Boston, Inc. (“Hughes”), in its capacity as subtenant. The sublease provides for the rental by Hughes of office space at 200 Clarendon Street, Boston, MA 02116. Under the terms of the sublease, Hughes subleases 6,041 square feet at an initial fixed annual rent of $0.6 million and will increase 3.0% on each anniversary of the sublease commencement date. The term of the sublease is through March 2026 (unless terminated as provided in the sublease) and the sublease commencement date was February 1, 2023. The sublease was terminated on April 17, 2024 in connection with the termination of the lease agreement with BP Hancock LLC, in its capacity as landlord.

 

During the three months ended September 30, 2024, and September 30, 2023, the Company recognized nil and $0.1 million, respectively, in rent income. During the nine months ended September 30, 2024 and September 30, 2023, the Company recognized $0.1 million and $0.1 million in rent income, respectively. Rent income is included within sublease income in the unaudited condensed consolidated statement of operations

 

Additionally, the Company’s subsidiaries, Advent Technologies S.A. and Advent Technologies LLC, have in place rental agreements for the lease of office and factory spaces.

 

On March 8, 2021, the Company entered into a lease for 21,401 square feet as a product development and manufacturing center at Hood Park in Charlestown, MA. Under the terms of the lease, the Company will pay an initial fixed annual rent of $1.5 million. The lease has a term of eight years and five months, with an option to extend for five years, and commenced in October 2022. The Company is obliged to provide security in the form of a security deposit in the amount of $0.8 million before commencement of the lease.

 

On April 1, 2024, the Company agreed with the landlord of the Hood Park facility for a 4-month rate abatement period (March through June 2024) and extend the term of the lease for 4 additional months. On June 29, 2024, in an effort to reduce costs, the Company decided to abandon the facility at Hood Park and was able to find a new tenant to occupy the space. The Company and the landlord agreed to accelerate the expiration of the lease to occur on June 30, 2024. The Company had a letter of credit in the amount of $750 thousand in favor of the landlord and that letter of the credit was released to the landlord in satisfaction of any claims against the Company.

 

Rental expense for all operating leases was nil and $0.3 million for the three months ended September 30, 2024, and 2023, respectively. For the three months ended September 30, 2024, and 2023, rental expense for short-term leases was nil and $0.3 million, respectively.

 

Rental expense for all operating leases was $4.7 million and $1.7 million for the nine months ended September 30, 2024, and 2023, respectively. For the nine months ended September 30, 2024, and 2023, rental expense for short-term leases was $0.01 million and $0.4 million, respectively.

 

As of September 30, 2024, and December 31, 2023, the right of use assets, net associated with operating leases was $0.3 million and $3.2 million, respectively.

 

As of September 30, 2024, undiscounted maturities of operating lease liabilities remaining are as follows (amounts in thousands):

 

       
    Operating
Leases		  
Fiscal Year Ended December 31,        
2024   $ 35  
2025     140  
2026     107  
2027     4  
2028     -  
Thereafter     -  
Total undiscounted lease payments   $ 286  
Less: imputed interest     (16 )
Total discounted lease payments   $ 270  
Less: current portion     (111 )
Long-term lease liabilities   $ 159  

 
v3.24.4
Private Placement Warrants and Working Capital Warrants
 9 Months Ended
Sep. 30, 2024
Private Placement Warrants And Working Capital Warrants  
Private Placement Warrants and Working Capital Warrants

13. Private Placement Warrants and Working Capital Warrants

 

In connection with the Business Combination, the Company assumed 131,343 Private Placement Warrants issued upon AMCI’s initial public offering. In addition, upon the closing of the Business Combination, the working capital loan provided by AMCI’s Sponsor to AMCI was converted into 13,333 Working Capital Warrants, which were also assumed. The terms of the Working Capital Warrants are the same as those of the Private Placement Warrants.

 

As of September 30, 2024 and December 31, 2023, the Company had an aggregate of 65,671 Private Placement Warrants and Working Capital Warrants outstanding. Each Private Placement Warrant and Working Capital Warrant entitles the registered holder to purchase one share of Common Stock at a price of $345.00 per share, subject to adjustment, at any time commencing 30 days after the completion of the Business Combination. The Public Warrants expire five years after the closing of the Business Combination or earlier upon redemption or liquidation.

 

The Private Placement Warrants and Working Capital Warrants are identical to the Public Warrants, except that the Private Placement Warrants and Working Capital Warrants and the common stock issuable upon the exercise of those warrants were not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants and Working Capital Warrants are exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If those warrants are held by someone other than the initial purchasers or their permitted transferees, they will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. As of September 30, 2024, an aggregate of 65,671 Private Placement Warrants and Working Capital Warrants are held by its initial purchasers.

 

According to the provisions of the Private Placement Warrants and Working Capital Warrants warrant agreements, the exercise price and number of shares of common stock issuable upon exercise of those warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. Private Placement Warrants and Working Capital Warrants are classified as liabilities in accordance with the Company’s evaluation of the provisions of ASC 815-40-15, which provides that a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant with a fixed exercise price and fixed number of underlying shares.

 
v3.24.4
Stockholders’ Equity
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Stockholders’ Equity

14. Stockholders’ Equity

 

Shares Authorized

 

As of September 30, 2024, the Company had authorized a total of 501,000,000 shares for issuance with 500,000,000 shares designated as common stock, par value $0.0001 per share, and 1,000,000 shares designated as preferred stock, par value $0.0001 per share.

 

Common Stock

 

From February 2, 2024, through March 28, 2024, 24,976 shares of common stock were issued in connection with the At the Market Offering with H.C. Wainwright & Co., LLC for net proceeds of $0.1 million

 

From April 1, 2024, through April 15, 2024, 31,373 shares of common stock were issued in connection with the At the Market Offering with H.C. Wainwright & Co., LLC for net proceeds of $0.2 million.

 

As of September 30, 2024, and December 31, 2023, there were 2,636,508 and 2,580,159 shares of issued and outstanding common stock with a par value of $0.0001 per share, respectively.

 

Reverse Stock Split

 

On April 29, 2024 and April 30, 2024, our stockholders and Board, respectively, approved a reverse stock split of our Common Stock, at a ratio of 1-for-30 (the “Reverse Stock Split”), as of the Effective Date. The Effective Date of the Reverse Stock Split with the Secretary of the Commonwealth of Massachusetts was 5:00 p.m. on May 13, 2024 and May 14, 2024 in the marketplace.

 

On May 13, 2024, the Company completed a 1-for-30 reverse stock split.

 

On the Effective Date, the total number of shares of our Common Stock held by each shareholder was converted automatically into the number of whole shares of Common Stock equal to (i) the number of issued and outstanding shares of Common Stock held by such shareholder immediately prior to the Reverse Stock Split, divided by (ii) 30.

 

No fractional shares were issued in connection with the Reverse Stock Split, and stockholders who would otherwise be entitled to a fractional share received a proportional cash payment in April 2024. The Reverse Stock Split did not have any effect on the stated par value of the Company’s Common Stock. The rights and privileges of the holders of shares of Common Stock will be unaffected by the Reverse Stock Split.

 

The Company is authorized to issue 501,000,000 shares of Common Stock and that number did not change as a result of the Reverse Stock Split.

 

The consolidated financial statements and footnote disclosures have been updated to reflect the retrospective effect of the reverse stock split for all periods presented.

 

At the Market Offering Agreement

 

On June 2, 2023, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (the “Agent”), to create an at-the-market equity program under which it may sell up to $50 million of shares of the Company’s common stock (the “Shares”) from time to time through the Agent (the “ATM Offering”). Under the ATM Agreement, the Agent will be entitled to a commission at a fixed rate of 3.0% of the gross proceeds from each sale of Shares under the ATM Agreement.

 

Sales of the Shares, if any, under the ATM Agreement may be made in transactions that are deemed to be “at-the-market equity offerings” as defined in Rule 415 under the Securities Act, including sales made by means of ordinary brokers’ transactions, including on the Nasdaq Capital Market, at prevailing market prices at the time of sale or as otherwise agreed with the Agent. The Company has no obligation to sell, and the Agent is not obligated to buy or sell, any of the Shares under the Agreement and may at any time suspend offers under the Agreement or terminate the Agreement. The ATM Offering will terminate upon the termination of the ATM Agreement as permitted therein. The Shares will be issued pursuant to the Company’s previously filed Registration Statement on Form S-3 (File No. 333-271389) that was declared effective on May 2, 2023, and a prospectus supplement and accompanying prospectus relating to the ATM Offering filed with the SEC on June 2, 2023.

 

Deferred offering costs associated with the ATM Agreement are reclassified to additional paid in capital on a pro-rata basis when the Company completes offerings under the ATM Agreement. Any remaining deferred costs will be expensed to the statements of operations should the planned offering be terminated.

 

Public Warrants

 

In connection with the Business Combination, the Company assumed the Public Warrants issued upon AMCI’s initial public offering.

 

As of December 31, 2020, the Company had 735,069 Public Warrants outstanding. Each Public Warrant entitles the registered holder to purchase one share of common stock at a price of $345.00 per share, subject to adjustment, at any time commencing 30 days after the completion of the Business Combination. The Public Warrants will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. During the second quarter of 2021, certain warrant holders exercised their option to purchase an additional 760 shares at $345.00 per share. These exercises generated $262,177 additional proceeds to the Company and increased the Company’s shares outstanding by 760 shares. During 2023, one original Private Warrant Holder sold all their Private Placement Warrants resulting in a reclassification to Public Warrants. Following these exercises, as of September 30, 2024, the Company’s Public Warrants amounted to 813,314.

 

Once the warrants become exercisable, the Company may redeem the Public Warrants:

 

– in whole and not in part;

 

– at a price of $0.01 per warrant;

 

– upon not less than 30 days’ prior written notice of redemption;

 

– if, and only if, the reported last sale price of the Company’s Common Stock equals or exceeds $540.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders; and

 

– if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying such warrants.

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Common Stock at a price below its exercise price. In addition, the warrant agreement provides that in case of a tender offer or exchange that involves 50% or more of the Company’s stockholders, the Public Warrants may be settled in cash, equity securities or other assets depending on the kind and amount received per share by the holders of the common stock in such consolidation or merger that affirmatively make such election.

 

The Public Warrants are classified in equity in accordance with the Company’s evaluation of the provisions of ASC 480 and ASC 815. The Company analyzed the terms of the Public Warrants and concluded that there are no terms that provide that the warrant is not indexed to the issuer’s common stock. The Company also analyzed the tender offer provision discussed above and considering that upon the Closing of the Business Combination the Company has a single class of common shares, concluded that the exception discussed in ASC 815-40-25 applies, and thus equity classification is not precluded.

 

Stock-Based Compensation Plans

 

2021 Equity Incentive Plan

 

The Company’s Board of Directors (sometimes referred to herein as the “Board”) and stockholders previously approved the 2021 Equity Incentive Plan (the “Plan”) to reward certain employees and directors of the Company. The Plan has been established to advance the interests of the Company by providing for the grant to Participants of Stock and Stock-based Awards. The maximum number of shares of Common Stock that may be delivered in satisfaction of Awards under the Plan is 569,273 shares. On April 29, 2024, the stockholders voted to increase the number of shares of Common Stock issuable under the Company’s 2021 Equity Incentive Plan from 230,530 to 569,306.

 

Stock Options

 

Pursuant to and subject to the terms of the Plan the Company entered into separate Stock Option Agreements with each participant according to which each participant is granted an option (the “Stock Option”) to purchase up to a specific number of shares of common stock set forth in each agreement with an exercise price equal to the market price of Company’s common stock at the date of grant. The Company did not grant Stock Options during the three and nine months ended September 30, 2024.

 

Stock Options are granted to each participant in connection with their employment with the Company. The Stock Options vest on a graded basis over four years. The Company has a policy of recognizing compensation cost on a straight-line basis over the total requisite service period for the stock options. The Company recognized compensation cost of $0.6 million and $2.0 million in respect of Stock Options granted, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2024, respectively. The Company recognized compensation cost of $0.8 million and $2.5 million in respect of Stock Options granted, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2023, respectively. The Company also has a policy of accounting for forfeitures when they occur.

 

The following table summarizes the activities for our unvested stock options for the nine months ended September 30, 2024:

 

               
    Number of
options		    

Weighted
Average
Grant Date

Fair Value

  
Unvested as of December 31, 2023     57,894     $ 124.24  
Vested     (21,920 )   $ 134.19  
Forfeited     (11,948 )   $ 96.94  
Unvested as of September 30, 2024     24,026     $ 128.75  

 

As of September 30, 2024, there was $1.4 million of unrecognized compensation cost related to unvested Stock Options. This amount is expected to be recognized over the remaining vesting period of Stock Options.

 

Restricted Stock Units

 

Pursuant to and subject to the terms of the Plan the Company entered into separate Restricted Stock Units (“RSUs”) with each participant. On the grant date of RSUs, the Company grants to each participant a specific number of RSUs as set forth in each agreement, giving each participant the conditional right to receive without payment one share of common stock. The RSUs are granted to each participant in connection with their ongoing employment with the Company. The Company has in place Restricted Stock Unit Agreements that vest within one year and Restricted Stock Unit Agreements that vest on a graded basis over four years. The Company has a policy of recognizing compensation cost on a straight-line basis over the total requisite service period. The Company recognized compensation cost of $1.4 million and $4.0 million in respect of RSUs, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2024, respectively. The Company recognized compensation cost of $1.6 million and $4.9 million in respect of RSUs, which is included in administrative and selling expenses in the consolidated statements of operations for the three and nine months ended September 30, 2023, respectively. The Company also has a policy of accounting for forfeitures when they occur. The Company did not grant RSUs during the nine months ended September 30, 2024.

 

The following table summarizes the activities for our unvested RSUs for the nine months ended September 30, 2024:

 

               
    Number of
Shares		     Weighted
Average
Grant Date
Fair Value		  
Unvested as of December 31, 2023     67,894     $ 200.1  
Vested     (29,503 )   $ 198.95  
Forfeited     (14,275 )   $ 126.55  
Unvested as of September 30, 2024     24,116     $ 244.63  

 

As of September 30, 2024, there was $2.5 million of unrecognized compensation cost related to unvested RSUs. This amount is expected to be recognized over the remaining vesting period of Restricted Stock Unit Agreements.

 
v3.24.4
Revenue
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue

15. Revenue

 

Revenue is analyzed as follows:

 

                               
   

Three Months Ended

September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
Sales of goods   $ 128     $ 112     $ 1,852     $ -  
Sales of services     -       -       1,668       222  
Total revenue from contracts with customers   $ 128     $ 112     $ 3,520     $ 222  

 

The timing of revenue recognition is analyzed as follows:

 

 

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
Timing of revenue recognition                                
Revenue recognized at a point in time   $ 128     $ 112     $ 3,520     $ 222  
Revenue recognized over time     -       -       -       -  
Total revenue from contracts with customers   $ 128     $ 112     $ 3,520     $ 222  

 

As of September 30, 2024, and December 31, 2023, Advent recognized contract assets of nil and $9 thousand, respectively, on the consolidated balance sheets.

 

As of September 30, 2024, and December 31, 2023, Advent recognized contract liabilities of $1.2 million and $0.4 million, respectively, in the consolidated balance sheets. During the nine months ended September 30, 2024, the Company recognized the amount of $0.1 million in revenues.

 
v3.24.4
Collaborative Arrangements
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Collaborative Arrangements

16. Collaborative Arrangements

 

Cooperative Research and Development Agreement

 

In August 2020, the Company entered into a Cooperative Research and Development Agreement (“CRADA”) with Triad National Security, LLC (“TRIAD”), Alliance for Sustainable Energy LLC (“ASE”), and Brookhaven Science Associates (“BSA”). The purpose of this project is to build a fuel cell prototype that moves this technology closer to commercial readiness which was sanctioned by the Los Alamos National Laboratory and the National Renewable Energy Laboratory. The Government’s estimated total contribution, which is provided through TRIAD’s, ASE’s, and BSA’s respective contracts with the Department of Energy is $1.2 million, subject to available funding. As a part of the CRADA, the Company is required to contribute $1.2 million in cash and $0.6 million of in-kind contributions, such as personnel salaries. The cash payments are capitalized and amortized on a straight-line basis over the life of the contract. In-kind contributions are expensed as incurred. To date, the Company has not recognized any revenue from the CRADA. In December 2022, the term of the agreement was extended until March 3, 2024. In January 2024, the term of the agreement was extended until September 3, 2024.

 

Expenses from Collaborative Arrangements

 

For the three and nine months ended September 30, 2024, an amount of nil and $0.1 million has been recognized in research and development expenses on the unaudited condensed consolidated statements of operations, respectively. For the three and nine months ended September 30, 2023, an amount of $0.2 million and $1.5 million has been recognized in research and development expenses on the consolidated statements of operations, respectively.

 
v3.24.4
Income Taxes
 9 Months Ended
Sep. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

17. Income Taxes

 

To calculate the interim tax provision, at the end of each interim period the Company estimates the annual effective tax rate and applies that to its ordinary quarterly earnings. The effect of changes in the enacted tax laws or rates is recognized in the interim period in which the change occurs. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and judgments including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in foreign jurisdictions, permanent differences between book and tax amounts, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, additional information is obtained, or the tax environment changes.

 

During the three and nine months ended September 30, 2024, the Company recorded income tax benefit of nil and $0.1 million, respectively, mainly related to net operating loss carryforwards. During the three and nine months ended September 30, 2023, the Company recorded income tax benefits of $80 thousand and $0.2 million, respectively, mainly related to the Company’s recoverability assessment of research and development tax credits in Denmark. As of September 30, 2024, and December 31, 2023, the Company provided a valuation allowance to offset the deferred tax asset related to the net operating loss carryforwards in Denmark.

 
v3.24.4
Segment Reporting and Information about Geographical Areas
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Segment Reporting and Information about Geographical Areas

18. Segment Reporting and Information about Geographical Areas

 

Reportable Segments

 

The Company develops and manufactures high-temperature proton exchange membranes (“HT-PEM” or “HT-PEMs”) and fuel cell systems for the off-grid and portable power markets and plans to expand into the mobility market. The Company’s current revenue is derived from the sale of fuel cell systems and from the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets. The research and development activities are viewed as another product line that contributes to the development, design, production and sale of fuel cell products; however, it is not considered a separate operating segment. The Company has identified one business segment.

 

Geographic Information

 

The following table presents revenues, by geographic location (based on the location of the entity selling the product) for the three and nine months ended September 30, 2024 and 2023:

 

                               
   

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
North America   $ 128     $ 63     $ 3,052     $ 173  
Europe     -       49       468       49  
Asia     -       -       -       -  
Total net sales   $ 128     $ 112     $ 3,520     $ 222  

 
v3.24.4
Commitments and contingencies
 9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies

19. Commitments and contingencies

 

Litigation

 

The Company is subject to legal and regulatory actions that arise from time to time in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events.

 

On June 7, 2023, the Company was served a Request for Arbitration from F.E.R. fischer Edelstahlrohre GmbH (“F.E.R.”), pursuant to the arbitration provisions of the Share Purchase Agreement dated June 25, 2021 whereby the Company acquired SerEnergy and FES, which acquisition closed on August 31, 2021. The arbitration was held in Frankfurt am Main, Germany in accordance with the Arbitration Rules of the German Arbitration Institute, and the parties presented closing arguments in May 2024. F.E.R. is asserting that it is due approximately €4.5 million based on the cap and corresponding value of the share consideration at the date of closing. On August 16, 2024, the Company was informed that an arbitration decision and award was decided in favor of F.E.R. in the amount of approximately €4.5 million. On November 18, 2024, the Company filed a motion with the Higher Regional Court of Frankfurt to set aside the arbitral award. At this time, the Company cannot accurately predict the outcome of this matter, however, has recorded a loss contingency in the amount of $4.9 million, accrued interest expense of $0.3 million for a total of $5.2 million accrued loss liability as of September 30, 2024.

 

There is no other material pending or threatened litigation against the Company that remains outstanding as of September 30, 2024, that is considered probable or reasonably possible.

 

Guarantee letters

 

The Company had contingent liabilities in relation to performance guarantee letters and other guarantees provided to third parties that arise from its normal business activity and from which no substantial charges are expected to arise. As of September 30, 2024 and December 31, 2023, the Company did not hold any letters of guarantee.

 

Contractual obligations

 

In December 2021, the Company entered into a supply agreement by and among the Company, in its capacity as Customer, and BASF New Business GmbH, in its capacity as Seller. The supply agreement provides for the purchase by the Company of 21,000m2 (Minimum Quantity) of membrane from BASF during the contract duration from January 1, 2022 until December 31, 2025. The Company has not purchased any additional quantities in 2024 under this agreement and on July 12, 2024, has formally requested to terminate the supply contract.

 

In June 2022, the Company entered into a supply agreement by and among the Company, in its capacity as Customer, and Shin-Etsu Polymer Singapore Pte, Ltd (“Shin-Etsu”), in its capacity as Seller. The supply agreement provides for the purchase by the Company of 318,400 pieces (Minimum Quantity) of bipolar plates from Shin-Etsu during the contract duration from June 1, 2022 until June 30, 2024. In May 2023, the Company amended the supply agreement with Shin-Etsu to reduce the Minimum Quantity of bipolar plates to 75,400 pieces. In January 2024, the Company amended the supply agreement with Shin-Etsu to shift the timing of the monthly minimum requirements and extend the agreement until September 2024. The Company has not made any purchases under the amended agreement in 2024, the contract is currently on hold pending negotiations with Shin Etsu. Under the contract, Shin- Etsu can claim Advent to buy the remaining purchase requirement with the agreed purchases by the end of September 2024. The Company has not purchased any additional quantities in 2024 under this agreement and has formally requested to terminate the supply contract.

 

The following table summarizes our contractual obligations as of September 30, 2024:

 

                       
Fiscal Year Ended December 31,   Quantity (pieces)     Quantity (m2)    

Price

(Amounts in thousands)

  
2024     57,600       6,174       2,304  
2025     -       8,000       2,150  
Total     57,600       14,174     $ 4,454  

 

The Company has not accrued for these unrecognized commitment obligations as of September 30, 2024, and December 31, 2023.

 
v3.24.4
Net loss per share
 9 Months Ended
Sep. 30, 2024
Net loss per share  
Net loss per share

20. Net loss per share

 

Net loss per share is computed by dividing net loss by the weighted-average number of shares of Common Stock outstanding during the year.

 

The following table sets forth the computation of the basic and diluted net loss per share for the three and nine months ended September 30, 2024 and 2023:

 

                               
   

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands, except share and per share amounts)   2024     2023     2024     2023  
Numerator:                                
Net loss from continuing operations   $ (9,615 )   $ (9,891 )   $ (29,244 )   $ (26,530 )
Net loss from discontinued operations   $ (8,907 )   $ (1,955 )   $ (9,907 )   $ (19,135 )
Net loss   $ (18,522 )   $ (11,846 )   $ (39,151 )   $ (45,665 )
Denominator:                                
Basic weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Diluted weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Net loss per share:                                
Basic loss per share from continuing operations   $ (3.65 )   $ (4.92 )   $ (11.17 )   $ (14.39 )
Basic loss per share from discontinued operations   $ (3.38 )   $ (0.97 )   $ (3.78 )   $ (10.38 )
Basic loss per share   $ (7.03 )   $ (5.89 )   $ (14.95 )   $ (24.78 )
Diluted loss per share from continuing operations   $ (3.65 )   $ (4.92 )   $ (11.17 )   $ (14.39 )
Diluted loss per share from discontinued operations   $ (3.38 )   $ (0.97 )   $ (3.78 )   $ (10.38 )
Diluted loss per share   $ (7.03 )   $ (5.89 )   $ (14.95 )   $ (24.78 )

 

Basic net loss per share is computed by dividing net loss for the periods presented by the weighted-average number of shares of Common Stock outstanding during these periods.

 

Diluted net loss per share is computed by dividing the net loss, by the weighted average number of shares of Common Stock outstanding for the periods, adjusted for the dilutive effect of shares of Common Stock equivalents resulting from the assumed exercise of the Public Warrants, Private Placements Warrants, Working Capital Warrants, Stock Options and RSUs. The treasury stock method was used to calculate the potential dilutive effect of these Common Stock equivalents.

 

As the Company incurred losses for the three and nine months ended September 30, 2024 and 2023, the effect of including any potential shares of Common Stock in the denominator of diluted per-share computations would have been anti-dilutive; therefore, basic and diluted losses per share are the same.

 
v3.24.4
Discontinued Operations
 9 Months Ended
Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

21. Discontinued Operations

 

The following table presents a reconciliation of the carrying amounts of the major classes of assets and liabilities of discontinued operations to the total assets and liabilities of discontinued operations as presented in the condensed consolidated balance sheet.

 

       
(Amounts in thousands)   December 31,
2023		  
Assets        
Cash and cash equivalents   $ 362  
Accounts receivable, net     128  
Contract assets     12  
Inventories, net     2,512  
Prepaid expenses and other current assets     1,416  
Property, plant and equipment, net     1,463  
Right-of-use assets     59  
Other non-current assets     66  
Total Assets   $ 6,018  

 

         
(Amounts in thousands)   December 31,
2023		  
Liabilities        
Trade payables   $ 1,091  
Deferred income from grants, current     7  
Contract liabilities     1,601  
Other current liabilities     881  
Operating lease liabilities     48  
Lease liabilities – long-term     12  
Other long-term liabilities     683  
Total Liabilities   $ 4,323  

 

During the three and nine months ended September 30, 2024, and 2023, the Company’s operating results for the discontinued entities (Advent Technologies A/S and Advent Green Energy Philippines, Inc.):

 

                               
    Three months ended
September 30,
(Unaudited)		     Nine months ended
September 30,
(Unaudited)		  
(Amounts in USD in thousands)   2024     2023     2024     2023  
Revenue, net   $ (135 )   $ 1,152     $ 728     $ 3,131  
Cost of revenues     (102 )     (1,649 )     (716 )     (4,509 )
Gross profit / (loss)     (237 )     (497 )     12       (1,378 )
Income from grants     (541 )     254       310       902  
Research and development expenses     -       (934 )     -       (3,410 )
Administrative and selling expenses     (2,067 )     (916 )     (4,167 )     (14,951 )
Credit loss – customer contracts     -       67       -       -  
Operating loss     (2,845 )     (2,026 )     (3,845 )     (18,837 )
Finance income / (expenses), net     -       72       -       640  
Foreign exchange gains / (losses), net     -       10       -       (1 )
Other income / (expenses), net     -       (11 )     -       (13 )
Net assets / (liabilities) – Advent Technologies A/S and Advent Green Energy Philippines, Inc.     6,278       -       6,278       -  
Payable to Advent Technologies A/S     (12,340 )              (12,340 )      -  
Loss before income tax     (8,907 )     (1,954 )     (9,907 )     (18,211 )
Income taxes     -       (1 )     -       (924 )
Net loss   $ (8,907 )   $ (1,955 )   $ (9,907 )   $ (19,135 )

 
v3.24.4
Subsequent Events
 9 Months Ended
Sep. 30, 2024
Subsequent Events [Abstract]  
Subsequent Events

22. Subsequent Events

 

On October 15, 2024, the Company reported that as disclosed previously, on May 24, 2024, and August 28, 2024, the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notified the Company that, as of the date of such notification, it no longer met the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1)(the “Rule”) because it had not yet filed its Quarterly Reports on Form 10-Q for the periods ended March 31, and June 30, 2024 (the “Form 10-Qs”). On October 15, 2024, the Company received a letter from the Staff indicating that based on the October 15, 2024 filings of the Quarterly Reports on Form 10-Qs for the periods ended March 31, and June 30, 2024, the Staff has determined that the Company complies with the Rule. Accordingly, this matter is now closed. 

 

On October 18, 2024, the Company received a letter from the Staff of Nasdaq notifying the Company that because the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024, reported stockholders’ equity of ($2,879,000), and as of the date of such letter, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations, the Company was no longer compliant with Nasdaq’s Listing Rule requiring the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing.

 

As a result, as of October 18, 2024, under Nasdaq Rules the Company had 45 calendar days to submit a plan to regain compliance. If the Company’s plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance.

 

On October 24, 2024, the Board of the Company approved the termination of the employment of Vassilios Gregoriou, the Chief Executive Officer, Acting Chief Financial Officer, for cause, effective immediately.

 

Further to said termination, in connection with Mr. Gregoriou’s termination, the Company’s Board of Directors appointed Mr. Gary Herman, who is currently serving as a member of the Board, to the additional role of interim chief executive officer, effective immediately, until a new Chief Executive Officer is appointed. Mr. Herman, 60, is a seasoned investor with many years of investment and business experience. From 2005 to 2020 he co-managed the Strategic Turnaround Equity Partners, LP (Cayman) fund and its affiliates. From January 2011 to August 2013, he was a managing member of Abacoa Capital Management, LLC, which managed Abacoa Capital Master Fund, Ltd., focused on a Global-Macro investment strategy. From 2005 to 2020, Mr. Herman was affiliated with Arcadia Securities LLC, a New York-based broker-dealer. From 1997 to 2002, he was an investment banker with Burnham Securities, Inc. From 1993 to 1997, he was a managing partner of Kingshill Group, Inc., a merchant banking and financial firm with offices in New York and Tokyo. Mr. Herman has a B.S. from the University at Albany with a major in Political Science and minors in Business and Music. Mr. Herman has many years of experience serving on the boards of public and private companies. He presently sits on the boards of Siyata Mobile, Inc. (NASDAQ: SYTA), Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), SRM Entertainment, Inc. (NASDAQ: SRM), LQR House, Inc. (NASDAQ: LQR), SusGlobal Energy Corp. (OTCQB: SNRG) and XS Financial, Inc. (CSE: XS).

 

There are no family relationships between Mr. Herman and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

On October 29, 2024, the Board of the Company approved the termination of the employment of Christos Kaskavelis, Chief Strategy Officer of the Company, for cause, effective immediately.

 

On November 8, 2024, the Company terminated the Securities Purchase Agreement it had previously entered into on July 30, 2024 (the “SPA”) with an institutional investor (the “Investor”) pursuant to which, at the closing, the Company was contemplated to have issued to the Investor a senior promissory note in the principal amount of $1,000,000 (the “Senior Note”). The Investor had also committed to provide the Company with a one-year revolving line of credit to the Company for an aggregate maximum principal amount of $2,000,000, contingent upon the Company’s filing of a Registration Statement on Form S-1 with the SEC with respect to an underwritten or “best efforts” public offering by the Company of its common stock, and/or common stock equivalents registered under the Securities Act of 1933, as amended (the “Securities Act”) for proceeds to the Company of not less than $5,000,000. This transaction is referred to herein as the “Financing.” Inasmuch as the Investor failed to comply with the terms of the SPA and did not provide any funds to the Company to ultimately complete the Financing, the Board voted to terminate the SPA and potential Financing. The Company had initially disclosed the SPA and Financing on its Current Report on Form 8-K filed with the SEC on August 5, 2024.

 

Effective as of November 4, 2024, the Company appointed Messrs. Seth M. Lukash and Joseph P. Celia to the Board as Class II directors. Mr. Lukash will serve on the compensation and audit committees, and as chair of the audit committee. Mr. Celia will serve on the audit and compensation committees and as a chair of the compensation committee.

 

Mr. Seth Lukash, 78, is a seasoned corporate director, officer, and investor. For 30 years he was a CEO for various technology and manufacturing companies. He was CEO and President of Tridex, Inc. (n/k/a TransAct Technologies (Nasdaq: TACT) a manufacturer of printers and peripherals to the banking, lottery/gaming, and retail sales markets. Mr. Lukash was Chairman and CEO of Progressive Software, a large provider of application software to the restaurant and hospitality industry. After the sale and divestiture of these companies he advised several technology companies. He has served as an advisor to OEM Capital a boutique investment banking firm and Strategic Turnaround Equity Partners, LP, a fund focused on investments in undervalued public companies. For the past two years he has advised an AI start-up with their organization and structuring for additional financing. He started his finance career as a research analyst for Carter Berlind & Weil. Mr. Lukash is a graduate of the University of Miami with a BA in Finance.

 

Mr. Joseph P. Celia, 60, is a technology industry veteran with 30 years of experience with an impressive track record in building strategic partnerships, driving new business initiatives, and penetrating new markets. His dynamic and results-oriented approach in sales leadership within the rapidly evolving tech sector has consistently led to significant achievements. Mr. Celia has held executive and senior-level sales management positions at some of the tech industry’s most respected organizations, including Hewlett Packard, Motorola, 3Com, Symbol Technologies, Bradford Networks, Accton Technology, and FIS Global. Mr. Celia has a BS from Northeastern University in Computer Technology.

 

In connection with his appointment, the Board has determined that Mr. Lukash (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); (ii) is an “independent director” as contemplated by Nasdaq Listing Rule 5605(b)(1); and (iii) is an “audit committee financial expert,” as defined in Item 407(d)(5)(ii) of Regulation S-K. In connection with his appointment, the Board has determined that Mr. Celia (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); and (ii) is an “independent director” as contemplated by Nasdaq Listing Rule 5605(b)(1).

 

There are no arrangements or understandings between any of the new Directors and any other person pursuant to which each was selected as a director, and there have been no transactions since the beginning of the Company’s last fiscal year, nor are there any currently proposed transactions, regarding the new Directors that are required to be disclosed by Item 404(a) of Regulation S-K promulgated under the Exchange Act.
v3.24.4
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an on-going basis, management evaluates the estimates and judgments, including those related to the selection of useful lives for tangible assets, expected future cash flows from long-lived assets to support impairment tests, the carrying value of goodwill, provisions necessary for accounts receivables and inventory write downs, provisions for legal disputes, and contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates under different assumptions and/or conditions.

 
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

 

Cash and cash equivalents are highly liquid investments with original maturities of three months or less. Cash and cash equivalents consist of cash on hand, deposits held on call with banks and investments in money market funds with original maturities of three months or less at the date of acquisition. As of December 31, 2023, the Company has cash and cash equivalents which are restricted of $0.9 million. The restricted cash equivalent was a letter of credit required by the Company’s lease agreement for the Hood Park facility in Boston, MA. The letter of credit is required for the duration of the lease agreement which commenced in October 2022 and then was terminated in June 2024 resulting in the release of the letter of credit in the benefit of the landlord.

 

The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported in the consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows:

 

               
 

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Cash and cash equivalents   $ 192     $ 3,200  
Restricted cash, current     -       100  
Restricted cash, non-current     -       750  
Cash, cash equivalents, restricted cash and restricted cash equivalents   $ 192     $ 4,050  

 
Credit Losses

Credit Losses

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which amends the requirement on the measurement and recognition of expected credit losses for financial assets held. Furthermore, amendments ASU 2019-10 and ASU 2019-11 provided additional clarification for implementing ASU 2016-13. ASU 2016-13 is effective for the Company beginning January 1, 2023, with early adoption permitted. The Company adopted the standard on January 1, 2023, in accordance with the adoption dates for private entities applicable to it under its emerging growth company status at that time and the standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements and related disclosures. The Company is exposed to credit losses primarily through sales of its products. The Company assesses each customer’s ability to pay and a credit loss estimate by conducting a credit review which includes consideration of established credit rating or an internal assessment of the customer’s creditworthiness based on an analysis of their payment history when a credit rating is not available. The Company monitors credit exposure through active review of customer balances. The Company’s expected loss methodology for accounts receivable is developed through consideration of factors including, but not limited to, historical collection experience, current customer credit ratings, current customer financial condition, current and future economic and market conditions, and age of the receivables. Charges related to credit losses are included in administrative and selling expenses and are recorded in the period that the outstanding receivables are determined to be doubtful. Account balances are written-off against the allowance when they are deemed uncollectible.

 

During the three months ended September 30, 2024, certain receivables totaling $4.3 million from Advent Technologies A/S were fully reserved as expected credit losses.

 
Inventories

Inventories

 

Inventories, which consist of raw materials, work-in-process and finished goods are stated at the lower of cost or net realizable value using the first-in, first-out cost method. Cost includes the cost of purchased materials, inbound freight charges, external and internal processing and applicable labor and overhead costs. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.

 

The Company periodically reviews quantities of inventories on hand and compares these amounts to the expected use of each product. Inventories are reviewed to determine if valuation allowances are required for obsolescence (excess, obsolete, and slow-moving inventory). This review includes analyzing inventory levels of individual parts considering the current design of our products and production requirements as well as the expected inventory requirements for maintenance on installed power platforms. The Company records a charge to cost of revenue for the amount required to reduce the carrying value of inventory to the net realizable value.

 
Fair Value Measurements

Fair Value Measurements

 

The Company follows the accounting guidance in ASC 820 for its fair value measurements of financial assets and liabilities measured at fair value on a recurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.

 

The accounting guidance requires fair value measurements be classified and disclosed in one of the following three categories:

 

● Level 1: Quoted prices in active markets for identical assets or liabilities.

 

● Level 2: Observable inputs other than Level 1 prices, for similar assets or liabilities that are directly or indirectly observable in the marketplace.

 

● Level 3: Unobservable inputs which are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

 

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 
Convertible Bond Loan

Convertible Bond Loan

 

On May 25, 2022, Advent Technologies S.A (“Advent SA”) and UNI.FUND Mutual Fund (“UNIFUND”) entered into an agreement to finance Cyrus SA (“Cyrus”) with a convertible bond loan (“Bond Loan”) of €1.0 million. As a part of this transaction, Advent SA offered €0.3 million in bond loans with an annual interest rate of 8.00%. The term of the loan is three years and there is a surcharge of 2.5% for overdue interest.

 

Cyrus business relates to the research and experimental development in natural sciences and mechanics, the construction of pumps and hydrogen compressors and the wholesale of compressors. Hydrogen compressors are a critical part of the Hydrogen Refueling Stations (HRS) to be used by transport applications. Cyrus has developed a prototype Metal Hydride Compressor which offers unique advantages. The proceeds from the Bond Loan are to cover Cyrus’s working capital needs in the context of its operation and the product development.

 

Mandatory conversion of the Bond Loan will occur in the event of qualified financing which is equivalent to a share capital increase by Cyrus in the first three years from the execution of the Bond Loan agreement with a total amount over €3 million which is covered by third parties unrelated to the basic shareholders or by investors related to them.

 

The Company classifies the Bond Loan as an available for sale financial asset on the consolidated balance sheets. The Company recognizes interest income within the consolidated statement of operations. For the three and nine months ended September 30, 2024, the Company recognized $7 thousand and $21 thousand of interest income related to the Bond Loan within the consolidated statements of operations, respectively. For the three and nine months ended September 30, 2023, the Company recognized $6 thousand and $19 thousand of interest income related to the Bond Loan within the consolidated statements of operations, respectively.

 

The Company initially measured the available for sale Bond Loan at the transaction price plus any applicable transaction costs. The Bond Loan is remeasured to its fair value at each reporting period and upon settlement. The estimated fair value of the Bond Loan is determined using Level 3 inputs by using a discounted cash flow model. The change in fair value is recognized within the consolidated statements of comprehensive loss. As of September 30, 2024, the Company continues to fully reserve the Bond Loan as an expected credit loss. The Company did not recognize any unrealized gain / (loss) during the three and nine months ended September 30, 2024, or 2023.

 
Warrant Liability

Warrant Liability

 

As a result of the Business Combination, the Company assumed a warrant liability (the “Warrant Liability”) related to previously issued 131,343 warrants, each exercisable to purchase one share of common stock at an exercise price of $345.00 per share, originally sold to AMCI Sponsor LLC (the “Sponsor”) in a private placement consummated in connection with AMCI’s initial public offering (the “Private Placement Warrants”) and the 13,333 warrants, each exercisable to purchase one share of Common Stock at an exercise price of $345.00 per share, converted from the Sponsor’s non-interest bearing loan to the Company of $0.4 million in connection with the closing of the Business Combination (the “Working Capital Warrants”) (Note 13). The Private Placement Warrants and the Working Capital Warrants have substantially the same terms as the 734,309 warrants, each exercisable to purchase one share of Common Stock at an exercise price of $345.00 per share, issued by AMCI in its initial public offering (the “Public Warrants”).

 

The following tables summarize the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023.

 

               
   

As of
September 30,
2024

(Unaudited)

  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ -     $ -  
    $ -     $ -  

 

    As of
December 31,
2023		  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ 59     $ 59  
    $ 59     $ 59  

 

The carrying amounts of the Company’s remaining financial instruments reflected on the consolidated balance sheets and which consist of cash and cash equivalents, accounts receivables, net, other current assets, trade and other payables, and other current liabilities, approximate their respective fair values due to their short-term nature.

 

Changes in the fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2024 and 2023 were as follows:

 

                               
Available for Sale Financial Asset
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 326     $ -     $ 320  
Estimated fair value of available for sale financial asset acquired     -       -       -       -  
Foreign exchange fluctuations     -       (10 )     -       (4 )
Change in estimated fair value     -       -       -       -  
Estimated fair value (end of period)   $ -     $ 316     $ -     $ 316  

 

Warrant Liability
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 177     $ 59     $ 998  
Change in estimated fair value     -       135       (59 )     (355 )
Reclassification of private placement warrants     -       (213 )     -       (545 )
Estimated fair value (end of period)   $ -     $ 99     $ -     $ 99  

 

The Warrant Liability is remeasured to its fair value at each reporting period and upon settlement. The change in fair value is recognized in “Fair value change of warrant liability” on the consolidated statements of operations.

 
v3.24.4
Basis of presentation (Tables)
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of subsidiaries in consolidation
                   
    Country of   Ownership Interest   Statements of Operations
Company Name   Incorporation   Direct   Indirect   2024   2023
Advent Technologies, Inc.   USA   100%   -   01/01 – 9/30   01/01 – 9/30
Advent Technologies S.A.   Greece   -   100%   01/01 – 9/30   01/01 – 9/30
Advent Technologies LLC   USA   -   100%   01/01 – 9/30   01/01 – 9/30
Advent Technologies GmbH   Germany   100%   -   01/01 – 9/30   01/01 – 9/30
v3.24.4
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of restricted cash and cash equivalents
               
 

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Cash and cash equivalents   $ 192     $ 3,200  
Restricted cash, current     -       100  
Restricted cash, non-current     -       750  
Cash, cash equivalents, restricted cash and restricted cash equivalents   $ 192     $ 4,050  
Schedule of liabilities measured at fair value on recurring basis
               
   

As of
September 30,
2024

(Unaudited)

  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ -     $ -  
    $ -     $ -  

 

    As of
December 31,
2023		  
(Amounts in thousands)   Fair Value     Unobservable
Inputs
(Level 3)		  
Assets                
Available for sale financial asset   $ -     $ -  
    $ -     $ -  
                 
Liabilities                
Warrant liability   $ 59     $ 59  
    $ 59     $ 59  
Schedule of change in fair value of warrant liability
                               
Available for Sale Financial Asset
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 326     $ -     $ 320  
Estimated fair value of available for sale financial asset acquired     -       -       -       -  
Foreign exchange fluctuations     -       (10 )     -       (4 )
Change in estimated fair value     -       -       -       -  
Estimated fair value (end of period)   $ -     $ 316     $ -     $ 316  

 

Warrant Liability
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Estimated fair value (beginning of period)   $ -     $ 177     $ 59     $ 998  
Change in estimated fair value     -       135       (59 )     (355 )
Reclassification of private placement warrants     -       (213 )     -       (545 )
Estimated fair value (end of period)   $ -     $ 99     $ -     $ 99  
v3.24.4
Related party disclosures (Tables)
 9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
Schedule of related parties
          
   September 30,
2024		   December 31,
2023		 
(Amounts in thousands)  (Unaudited)     
Due to related parties          
Vassilios Gregoriou  $75   $- 
Maria Gregoriou   50    - 
Emory S. De Castro   128    - 
Total  $253   $- 
v3.24.4
Accounts receivable, net (Tables)
 9 Months Ended
Sep. 30, 2024
Receivables [Abstract]  
Schedule of accounts receivable
               
  September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accounts receivable from third party customers   $ 2,142     $ 348  
Less: Allowance for credit losses     (1,868 )     (285 )
Accounts receivable, net   $ 274     $ 63  
v3.24.4
Inventories (Tables)
 9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
Schedule of inventories
               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Raw materials and supplies   $ 4,967     $ 4,864  
Work-in-process     228       90  
Finished goods     264       259  
Total   $ 5,459     $ 5,213  
Provision for inventory     (5,362 )     (5,018 )
Total   $ 97     $ 195  
Schedule of changes in provision for slow moving inventory
                               
    For the
Three Months Ended
September 30,
2024		     For the
Three Months Ended
September 30,
2023		     For the
Nine Months Ended
September 30,
2024		    

For the

Nine Months Ended
September 30,
2023

  
(Amounts in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Balance at beginning of period   $ (5,175 )   $ (46 )   $ (5,018 )   $ (45 )
Additions during the period     (11 )     (449 )     (250 )     (449 )
Exchange differences     (176 )     2       (94 )     1  
Balance at end of period   $ (5,362 )   $ (493 )   $ (5,362 )   $ (493 )
v3.24.4
Prepaid expenses and other current assets (Tables)
 9 Months Ended
Sep. 30, 2024
Prepaid Expenses And Other Current Assets  
Schedule of prepaid expenses
               
   

September 30,
2024

    

December 31,

2023

  
(Amounts in thousands)   (Unaudited)        
Prepaid insurance expenses   $ 410     $ 155  
Prepaid research expenses     13       36  
Other prepaid expenses     125       27  
Total   $ 548     $ 218  
Schedule of other current assets
               
   

September 30,
2024

     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
VAT receivable   $ 56     $ 267  
Withholding tax     -       -  
Grant receivable     185       181  
Purchases under receipt     -       1  
Guarantees     -       -  
Other receivables     72       91  
Accrued sublease income     -       80  
Accrued interest income     -       -  
Total   $ 313     $ 620  
v3.24.4
Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets
                               
    As of September 30, 2024 (Unaudited)  
(Amounts in thousands)   Gross
Carrying
Amount		     Accumulated
Amortization		     Cumulative
Impairment		     Net
Carrying
Amount		  
Finite-lived intangible assets:                                
Software     237       (160 )     -       77  
Total intangible assets   $ 237     $ (160 )   $ -     $ 77  

 

    As of December 31, 2023  
(Amounts in thousands)   Gross
Carrying
Amount		     Accumulated
Amortization		     Cumulative
Impairment		     Net
Carrying
Amount		  
Indefinite-lived intangible assets:                                
Trade name “UltraCell”   $ 406     $ -     $ (406 )   $ -  
Total indefinite-lived intangible assets   $ 406     $ -     $ (406 )   $ -  
Finite-lived intangible assets:                                
Patents     21,221       (3,247 )     (17,974 )     -  
Process know-how (IPR&D)     2,612       (1,017 )     (1,595 )     -  
Order backlog     266       (266 )     -       -  
Software     233       (154 )     -       79  
Total finite-lived intangible assets   $ 24,332     $ (4,684 )   $ (19,569 )   $ 79  
Total intangible assets   $ 24,738     $ (4,684 )   $ (19,975 )   $ 79  
Schedule of future amortization expense
       
(Amounts in thousands)      
Fiscal Year Ended December 31,        
2024   $ 7  
2025     28  
2026     42  
2027     -  
2028     -  
Thereafter     -  
Total   $ 77  
v3.24.4
Property, plant and equipment, net (Tables)
 9 Months Ended
Sep. 30, 2024
Property, Plant and Equipment [Abstract]  
Schedule of property, plant and equipment, net
               
    September 30,
2024		    

December 31,

2023

  
(Amounts in thousands)   (Unaudited)        
Land, Buildings & Leasehold Improvements   $ 1,014     $ 12,632  
Machinery     6,176       10,908  
Equipment     1,911       2,591  
    $ 9,101     $ 26,131  
Less: accumulated depreciation     (1,407 )     (3,661 )
Less: impairment     (2,384 )     (2,384 )
Total   $ 5,310     $ 20,086  
v3.24.4
Other current liabilities (Tables)
 9 Months Ended
Sep. 30, 2024
Other Current Liabilities  
Schedule of other current liabilities
               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accrued expenses(1)   $ 563     $ 653  
Other short-term payables     802       44  
Taxes and duties payable     299       255  
Provision for unused vacation     4       4  
Social security funds     108       70  
Overtime provision     9       9  
Total   $ 1,785     $ 1,035  

 

 
(1) Accrued expenses are analyzed as follows:
Schedule of accrued expenses
               
    September 30,
2024		     December 31,
2023		  
(Amounts in thousands)   (Unaudited)        
Accrued expenses for legal and consulting fees   $ 243     $ 219  
Accrued payroll fees     39       139  
Other accrued expenses     281       295  
Total   $ 563     $ 653  
v3.24.4
Leases (Tables)
 9 Months Ended
Sep. 30, 2024
Leases  
Schedule of maturities of operating lease liabilities
       
    Operating
Leases		  
Fiscal Year Ended December 31,        
2024   $ 35  
2025     140  
2026     107  
2027     4  
2028     -  
Thereafter     -  
Total undiscounted lease payments   $ 286  
Less: imputed interest     (16 )
Total discounted lease payments   $ 270  
Less: current portion     (111 )
Long-term lease liabilities   $ 159  
v3.24.4
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of activities for unvested stock
               
    Number of
options		    

Weighted
Average
Grant Date

Fair Value

  
Unvested as of December 31, 2023     57,894     $ 124.24  
Vested     (21,920 )   $ 134.19  
Forfeited     (11,948 )   $ 96.94  
Unvested as of September 30, 2024     24,026     $ 128.75  
Schedule of restricted stock units granted
               
    Number of
Shares		     Weighted
Average
Grant Date
Fair Value		  
Unvested as of December 31, 2023     67,894     $ 200.1  
Vested     (29,503 )   $ 198.95  
Forfeited     (14,275 )   $ 126.55  
Unvested as of September 30, 2024     24,116     $ 244.63  
v3.24.4
Revenue (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of revenue
                               
   

Three Months Ended

September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
Sales of goods   $ 128     $ 112     $ 1,852     $ -  
Sales of services     -       -       1,668       222  
Total revenue from contracts with customers   $ 128     $ 112     $ 3,520     $ 222  

 

The timing of revenue recognition is analyzed as follows:

 

 

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
Timing of revenue recognition                                
Revenue recognized at a point in time   $ 128     $ 112     $ 3,520     $ 222  
Revenue recognized over time     -       -       -       -  
Total revenue from contracts with customers   $ 128     $ 112     $ 3,520     $ 222  
v3.24.4
Segment Reporting and Information about Geographical Areas (Tables)
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Segment Reporting and Information about Geographical Areas
                               
   

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands)   2024     2023     2024     2023  
North America   $ 128     $ 63     $ 3,052     $ 173  
Europe     -       49       468       49  
Asia     -       -       -       -  
Total net sales   $ 128     $ 112     $ 3,520     $ 222  
v3.24.4
Commitments and contingencies (Tables)
 9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of contractual obligations
                       
Fiscal Year Ended December 31,   Quantity (pieces)     Quantity (m2)    

Price

(Amounts in thousands)

  
2024     57,600       6,174       2,304  
2025     -       8,000       2,150  
Total     57,600       14,174     $ 4,454  
v3.24.4
Net loss per share (Tables)
 9 Months Ended
Sep. 30, 2024
Net loss per share  
Schedule of computation of basic and diluted net loss per share
                               
   

Three Months Ended
September 30,

(Unaudited)

    

Nine Months Ended
September 30,

(Unaudited)

  
(Amounts in thousands, except share and per share amounts)   2024     2023     2024     2023  
Numerator:                                
Net loss from continuing operations   $ (9,615 )   $ (9,891 )   $ (29,244 )   $ (26,530 )
Net loss from discontinued operations   $ (8,907 )   $ (1,955 )   $ (9,907 )   $ (19,135 )
Net loss   $ (18,522 )   $ (11,846 )   $ (39,151 )   $ (45,665 )
Denominator:                                
Basic weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Diluted weighted average number of shares     2,636,508       2,012,382       2,618,601       1,843,154  
Net loss per share:                                
Basic loss per share from continuing operations   $ (3.65 )   $ (4.92 )   $ (11.17 )   $ (14.39 )
Basic loss per share from discontinued operations   $ (3.38 )   $ (0.97 )   $ (3.78 )   $ (10.38 )
Basic loss per share   $ (7.03 )   $ (5.89 )   $ (14.95 )   $ (24.78 )
Diluted loss per share from continuing operations   $ (3.65 )   $ (4.92 )   $ (11.17 )   $ (14.39 )
Diluted loss per share from discontinued operations   $ (3.38 )   $ (0.97 )   $ (3.78 )   $ (10.38 )
Diluted loss per share   $ (7.03 )   $ (5.89 )   $ (14.95 )   $ (24.78 )
v3.24.4
Discontinued Operations (Tables)
 9 Months Ended
Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of condensed consolidated balance sheet
       
(Amounts in thousands)   December 31,
2023		  
Assets        
Cash and cash equivalents   $ 362  
Accounts receivable, net     128  
Contract assets     12  
Inventories, net     2,512  
Prepaid expenses and other current assets     1,416  
Property, plant and equipment, net     1,463  
Right-of-use assets     59  
Other non-current assets     66  
Total Assets   $ 6,018  

 

         
(Amounts in thousands)   December 31,
2023		  
Liabilities        
Trade payables   $ 1,091  
Deferred income from grants, current     7  
Contract liabilities     1,601  
Other current liabilities     881  
Operating lease liabilities     48  
Lease liabilities – long-term     12  
Other long-term liabilities     683  
Total Liabilities   $ 4,323  
Schedule of operating results for the discontinued entities
                               
    Three months ended
September 30,
(Unaudited)		     Nine months ended
September 30,
(Unaudited)		  
(Amounts in USD in thousands)   2024     2023     2024     2023  
Revenue, net   $ (135 )   $ 1,152     $ 728     $ 3,131  
Cost of revenues     (102 )     (1,649 )     (716 )     (4,509 )
Gross profit / (loss)     (237 )     (497 )     12       (1,378 )
Income from grants     (541 )     254       310       902  
Research and development expenses     -       (934 )     -       (3,410 )
Administrative and selling expenses     (2,067 )     (916 )     (4,167 )     (14,951 )
Credit loss – customer contracts     -       67       -       -  
Operating loss     (2,845 )     (2,026 )     (3,845 )     (18,837 )
Finance income / (expenses), net     -       72       -       640  
Foreign exchange gains / (losses), net     -       10       -       (1 )
Other income / (expenses), net     -       (11 )     -       (13 )
Net assets / (liabilities) – Advent Technologies A/S and Advent Green Energy Philippines, Inc.     6,278       -       6,278       -  
Payable to Advent Technologies A/S     (12,340 )              (12,340 )      -  
Loss before income tax     (8,907 )     (1,954 )     (9,907 )     (18,211 )
Income taxes     -       (1 )     -       (924 )
Net loss   $ (8,907 )   $ (1,955 )   $ (9,907 )   $ (19,135 )
v3.24.4
Basis of presentation (Details)
Pure in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Advent Technologies Inc. [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Company Name Advent Technologies, Inc.  
Country of Incorporation USA  
Statements of Operations date 01/01 – 9/30 01/01 – 9/30
Advent Technologies Inc. [Member] | Direct Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest 100.00%  
Advent Technologies Inc. [Member] | Indirect Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest  
Advent Technologies S.A. [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Company Name Advent Technologies S.A.  
Country of Incorporation Greece  
Statements of Operations date 01/01 – 9/30 01/01 – 9/30
Advent Technologies S.A. [Member] | Direct Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest  
Advent Technologies S.A. [Member] | Indirect Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest 100.00%  
Advent Technologies LLC [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Company Name Advent Technologies LLC  
Country of Incorporation USA  
Statements of Operations date 01/01 – 9/30 01/01 – 9/30
Advent Technologies LLC [Member] | Direct Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest  
Advent Technologies LLC [Member] | Indirect Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest 100.00%  
Advent Technologies GmbH [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Company Name Advent Technologies GmbH  
Country of Incorporation Germany  
Statements of Operations date 01/01 – 9/30 01/01 – 9/30
Advent Technologies GmbH [Member] | Direct Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest 100.00%  
Advent Technologies GmbH [Member] | Indirect Ownership [Member]    
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
Ownership Interest  
v3.24.4
Basis of presentation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 25, 2024
Dec. 31, 2023
Sep. 30, 2023
Feb. 04, 2021
Restructuring Cost and Reserve [Line Items]          
Common stock, par value (in dollars per share) $ 0.0001   $ 0.0001    
Net cash used in operating activities $ 3,088        
Negative net working capital 23,000        
Cash and cash equivalents 192   $ 3,200 $ 3,661  
Cash Equivalents [Member]          
Restructuring Cost and Reserve [Line Items]          
Cash and cash equivalents $ 200 $ 500      
AMCI Acquisition Corp [Member]          
Restructuring Cost and Reserve [Line Items]          
Acquired percentage         100.00%
Common stock, par value (in dollars per share)         $ 0.0001
v3.24.4
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Accounting Policies [Abstract]        
Cash and cash equivalents $ 192 $ 3,200 $ 3,661  
Restricted cash, current 100 2,018  
Restricted cash, non-current 750    
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 192 $ 4,050 $ 6,429 $ 33,619
v3.24.4
Summary of Significant Accounting Policies (Details 1) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Assets
Liabilities 59
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Assets
Liabilities 59
Derivative Financial Instruments, Assets [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Assets
Derivative Financial Instruments, Assets [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Assets
Derivative Financial Instruments, Liabilities [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Liabilities 59
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Liabilities $ 59
v3.24.4
Summary of Significant Accounting Policies (Details 2) - Derivative Financial Instruments, Liabilities [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Estimated fair value at beginning balance $ 326 $ 320
Estimated fair value of available for sale financial asset acquired
Foreign exchange fluctuations (10) (4)
Change in estimated fair value
Estimated fair value at ending balance 316 316
Estimated fair value at beginning balance 177 59 998
Change in estimated fair value 135 (59) (355)
Reclassification of private placement warrants (213) (545)
Estimated fair value at ending balance $ 99 $ 99
v3.24.4
Summary of Significant Accounting Policies (Details Narrative)
$ / shares in Units, € in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
May 25, 2022
EUR (€)
Debt Instrument [Line Items]            
Restricted cash and cash equivalents | $         $ 900  
Credit Losses | $ $ 4,300   $ 4,300      
Interest income | $ $ 7 $ 6 21 $ 19    
Investor [Member]            
Debt Instrument [Line Items]            
Non-interest bearing loan | $     $ 400      
Working Capital Warrants [Member]            
Debt Instrument [Line Items]            
Warrants issued (in shares) | shares     13,333      
Private Placement Warrant [Member]            
Debt Instrument [Line Items]            
Warrants issued (in shares) | shares     734,309      
Exercise price (in dollars per share) | $ / shares $ 345.00   $ 345.00      
Common Stock [Member] | Working Capital Warrants [Member]            
Debt Instrument [Line Items]            
Exercise price (in dollars per share) | $ / shares 345.00   345.00      
Common Stock [Member] | Private Placement Warrant [Member]            
Debt Instrument [Line Items]            
Exercise price (in dollars per share) | $ / shares 345.00   $ 345.00      
Derivative Financial Instruments, Liabilities [Member]            
Debt Instrument [Line Items]            
Warrants issued (in shares) | shares     131,343      
Derivative Financial Instruments, Liabilities [Member] | Common Stock [Member]            
Debt Instrument [Line Items]            
Exercise price (in dollars per share) | $ / shares $ 345.00   $ 345.00      
Convertible Bond Loan [Member]            
Debt Instrument [Line Items]            
Debt carrying amount | €           € 1,000
Debt offered amount | €           € 300
Annual interest rate           8.00%
Overdue interest rate           2.50%
v3.24.4
Related party disclosures (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]      
Due to related parties   $ 253
Vassilios Gregoriou [Member]      
Related Party Transaction [Line Items]      
Due to related parties   75
Maria Gregoriou [Member]      
Related Party Transaction [Line Items]      
Due to related parties   50
Emory S. De Castro [Member]      
Related Party Transaction [Line Items]      
Due to related parties $ 128  
v3.24.4
Related party disclosures (Details Narrative)
 9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
Interest rate 5.00%
v3.24.4
Accounts receivable, net (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Receivables [Abstract]    
Accounts receivable from third party customers $ 2,142 $ 348
Less: Allowance for credit losses (1,868) (285)
Accounts receivable, net $ 274 $ 63
v3.24.4
Inventories (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 4,967 $ 4,864
Work-in-process 228 90
Finished goods 264 259
Total 5,459 5,213
Provision for inventory (5,362) (5,018)
Total $ 97 $ 195
v3.24.4
Inventories (Details 1) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Inventory Disclosure [Abstract]        
Balance at beginning of year $ (5,175) $ (46) $ (5,018) $ (45)
Additions (11) (449) (250) (449)
Foreign exchange fluctuations (176) 2 (94) 1
Balance at end of year $ (5,362) $ (493) $ (5,362) $ (493)
v3.24.4
Prepaid expenses and other current assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Prepaid Expenses And Other Current Assets    
Prepaid insurance expenses $ 410 $ 155
Prepaid research expenses 13 36
Other prepaid expenses 125 27
Total $ 548 $ 218
v3.24.4
Prepaid expenses and other current assets (Details 1) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Prepaid Expenses And Other Current Assets    
VAT receivable $ 56 $ 267
Withholding tax
Grant receivable 185 181
Purchases under receipt 1
Guarantees
Other receivables 72 91
Accrued sublease income 80
Accrued interest income
Total $ 313 $ 620
v3.24.4
Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Sep. 30, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 24,332  
Accumulated Amortization (4,684)  
Cumulative Impairment on intangible assets (19,975)  
Net Carrying Amount 79  
Gross Carrying Amount 24,738 $ 237
Accumulated Amortization (4,684) (160)
Cumulative Impairment (19,569)
Net Carrying Amount 79 77
Indefinite-lived intangible assets 406  
Total indefinite-lived intangible assets, Cumulative Impairment (406)  
Ultra Cell LLC [Member] | Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 406  
Total indefinite-lived intangible assets, Cumulative Impairment (406)  
Computer Software, Intangible Asset [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 233 237
Accumulated Amortization (154) (160)
Cumulative Impairment on intangible assets  
Net Carrying Amount 79 $ 77
Cumulative Impairment  
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 21,221  
Accumulated Amortization (3,247)  
Net Carrying Amount  
Cumulative Impairment (17,974)  
In Process Research and Development [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,612  
Accumulated Amortization (1,017)  
Net Carrying Amount  
Cumulative Impairment (1,595)  
Order or Production Backlog [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 266  
Accumulated Amortization (266)  
Net Carrying Amount  
Cumulative Impairment  
v3.24.4
Intangible Assets (Details 1) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Change in Accounting Estimate [Line Items]    
Total   $ 79
Intangible Assets, Amortization Period [Member]    
Change in Accounting Estimate [Line Items]    
2024 $ 7  
2025 28  
2026 42  
2027  
2028  
Thereafter  
Total $ 77  
v3.24.4
Intangible Assets (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Impairment Effects on Earnings Per Share [Line Items]        
Amortization of intangible assets $ 1 $ 117 $ 3 $ 526
Finite-Lived Intangible Assets [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Amortization of intangible assets $ 0 $ 100 $ 2 $ 500
v3.24.4
Property, plant and equipment, net (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 9,101 $ 26,131
Less: accumulated depreciation (1,407) (3,661)
Less: cumulative impairment (2,384) (2,384)
Total 5,310 20,086
Land, Buildings and Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 1,014 12,632
Machinery [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 6,176 10,908
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 1,911 $ 2,591
v3.24.4
Property, plant and equipment, net (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
May 07, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Addition to property and equipment   $ 0 $ 5,100 $ 28 $ 9,000  
Proceeds from sale of property and equipment       900    
Loss on disposition of assets       12,700    
Plant and machinery description On May 7, 2024, the Company entered into an agreement to sell some of its coating machines (part of its property, plant and equipment) from the Hood Park facility for $0.9 million resulting in a loss of $2.5 million. On May 8, 2024, the Company received an initial deposit of $0.3 million and the remaining $0.6 million in July 2024. The remaining machinery and equipment from Hood Park were relocated and is planned for use at the Company’s other locations.          
Depreciation expense   200 $ 900 1,157 $ 1,596  
Hood Park [Member]            
Letter of credit   750   750    
Leasehold improvements   9,800   9,800   $ 10,400
Furniture forfeited   $ 500   $ 500   $ 500
v3.24.4
Other non-current assets (Details Narrative) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Other Assets, Noncurrent $ 239 $ 242
Suppliers [Member]    
Other Assets, Noncurrent $ 200 $ 200
v3.24.4
Trade and other payables (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Payables and Accruals [Abstract]        
Trade and other payables $ 16,420 $ 16,420   $ 3,996
Increase in trade and other payables $ 11,600 $ 12,117 $ (5,244)  
v3.24.4
Other current liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Other Current Liabilities    
Accrued expenses [1] $ 563 $ 653
Other short-term payables 802 44
Taxes and duties payable 299 255
Provision for unused vacation 4 4
Social security funds 108 70
Overtime provision 9 9
Total $ 1,785 $ 1,035
[1] Accrued expenses are analyzed as follows:
v3.24.4
Other current liabilities (Details 1) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Other Current Liabilities    
Accrued expenses for legal and consulting fees $ 243 $ 219
Accrued payroll fees 39 139
Other accrued expenses 281 295
Total $ 563 $ 653
v3.24.4
Leases (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Leases    
2024 $ 35  
2025 140  
2026 107  
2027 4  
2028  
Thereafter  
Total undiscounted lease payments 286  
Less: imputed interest (16)  
Total discounted lease payments 270  
Less: current portion (111) $ (2,138)
Long-term lease liabilities $ 159  
v3.24.4
Leases (Details Narrative)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Jan. 09, 2023
USD ($)
ft²
Mar. 08, 2021
USD ($)
ft²
Feb. 05, 2021
USD ($)
ft²
Area of leased space | ft²           6,041 21,401 6,041
Annual rent           $ 600 $ 1,500 $ 500
Lease contract term             8 years 6 months 5 years
Security deposit             $ 800  
Rent income $ 0 $ 100 $ 100 $ 100        
Term of option to extend lease             5 years  
Rental expense 0 300 4,700 1,700        
Short-term leases 0 $ 300 10 $ 400        
Right-of-use assets 279   279   $ 3,157      
Hood Park [Member]                
Long-Term Line of Credit 750   750          
Other Noncurrent Assets [Member]                
Security deposit $ 100   $ 100   $ 100      
v3.24.4
Private Placement Warrants and Working Capital Warrants (Details Narrative) - $ / shares
 9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Private Placement Warrant [Member]    
Class of Warrant or Right [Line Items]    
Warrants issued 734,309  
Warrants outstanding 65,671 65,671
Number of shares called by each warrant 1  
Exercise price $ 345.00  
Warrants expiration period 5 years  
Private Placement Warrant [Member] | IPO [Member]    
Class of Warrant or Right [Line Items]    
Warrants issued 131,343  
Working Capital Warrants [Member]    
Class of Warrant or Right [Line Items]    
Warrants issued 13,333  
Period to exercise warrants after business combination 30 days  
Period not to transfer, assign or sell warrants 30 days  
v3.24.4
Stockholders Equity (Details) - Share-Based Payment Arrangement, Option [Member]
 9 Months Ended
Sep. 30, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of options unvested at beginning | shares 57,894
Weighted average grant date fair value unvested at beginning | $ / shares $ 124.24
Number of options vested | shares (21,920)
Weighted average grant date fair value, vested | $ / shares $ 134.19
Number of options forfeited | shares (11,948)
Weighted average grant date fair value, forfeited | $ / shares $ 96.94
Number of options unvested at end | shares 24,026
Weighted average grant date fair value unvested at end | $ / shares $ 128.75
v3.24.4
Stockholders Equity (Details 1) - Restricted Stock Units (RSUs) [Member]
 9 Months Ended
Sep. 30, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares unvested at beginning | shares 67,894
Weighted average grant date fair value unvested at beginning | $ / shares $ 200.1
Number of shares vested | shares (29,503)
Weighted average grant date fair value vested | $ / shares $ 198.95
Number of shares forfeited | shares (14,275)
Weighted average grant date fair value forfeited | $ / shares $ 126.55
Number of shares unvested at end | shares 24,116
Weighted average grant date fair value unvested at end | $ / shares $ 244.63
v3.24.4
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
May 13, 2024
Apr. 29, 2024
Apr. 15, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2021
Sep. 30, 2024
Sep. 30, 2023
Mar. 28, 2024
Dec. 31, 2023
Class of Warrant or Right [Line Items]                    
Shares authorized       501,000,000     501,000,000      
Common stock, shares designated       500,000,000     500,000,000      
Common stock, par value       $ 0.0001     $ 0.0001     $ 0.0001
Preferred stock, shares authorized       1,000,000     1,000,000     1,000,000
Preferred stock, par value (in dollars per share)       $ 0.0001     $ 0.0001     $ 0.0001
Common stock, shares issued       2,636,508     2,636,508     2,580,159
Common stock, shares outstanding       2,636,508     2,636,508     2,580,159
Proceeds from exercise of warrants             $ 282 $ 5,488    
Share-Based Payment Arrangement, Option [Member]                    
Class of Warrant or Right [Line Items]                    
Compensation cost       $ 600 $ 800   2,000 2,500    
Unrecognized compensation cost       $ 1,400     $ 1,400      
Equity Incentive Plan 2021 [Member]                    
Class of Warrant or Right [Line Items]                    
Maximum number of shares of stock       569,273     569,273      
Equity Incentive Plan 2021 [Member] | Restricted Stock Units (RSUs) [Member]                    
Class of Warrant or Right [Line Items]                    
Compensation cost       $ 1,400 $ 1,600   $ 4,000 $ 4,900    
Unrecognized compensation cost       $ 2,500     $ 2,500      
Warrant [Member]                    
Class of Warrant or Right [Line Items]                    
Warrants outstanding (in shares)       735,069     735,069      
Exercise price of warrant (in dollars per share)       $ 345.00   $ 345.00 $ 345.00      
Increase in shares outstanding (in shares)           760        
Proceeds from exercise of warrants           $ 262,177        
Warrant holders exercised options to purchase additional shares (in shares)           760        
Warrant redemption price (in dollars per share)       0.01     $ 0.01      
Notice period to redeem warrants             30 days      
Share price (in dollars per share)       $ 540.00     $ 540.00      
Private Placement Warrants [Member]                    
Class of Warrant or Right [Line Items]                    
Warrants outstanding (in shares)       813,314     813,314      
Stockholders [Member]                    
Class of Warrant or Right [Line Items]                    
Reverse stock split   1-for-30                
Board [Member]                    
Class of Warrant or Right [Line Items]                    
Reverse stock split 1-for-30                  
H.C. Wainwright & Co., LLC [Member]                    
Class of Warrant or Right [Line Items]                    
Common stock, shares issued     31,373           24,976  
Proceeds from sale of common stock     $ 200              
v3.24.4
Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 128 $ 112 $ 3,520 $ 222
Transferred at Point in Time [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 128 112 3,520 222
Transferred over Time [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers
Sales of Goods [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 128 112 1,852
Service [Member]        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 1,668 $ 222
v3.24.4
Revenue (Details Narrative) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]    
Contract assets $ 0 $ 9
Contract liabilities 1,200 $ 400
Revenue recognized from contract liabilites $ 100  
v3.24.4
Collaborative Arrangements (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2020
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Research and development expenses   $ 411 $ 1,197 $ 2,521 $ 4,745
Cooperative Research and Development Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Estimated total contribution of project $ 1,200        
Contribution in cash 1,200        
Contribution in-kind, personnel salaries $ 600        
Collaborative Arrangement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Research and development expenses   $ 0 $ 200 $ 100 $ 1,500
v3.24.4
Income Taxes (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Tax Disclosure [Abstract]        
Income tax benefit $ 0 $ (81) $ (55) $ (204)
v3.24.4
Segment Reporting and Information about Geographical Areas (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net sales $ 128 $ 112 $ 3,520 $ 222
North America [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net sales 128 63 3,052 173
Europe [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net sales 49 468 49
Asia [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net sales
v3.24.4
Segment Reporting and Information about Geographical Areas (Details Narrative)
 9 Months Ended
Sep. 30, 2024
Integer
Segment Reporting [Abstract]  
Business segment 1
v3.24.4
Commitments and contingencies (Details)
ft² in Thousands, Integer in Thousands, $ in Thousands
Sep. 30, 2024
USD ($)
ft²
Integer
Commitments and Contingencies Disclosure [Abstract]  
Contractual Obligation Quantity Pieces Year One | Integer 57,600
Contractual Obligation, Quantity, Year One | ft² 6,174
Contractual Obligation, to be Paid, Year One | $ $ 2,304
Contractual Obligation, Quantity, Year Two | Integer
Contractual Obligation, Quantity, Year Two | ft² 8,000
Contractual Obligation, to be Paid, Year Two | $ $ 2,150
Contractual Obligation Quantity Pieces | Integer 57,600
Contractual Obligation, Quantity | ft² 14,174
Contractual Obligation | $ $ 4,454
v3.24.4
Commitments and contingencies (Details Narrative)
$ in Thousands
Sep. 30, 2024
USD ($)
Integer
Dec. 31, 2023
ft²
May 31, 2023
Integer
Commitments and Contingencies Disclosure [Abstract]      
Accrued interest expense $ 300    
Accrued loss liability 5,200    
Issued letters of guarantee $ 0    
Contractual obligation, minimum quantity | ft²   21,000  
Contractual obligation, minimum quantity, pieces | Integer 318,400   75,400
v3.24.4
Net loss per share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator:        
Net loss from continuing operations $ (9,615) $ (9,891) $ (29,244) $ (26,530)
Net loss from discontinued operations (8,907) (1,955) (9,907) (19,135)
Net loss $ (18,522) $ (11,846) $ (39,151) $ (45,665)
Denominator:        
Basic weighted average number of shares 2,636,508 2,012,382 2,618,601 1,843,154
Diluted weighted average number of shares 2,636,508 2,012,382 2,618,601 1,843,154
Net loss per share:        
Basic loss per share from continuing operations $ (3.65) $ (4.92) $ (11.17) $ (14.39)
Basic loss per share from discontinued operations (3.38) (0.97) (3.78) (10.38)
Basic loss per share (7.03) (5.89) (14.95) (24.78)
Diluted loss per share from continuing operations (3.65) (4.92) (11.17) (14.39)
Diluted loss per share from discontinued operations (3.38) (0.97) (3.78) (10.38)
Diluted loss per share $ (7.03) $ (5.89) $ (14.95) $ (24.78)
v3.24.4
Discontinued Operations (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Assets      
Cash and cash equivalents $ 192 $ 3,200 $ 3,661
Accounts receivable, net 274 63  
Contract assets 9  
Inventories, net 97 195  
Prepaid expenses and other current assets 861 838  
Property, plant and equipment, net 5,310 20,086  
Right-of-use assets 279 3,157  
Other non-current assets 239 242  
Total Assets 7,329 34,737  
Liabilities      
Trade payables 16,420 3,996  
Deferred income from grants, current 523  
Contract liabilities 1,230 414  
Other current liabilities 1,785 1,035  
Operating lease liabilities 111 2,138  
Other long-term liabilities 1 1  
Total Liabilities $ 25,403 21,289  
Discontinued Operations [Member]      
Assets      
Cash and cash equivalents   362  
Accounts receivable, net   128  
Contract assets   12  
Inventories, net   2,512  
Prepaid expenses and other current assets   1,416  
Property, plant and equipment, net   1,463  
Right-of-use assets   59  
Other non-current assets   66  
Total Assets   6,018  
Liabilities      
Trade payables   1,091  
Deferred income from grants, current   7  
Contract liabilities   1,601  
Other current liabilities   881  
Operating lease liabilities   48  
Lease liabilities – long-term   12  
Other long-term liabilities   683  
Total Liabilities   $ 4,323  
v3.24.4
Discontinued Operations (Details 1) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue, net $ 128 $ 112 $ 3,520 $ 222
Cost of revenues (336) (807) (896) (1,336)
Gross profit / (loss) (208) (695) 2,624 (1,114)
Income from grants 137 242 1,399 788
Research and development expenses (411) (1,197) (2,521) (4,745)
Administrative and selling expenses (3,135) (8,000) (6,954) (10,786)
Credit loss – customer contracts (4,309) (3) (4,309) (63)
Operating loss (7,927) (9,631) (9,619) (25,805)
Finance income / (expenses), net (14) (72) (300) (522)
Foreign exchange gains / (losses), net (1,672) (22) (1,837) 107
Other income / (expenses), net (2) (113) 4 (869)
Loss before income tax (9,615) (9,972) (29,299) (26,734)
Income taxes 0 81 55 204
Net loss (18,522) (11,846) (39,151) (45,665)
Discontinued Operations [Member]        
Revenue, net (135) 1,152 728 3,131
Cost of revenues (102) (1,649) (716) (4,509)
Gross profit / (loss) (237) (497) 12 (1,378)
Income from grants (541) 254 310 902
Research and development expenses (934) (3,410)
Administrative and selling expenses (2,067) (916) (4,167) (14,951)
Credit loss – customer contracts (67)
Operating loss (2,845) (2,026) (3,845) (18,837)
Finance income / (expenses), net 72 640
Foreign exchange gains / (losses), net 10 (1)
Other income / (expenses), net (11) (13)
Net assets / (liabilities) – Advent Technologies A/S and Advent Green Energy Philippines, Inc. (6,278) (6,278)
Payable to Advent Technologies A/S (12,340)   (12,340)
Loss before income tax (8,907) (1,954) (9,907) (18,211)
Income taxes 1 924
Net loss $ (8,907) $ (1,955) $ (9,907) $ (19,135)
v3.24.4
Subsequent Events (Details Narrative) - USD ($)
$ in Thousands
Nov. 08, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stockholders' equity   $ (18,074) $ (2,879) $ 13,448 $ 32,582 $ 40,059 $ 64,148
Purchase Agreement [Member] | Senior Note [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Note description Company terminated the Securities Purchase Agreement it had previously entered into on July 30, 2024 (the “SPA”) with an institutional investor (the “Investor”) pursuant to which, at the closing, the Company was contemplated to have issued to the Investor a senior promissory note in the principal amount of $1,000,000 (the “Senior Note”). The Investor had also committed to provide the Company with a one-year revolving line of credit to the Company for an aggregate maximum principal amount of $2,000,000, contingent upon the Company’s filing of a Registration Statement on Form S-1 with the SEC with respect to an underwritten or “best efforts” public offering by the Company of its common stock, and/or common stock equivalents registered under the Securities Act of 1933, as amended (the “Securities Act”) for proceeds to the Company of not less than $5,000,000.            
Advent Technologies (NASDAQ:ADNWW)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025 Advent Technologies 차트를 더 보려면 여기를 클릭.
Advent Technologies (NASDAQ:ADNWW)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025 Advent Technologies 차트를 더 보려면 여기를 클릭.